var title_f27_45_28368="Gingival overgrowth";
var content_f27_45_28368=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F54440&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F54440&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Gingival overgrowth",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 360px; height: 236px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Gingival overgrowth in a 14-year-old who is taking cyclosporin A following a liver transplant.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Delaney JE, Keels MA. Pediatric oral pathology. Soft tissue and periodontal conditions. Pediatr Clin North Am 2000; 47:1125. Copyright &copy; 2000, W.B. Saunders.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f27_45_28368=[""].join("\n");
var outline_f27_45_28368=null;
var title_f27_45_28369="Distal femoral fracture findings in a child";
var content_f27_45_28369=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F83181&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F83181&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 486px\">",
"   <div class=\"ttl\">",
"    Clinical findings of a distal femoral fracture in a child",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 466px; height: 348px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This six year old girl has physical findings of a distal femoral fracture after a motor vehicle collision including swelling and anterior displacement of the distal femur (red arrow) and ecchymosis of the popliteal fossa (white arrow). Physical examination also revealed absent peroneal nerve function and a cold, pulseless foot.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Price CT, Herrera-Soto J. Extra-articular injuries of the knee. In: Rockwood and Wilkins' Fractures in Children, 7th edition, Beaty JH, Kasser JR. (Eds), Lippincott Williams &amp; Wilkins, Philadelphia 2010. Copyright &copy; 2010 Lippincott Williams &amp; Wilkins.",
"    </div>",
"    <div class=\"contractual\">",
"     <br/>",
"     <a href=\"file://www.lww.com\">",
"      file://www.lww.com",
"     </a>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f27_45_28369=[""].join("\n");
var outline_f27_45_28369=null;
var title_f27_45_28370="Calculator: Serum osmolal gap";
var content_f27_45_28370=[" <div id=\"topicText\">",
"  <div id=\"mc3k\">",
"   <form action=\"\" id=\"OsmolalGap_form\" name=\"OsmolalGap_form\" onkeydown=\"clrResults();\" onkeyup=\"OsmolalGap_fx();\" onsubmit=\"return false;\">",
"    <table cellpadding=\"4\" cellspacing=\"0\" summary=\"MedCalc 3000 Table\" width=\"100%\">",
"     <tr>",
"      <td bgcolor=\"#eeeeee\" width=\"1%\">",
"       <br/>",
"      </td>",
"      <td align=\"left\" bgcolor=\"#eeeeee\">",
"       <span class=\"medCalcFontTitleBox\">",
"        Calculator: Serum osmolal gap",
"       </span>",
"      </td>",
"     </tr>",
"    </table>",
"    <br/>",
"    &nbsp;",
"    <br/>",
"    <center>",
"     <div id=\"calc_equation\">",
"      <table cellpadding=\"10\" cellspacing=\"0\" summary=\"MedCalc 3000 Table\">",
"       <tr>",
"        <td align=\"left\" bgcolor=\"#6c9a9c\">",
"         <span class=\"medCalcFontFormuli\">",
"          CalculatedOsm = (SerumNa * 2) + (SerumGlucose / 18) + (SerumBUN / 2.8) + (SerumEthanol / 3.7)",
"         </span>",
"        </td>",
"       </tr>",
"       <tr>",
"        <td align=\"left\" bgcolor=\"#6c9a9c\">",
"         <span class=\"medCalcFontFormuli\">",
"          OsmolalGap = MeasuredOsm - CalculatedOsm",
"         </span>",
"        </td>",
"       </tr>",
"      </table>",
"      <br/>",
"      &nbsp;",
"      <br/>",
"     </div>",
"    </center>",
"    <div id=\"calc_main\">",
"     <center>",
"      <table cellpadding=\"6\" cellspacing=\"0\" summary=\"MedCalc 3000 Table\" width=\"95%\">",
"       <tr>",
"        <td align=\"right\" width=\"50%\">",
"         <center>",
"          <span class=\"medCalcFontIO\">",
"           Input:",
"          </span>",
"          <br/>",
"          &nbsp;",
"          <br/>",
"          <table cellpadding=\"3\" cellspacing=\"0\" summary=\"MedCalc 3000 Table\">",
"           <tr>",
"            <td align=\"right\" width=\"42%\">",
"             <span class=\"medCalcFontOneBold\">",
"              Serum Na",
"             </span>",
"            </td>",
"            <td align=\"left\" nowrap=\"nowrap\" valign=\"top\" width=\"5%\">",
"             &nbsp;",
"             <input name=\"Serum_Na_param\" onblur=\"OsmolalGap_fx(); minMaxCheck();\" onchange=\"OsmolalGap_fx();\" size=\"6\" type=\"text\" value=\"\"/>",
"            </td>",
"            <td align=\"left\" valign=\"top\" width=\"115\">",
"             <select class=\"medCalcFontSelect\" name=\"Serum_Na_unit\" onchange=\"OsmolalGap_fx();\" style=\"width:105px;\">",
"              <option selected=\"selected\" value=\"1|0|mEq/L\">",
"               mEq/L",
"              </option>",
"             </select>",
"            </td>",
"           </tr>",
"           <tr>",
"            <td align=\"right\" width=\"42%\">",
"             <span class=\"medCalcFontOneBold\">",
"              Serum Glucose",
"             </span>",
"            </td>",
"            <td align=\"left\" nowrap=\"nowrap\" valign=\"top\" width=\"5%\">",
"             &nbsp;",
"             <input name=\"Serum_Glucose_param\" onblur=\"OsmolalGap_fx(); minMaxCheck();\" onchange=\"OsmolalGap_fx();\" size=\"6\" type=\"text\" value=\"\"/>",
"            </td>",
"            <td align=\"left\" valign=\"top\" width=\"115\">",
"             <select class=\"medCalcFontSelect\" name=\"Serum_Glucose_unit\" onchange=\"OsmolalGap_fx();\" style=\"width:105px;\">",
"              <option value=\"100|0|gm/L\">",
"               gm/L",
"              </option>",
"              <option value=\"1000|0|gm/dL\">",
"               gm/dL",
"              </option>",
"              <option value=\"0.001|0|mcg/dL\">",
"               mcg/dL",
"              </option>",
"              <option value=\"0.1|0|mcg/mL\">",
"               mcg/mL",
"              </option>",
"              <option value=\"1|0|mg%\">",
"               mg%",
"              </option>",
"              <option selected=\"selected\" value=\"1|0|mg/dL\">",
"               mg/dL",
"              </option>",
"              <option value=\"100|0|mg/mL\">",
"               mg/mL",
"              </option>",
"              <option value=\"0.0001|0|ng/mL\">",
"               ng/mL",
"              </option>",
"             </select>",
"            </td>",
"           </tr>",
"           <tr>",
"            <td align=\"right\" width=\"42%\">",
"             <span class=\"medCalcFontOneBold\">",
"              Serum BUN",
"             </span>",
"            </td>",
"            <td align=\"left\" nowrap=\"nowrap\" valign=\"top\" width=\"5%\">",
"             &nbsp;",
"             <input name=\"Serum_BUN_param\" onblur=\"OsmolalGap_fx(); minMaxCheck();\" onchange=\"OsmolalGap_fx();\" size=\"6\" type=\"text\" value=\"\"/>",
"            </td>",
"            <td align=\"left\" valign=\"top\" width=\"115\">",
"             <select class=\"medCalcFontSelect\" name=\"Serum_BUN_unit\" onchange=\"OsmolalGap_fx();\" style=\"width:105px;\">",
"              <option value=\"100|0|gm/L\">",
"               gm/L",
"              </option>",
"              <option value=\"1000|0|gm/dL\">",
"               gm/dL",
"              </option>",
"              <option value=\"0.001|0|mcg/dL\">",
"               mcg/dL",
"              </option>",
"              <option value=\"0.1|0|mcg/mL\">",
"               mcg/mL",
"              </option>",
"              <option value=\"1|0|mg%\">",
"               mg%",
"              </option>",
"              <option selected=\"selected\" value=\"1|0|mg/dL\">",
"               mg/dL",
"              </option>",
"              <option value=\"100|0|mg/mL\">",
"               mg/mL",
"              </option>",
"              <option value=\"0.0001|0|ng/mL\">",
"               ng/mL",
"              </option>",
"             </select>",
"            </td>",
"           </tr>",
"           <tr>",
"            <td align=\"right\" width=\"42%\">",
"             <span class=\"medCalcFontOneBold\">",
"              Serum Ethanol",
"             </span>",
"            </td>",
"            <td align=\"left\" nowrap=\"nowrap\" valign=\"top\" width=\"5%\">",
"             &nbsp;",
"             <input name=\"Serum_Ethanol_param\" onblur=\"OsmolalGap_fx(); minMaxCheck();\" onchange=\"OsmolalGap_fx();\" size=\"6\" type=\"text\" value=\"\"/>",
"            </td>",
"            <td align=\"left\" valign=\"top\" width=\"115\">",
"             <select class=\"medCalcFontSelect\" name=\"Serum_Ethanol_unit\" onchange=\"OsmolalGap_fx();\" style=\"width:105px;\">",
"              <option value=\"100|0|gm/L\">",
"               gm/L",
"              </option>",
"              <option value=\"1000|0|gm/dL\">",
"               gm/dL",
"              </option>",
"              <option value=\"0.001|0|mcg/dL\">",
"               mcg/dL",
"              </option>",
"              <option value=\"0.1|0|mcg/mL\">",
"               mcg/mL",
"              </option>",
"              <option value=\"1|0|mg%\">",
"               mg%",
"              </option>",
"              <option selected=\"selected\" value=\"1|0|mg/dL\">",
"               mg/dL",
"              </option>",
"              <option value=\"100|0|mg/mL\">",
"               mg/mL",
"              </option>",
"              <option value=\"0.0001|0|ng/mL\">",
"               ng/mL",
"              </option>",
"             </select>",
"            </td>",
"           </tr>",
"           <tr>",
"            <td align=\"right\" width=\"42%\">",
"             <span class=\"medCalcFontOneBold\">",
"              Measured Osm",
"             </span>",
"            </td>",
"            <td align=\"left\" nowrap=\"nowrap\" valign=\"top\" width=\"5%\">",
"             &nbsp;",
"             <input name=\"Measured_Osm_param\" onblur=\"OsmolalGap_fx(); minMaxCheck();\" onchange=\"OsmolalGap_fx();\" size=\"6\" type=\"text\" value=\"\"/>",
"            </td>",
"            <td align=\"left\" valign=\"top\" width=\"115\">",
"             <select class=\"medCalcFontSelect\" name=\"Measured_Osm_unit\" onchange=\"OsmolalGap_fx();\" style=\"width:105px;\">",
"              <option value=\"10|0|mOsm/dL\">",
"               mOsm/dL",
"              </option>",
"              <option selected=\"selected\" value=\"1|0|mOsm/kg\">",
"               mOsm/kg",
"              </option>",
"             </select>",
"            </td>",
"           </tr>",
"          </table>",
"         </center>",
"        </td>",
"        <td align=\"left\" bgcolor=\"#eeeeee\">",
"         <center>",
"          <span class=\"medCalcFontIO\">",
"           Results:",
"          </span>",
"          <br/>",
"          &nbsp;",
"          <br/>",
"          <table bgcolor=\"#eeeeee\" cellspacing=\"4\" summary=\"MedCalc 3000 Table\">",
"           <tr>",
"            <td align=\"right\">",
"             <span class=\"medCalcFontOneBold\">",
"              Calculated Osm",
"             </span>",
"            </td>",
"            <td nowrap=\"nowrap\" valign=\"top\">",
"             &nbsp;",
"             <input name=\"Calculated_Osm_param\" onfocus=\"blur();\" size=\"6\" type=\"text\"/>",
"            </td>",
"            <td valign=\"top\">",
"             <span class=\"medCalcFontOne\">",
"              <select class=\"medCalcFontSelect\" name=\"Calculated_Osm_unit\" onchange=\"OsmolalGap_fx();\" style=\"width:105px;\">",
"               <option value=\"10|0|mOsm/dL\">",
"                mOsm/dL",
"               </option>",
"               <option selected=\"selected\" value=\"1|0|mOsm/kg\">",
"                mOsm/kg",
"               </option>",
"              </select>",
"             </span>",
"            </td>",
"           </tr>",
"           <tr>",
"            <td align=\"right\">",
"             <span class=\"medCalcFontOneBold\">",
"              Osmolal Gap",
"             </span>",
"            </td>",
"            <td nowrap=\"nowrap\" valign=\"top\">",
"             &nbsp;",
"             <input name=\"Osmolal_Gap_param\" onfocus=\"blur();\" size=\"6\" type=\"text\"/>",
"            </td>",
"            <td valign=\"top\">",
"             <span class=\"medCalcFontOne\">",
"              <select class=\"medCalcFontSelect\" name=\"Osmolal_Gap_unit\" onchange=\"OsmolalGap_fx();\" style=\"width:105px;\">",
"               <option value=\"10|0|mOsm/dL\">",
"                mOsm/dL",
"               </option>",
"               <option selected=\"selected\" value=\"1|0|mOsm/kg\">",
"                mOsm/kg",
"               </option>",
"              </select>",
"             </span>",
"            </td>",
"           </tr>",
"           <tr>",
"            <td colspan=\"3\">",
"             &nbsp;",
"             <br/>",
"            </td>",
"           </tr>",
"           <tr>",
"            <td align=\"center\" colspan=\"3\">",
"             <span class=\"medCalcFontOneBold\">",
"              Decimal Precision:",
"             </span>",
"             <select class=\"medCalcFontSelect\" name=\"decpts\" onchange=\"OsmolalGap_fx();\">",
"              <option>",
"               0",
"              </option>",
"              <option>",
"               1",
"              </option>",
"              <option selected=\"selected\">",
"               2",
"              </option>",
"              <option>",
"               3",
"              </option>",
"             </select>",
"            </td>",
"           </tr>",
"          </table>",
"         </center>",
"         <br/>",
"         &nbsp;",
"         <br/>",
"         <center>",
"          <span class=\"medCalcFontOne\">",
"           <input name=\"reset\" type=\"reset\" value=\"Reset form\"/>",
"          </span>",
"         </center>",
"        </td>",
"       </tr>",
"      </table>",
"     </center>",
"    </div>",
"    <br/>",
"    &nbsp;",
"    <br/>",
"    <div id=\"calc_hints\">",
"     <span class=\"medCalcFontOne\">",
"      The plasma osmolality is determined by the concentration of the different solutes in the plasma.",
"In normal subjects, sodium salts (chloride and bicarbonate), glucose, and urea are the primary",
"circulating solutes. The calculated plasma osmolality normally is between",
"270 and 290 mOsm/kg H2O and the",
"      <b>",
"       Osmolal Gap",
"      </b>",
"      is normally &lt;10 mOsm/kg H2O. You can calculate the",
"      <b>",
"       Osmolal Gap",
"      </b>",
"      from the formulas depicted.",
"     </span>",
"    </div>",
"    <br/>",
"    &nbsp;",
"    <br/>",
"    <div id=\"calc_refs\">",
"     <span class=\"medCalcFontRef\">",
"      <b>",
"       References",
"      </b>",
"     </span>",
"     <ol>",
"      <li>",
"       <span class=\"medCalcFontRef\">",
"        Bhagat CI, Garcia-Webb P, Fletcher E, et. al. Calculated vs measured plasma osmolalities revisited.",
"        <i>",
"         Clin Chem",
"        </i>",
"        . 1984 Oct;30(10):1703-5.",
"       </span>",
"      </li>",
"      <li>",
"       <span class=\"medCalcFontRef\">",
"        Purssell RA, Pudek M, Brubacher J, et. al. Derivation and validation of a formula to calculate the  contribution of ethanol to the osmolal gap.",
"        <i>",
"         Ann Emerg Med",
"        </i>",
"        . 2001; 38:653.",
"       </span>",
"      </li>",
"     </ol>",
"    </div>",
"   </form>",
"  </div>",
" </div>",
" <div id=\"topicAgreement\">",
"  Use of UpToDate is subject to the",
"  <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"   Subscription and License Agreement",
"  </a>",
"  .",
" </div>",
" <div id=\"printDisclaimer\">",
"  Information on this page may not appear correctly if printed.",
" </div>",
" <div id=\"disclaimerCalculator\">",
"  <div class=\"medCalcFontTwo\">",
"   <p class=\"header\">",
"    Legal Notices and Disclaimer",
"   </p>",
"   <p>",
"    All information contained in and produced by the MedCalc 3000 system is provided",
"			for educational purposes only. This information should not be used for the diagnosis or treatment",
"			of any health problem or disease.",
"    <b>",
"     THIS INFORMATION IS NOT INTENDED TO REPLACE CLINICAL JUDGMENT OR",
"			GUIDE INDIVIDUAL PATIENT CARE IN ANY MANNER.",
"    </b>",
"    <a class=\"medCalcDisclaimerLink\" href=\"./med-calc-disclaimer\">",
"     Click here for",
"				full notice and disclaimer.",
"    </a>",
"   </p>",
"   <p class=\"copy\">",
"    MedCalc 3000 is Copyright &copy; 1998-2013 Foundation Internet Services",
"   </p>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f27_45_28370=[" ",
"",
"",
"function log(i){",
"return Math.log(i) * Math.LOG10E;   ",
"}",
"",
"function ln(i){",
"return Math.log(i);",
"}",
"",
"function sq(i){",
"return i * i;",
"}",
"",
"function sqr(i){",
"return Math.sqrt(i);",
"}",
"",
"",
"function power(x,y){",
"return Math.pow(x,y);",
"}",
"",
"function eTo(x){",
"return Math.exp(x);",
"}",
"",
"",
"function fixDP(r, dps) {",
"if (isNaN(r)) return \"NaN\";",
"var msign = '';",
"if (r < 0) msign = '-';",
"x = Math.abs(r);",
"if (x > Math.pow(10, 21)) return msign + x.toString();",
"var m = Math.round(x * Math.pow(10, dps)).toString();",
"if (dps == 0) return msign + m;",
"while (m.length <= dps) m = \"0\" + m;",
"return msign + m.substring(0, m.length - dps) + \".\" + m.substring(m.length - dps);",
"}",
"",
"var currenttimeout;",
"",
"",
"var calctxt = ''; ",
"var xmltxt = ''; ",
"var htmtxt = ''; ",
"",
"",
"",
"function OsmolalGap_fx() {",
"",
"currenttimeout = self.setTimeout('minMaxCheck();', 3000);",
"",
"with(document.OsmolalGap_form){",
"",
"",
"doCalc = true;",
"if (Serum_Na_param.value.indexOf(',') >= 0){ Serum_Na_param.value = ''; doCalc = false; alert('Comma character not allowed'); }",
"param_value = parseFloat(Serum_Na_param.value);",
"if (isNaN(param_value)){param_value = \"\"; doCalc = false;}",
"unit_parts = Serum_Na_unit.options[Serum_Na_unit.selectedIndex].value.split('|');",
"Serum_Na = param_value * parseFloat(unit_parts[0]) + parseFloat(unit_parts[1]);",
"if (Serum_Glucose_param.value.indexOf(',') >= 0){ Serum_Glucose_param.value = ''; doCalc = false; alert('Comma character not allowed'); }",
"param_value = parseFloat(Serum_Glucose_param.value);",
"if (isNaN(param_value)){param_value = \"\"; doCalc = false;}",
"unit_parts = Serum_Glucose_unit.options[Serum_Glucose_unit.selectedIndex].value.split('|');",
"Serum_Glucose = param_value * parseFloat(unit_parts[0]) + parseFloat(unit_parts[1]);",
"if (Serum_BUN_param.value.indexOf(',') >= 0){ Serum_BUN_param.value = ''; doCalc = false; alert('Comma character not allowed'); }",
"param_value = parseFloat(Serum_BUN_param.value);",
"if (isNaN(param_value)){param_value = \"\"; doCalc = false;}",
"unit_parts = Serum_BUN_unit.options[Serum_BUN_unit.selectedIndex].value.split('|');",
"Serum_BUN = param_value * parseFloat(unit_parts[0]) + parseFloat(unit_parts[1]);",
"if (Serum_Ethanol_param.value.indexOf(',') >= 0){ Serum_Ethanol_param.value = ''; doCalc = false; alert('Comma character not allowed'); }",
"param_value = parseFloat(Serum_Ethanol_param.value);",
"if (isNaN(param_value)){param_value = \"\"; doCalc = false;}",
"unit_parts = Serum_Ethanol_unit.options[Serum_Ethanol_unit.selectedIndex].value.split('|');",
"Serum_Ethanol = param_value * parseFloat(unit_parts[0]) + parseFloat(unit_parts[1]);",
"if (Measured_Osm_param.value.indexOf(',') >= 0){ Measured_Osm_param.value = ''; doCalc = false; alert('Comma character not allowed'); }",
"param_value = parseFloat(Measured_Osm_param.value);",
"if (isNaN(param_value)){param_value = \"\"; doCalc = false;}",
"unit_parts = Measured_Osm_unit.options[Measured_Osm_unit.selectedIndex].value.split('|');",
"Measured_Osm = param_value * parseFloat(unit_parts[0]) + parseFloat(unit_parts[1]);",
"dp = decpts.options[decpts.selectedIndex].text;",
"Calculated_Osm =  (Serum_Na * 2) + (Serum_Glucose / 18) + (Serum_BUN / 2.8) + (Serum_Ethanol / 3.7);",
"",
"unit_parts = Calculated_Osm_unit.options[Calculated_Osm_unit.selectedIndex].value.split('|');",
"if (doCalc) Calculated_Osm_param.value = fixDP((Calculated_Osm - parseFloat(unit_parts[1])) / parseFloat(unit_parts[0]), dp);",
"",
"",
"",
"Osmolal_Gap =  Measured_Osm - Calculated_Osm;",
"",
"unit_parts = Osmolal_Gap_unit.options[Osmolal_Gap_unit.selectedIndex].value.split('|');",
"if (doCalc) Osmolal_Gap_param.value = fixDP((Osmolal_Gap - parseFloat(unit_parts[1])) / parseFloat(unit_parts[0]), dp);",
"",
"",
"",
"",
"",
"}",
"",
"}",
"",
"function minMaxCheck(){",
"",
"if (currenttimeout) self.clearTimeout(currenttimeout);",
"",
"with(document.OsmolalGap_form){",
"",
"if (Serum_Na_param.value && Serum_Na < 50) {",
"Serum_Na = 0;",
"Serum_Na_param.value = \"\";",
"clrResults();",
"doCalc = false;",
"alert(\"The minimum value for Serum Na is 50 mEq/L.\\nIf you are specifying a value with a different unit,\\nchange the unit selector first.\");",
"}",
"if (Serum_Na_param.value && Serum_Na > 200) {",
"Serum_Na_param.value = \"\";",
"clrResults();",
"Serum_Na = 0;",
"doCalc = false;",
"alert(\"The maximum value for Serum Na is 200 mEq/L.\\nIf you are specifying a value with a different unit,\\nchange the unit selector first.\");",
"}",
"if (Serum_Glucose_param.value && Serum_Glucose < 0) {",
"Serum_Glucose = 0;",
"Serum_Glucose_param.value = \"\";",
"clrResults();",
"doCalc = false;",
"alert(\"The minimum value for Serum Glucose is 0 mg/dL.\\nIf you are specifying a value with a different unit,\\nchange the unit selector first.\");",
"}",
"if (Serum_Glucose_param.value && Serum_Glucose > 1500) {",
"Serum_Glucose_param.value = \"\";",
"clrResults();",
"Serum_Glucose = 0;",
"doCalc = false;",
"alert(\"The maximum value for Serum Glucose is 1500 mg/dL.\\nIf you are specifying a value with a different unit,\\nchange the unit selector first.\");",
"}",
"if (Serum_BUN_param.value && Serum_BUN < 0) {",
"Serum_BUN = 0;",
"Serum_BUN_param.value = \"\";",
"clrResults();",
"doCalc = false;",
"alert(\"The minimum value for Serum BUN is 0 mg/dL.\\nIf you are specifying a value with a different unit,\\nchange the unit selector first.\");",
"}",
"if (Serum_BUN_param.value && Serum_BUN > 150) {",
"Serum_BUN_param.value = \"\";",
"clrResults();",
"Serum_BUN = 0;",
"doCalc = false;",
"alert(\"The maximum value for Serum BUN is 150 mg/dL.\\nIf you are specifying a value with a different unit,\\nchange the unit selector first.\");",
"}",
"if (Serum_Ethanol_param.value && Serum_Ethanol < 0) {",
"Serum_Ethanol = 0;",
"Serum_Ethanol_param.value = \"\";",
"clrResults();",
"doCalc = false;",
"alert(\"The minimum value for Serum Ethanol is 0 mg/dL.\\nIf you are specifying a value with a different unit,\\nchange the unit selector first.\");",
"}",
"if (Serum_Ethanol_param.value && Serum_Ethanol > 2000) {",
"Serum_Ethanol_param.value = \"\";",
"clrResults();",
"Serum_Ethanol = 0;",
"doCalc = false;",
"alert(\"The maximum value for Serum Ethanol is 2000 mg/dL.\\nIf you are specifying a value with a different unit,\\nchange the unit selector first.\");",
"}",
"",
"",
"}",
"",
"}",
"",
"",
"function clrResults(){",
"",
"if (currenttimeout) self.clearTimeout(currenttimeout);",
"",
"with(document.OsmolalGap_form){",
"",
"Calculated_Osm_param.value = '';",
"Osmolal_Gap_param.value = '';",
"",
"",
"}",
"",
"}",
"",
"",
"",
"",
"",
"",
"",
"",
"",
"",
"",
""].join("\n");
var outline_f27_45_28370=null;
var title_f27_45_28371="Height measurement technique";
var content_f27_45_28371=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F56127&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F56127&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Height measurement technique",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 421px; height: 441px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The child's shoes and any hats or hair ornaments are removed. The child faces away from the wall with the heels together and the back as straight as possible. The head, shoulders, buttocks, and heels should be in contact with the vertical surface. With the child looking straight ahead, the head projection is placed at the crown of the head. The child steps away from the wall, and the height measurement is recorded to the nearest 0.1 cm.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f27_45_28371=[""].join("\n");
var outline_f27_45_28371=null;
var title_f27_45_28372="Flame cell myeloma";
var content_f27_45_28372=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=HEME%2F72153&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=HEME%2F72153&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Flame cell in multiple myeloma",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 401px; height: 288px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    High power view of a bone marrow aspirate from a patient with multiple myeloma of the IgA type. Multiple abnormal plasma cells can be seen in this view, including a binucleate form (small arrows). The large cell on the right has an abnormal nucleus and a cytoplasm with a reddish (flame-like) tint, due to the presence of IgA protein (arrow).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of David S Rosenthal, MD and William C. Moloney, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f27_45_28372=[""].join("\n");
var outline_f27_45_28372=null;
var title_f27_45_28373="Mucinous neoplasm panc Gross II";
var content_f27_45_28373=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F66804&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F66804&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Pancreatic mucinous cystadenoma",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 333px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAFNAfgDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwDwWwhW2tY0U5JAc/U1YJzTIBm2hOOSin9KfivvKUVGnFR2seLJ3bY2ilpKGrCFzRSfTrSimmAGkpe1JSkA00nan0hFA7gOnrQe9HPagZxSAM0ZyaMkNkcHtTcUwsPBxzRTcZNKBSAUnNB6UmOBzk96UEBTu+92oCw3Heg84ozSMQBUuSKSYZ4xSjkiprK0mvbhYbaMyytwAOB+J7Cu4Hgi20+8SG6vBeXUMix3VvEp2RkjJ+dck4/WuHE5hQw7/ePXsduFy6tidaa0OAP15prZr02O10aWZLTTrSAzSHDHYxyvc896zvFWh6Xp9vFFHlriddyqqY24bBzjP8682fEFFO3Kz0Y5DVa3RwHIPSk3EnAHNdBZadbXUbW7QEXan5ChPzVhXY+yXUsEgO9GKnPb61eHzmnWbTVmYYnKqlBKV7ojYFDkjFOVgOMA5prSkrtJwB09qjL9PWvQVXa55zgWHlLRlNqgdeBUGecelML+hpC2evWr5lcXKx5PpSdaTdRnjI6GmpIaTQ7+KjPNNzzTuopiaCg0mccU6gBVp44GKjFOHPFWtiWPzzUqngZqA8U03MSkAuSfQDNN1FDWTDlctkWc9OKd2qg1+ASAmV9ScUhv27KorGWPoLeRSw1R9DRoNUF1DPWMfgamjuEkzglfrV08XRqfDImVCcd0WMntzSE5pvQfWgmujmM7CmikzS007gA60+mUA4NMQ7vS01etOpAFFGM9KKAClpKUdKcdxBRRRVgFL1oFKoFAgFO7U0jFL1BrQQEZBHBB4NFGKKTSe4XsMj/1UYDHGxf5Up+tIpBhjI/uL/IU45HQ8VEPhRUtxtJTjnvSUmrgHeijvRRawBQaKKYCUhzmnGkqGgENLu+UDgUmRTTSGL1pKTNBzz7VN0h2Fzg0Enim0o4NK7GDEdqaOxpwGTXR+GvBura/5b2lv5Vs+7ZdTZWJivBAPJJzxwOufSsqlWMdW7GkKcpu0Uc2Bk1Ys7aa6nSG2iaWVuirya9Nsfg5qUupwQXOrabDbOWJdXJl2gAkhSMZ54BbtXcavoWkeC9BgEEP71cAF1HmzZyOOOp6mvIxea0qcOam7s9TC5ZOpO09Ct8N9Os9G8H28upSSWsKGR7x2XIklGW2oQOSFCj2AY10EMF5qFlFNZWrQRSuzxsPlAQj5OP72Ovp0qz8M9/iWwe/urYGOO5eK1jkTCwoECuV/vbiSCT6V6dJbwBVQMinPA9TXys4zrSdV7s+ijWjhrU0tjxG38HSHVTPdtILqMbvkwGVWPJ/HFaNxoe4SMB5nmL/AB8e1ekLpTNf3MjM2ZQBg/wgDoPxyfxqte6asS4wGIHXHFZLDtx1N3jU3oeMtothb3C/ZrZPtAXZJJj35+lct8SfCi3WoQ6hYFJnMSpco+UXOOufbOM9OnrXrmvWMOnXnmXO5kuMnGBhW4zjpjpn8TWJFDbah9qikXEcylQC2AQeoz2PcfStqScVyxMaqVVtyPAR4Vv8PtEe1emJQw+mRWVf6dd2aiS4t5Y4mcxrIy/KzDsDXtYtFgmlglOyRDhd4wAfXHpjBzU9v4dt9Q0l5dYhW5haUtEMfM+OpI/EgH0NetRxVSCSeqPIrYOm27aM8BOQeaUfWvStY+H9tPG91pd0tlGwyI7knaDkjaMAsemelcHrWiXmktmbyZYScCaCUSIfy5U+zAGvSpYunPS+p59TCVKerWhn7vanBwO1VyTS7q6Pavoc/KWPMGaUOOlVi3FOV+eatV31JcCfcPpRuGBzUJOfpT0Uk8dKr2tldgqd3ZEoYDqajmuNoOwZ96esZb5R6ZJ7Co2jweMH37V5tfNJfDS+87qWCVrzKp3yNl2OPelck4HQVN5Y6saesaMfvgY9a8qVVt3bO2NCyKeOeaUenTFWTb89Rz6GgWzZwASfpUc6L9k+xXK4PWpE3Yzg4qRrZxzg4qfyWt3KTLtYAHb9QCP0Io57aoFSb0ZGkpTHaraTb8DH1qnOildw3cdsUqTrC4JUkHgAV1YfG1KT91mdXDU5q0kaBHAPagGooZTIhdUYRZ25PrzwPyNPHtX0OFx8K+j0Z4+IwcqWsdUOyKM5pOM0tehzM47C5pwYUzvRRzMViQmjNM+tAqlrqKw+lFN/HFKKd7CFooHJwOppXUo7I3DKSCM96u4CU4dMZpM0DigTHDg80tJ168ilzViExRSmimBHEVEMQ5J2L/KpGJ6dcdKjt1/cRkjB2D+VSc1nT+FDluNOcc02nkHuabjgnNNoLiUUoxzmkxycdBSGHeilOKSgAPSmE04+lMPHWs5DQfhSGnKR0A+Y9DSMOT2qG7oYmOKQk5zS84ppPNQ3ZDFpR7009eafxg4600xpADjJx05r6Q8OpFpXhDQ7FLvzLq0twQ8ihEO4tIMZ6gqwwfTr3r5wQY68cZz6V9I/Dbwe/wDwrPTF1uCQXcssl1ZxzRh/IRsBflbgZG58dMN0zXj5rJRpp+Z6mXx5p27mxJpeo6loU8+oMljdvh7OONz5kXXAbHckqcLnjg1j3tjqOv6/YaTdXUkoVWimkjQDyIgvMx9GJwq/UV0OteIBpOlyw38vn3SREb2jC447Yrl/hLNcXGq6ne3DbpbldqkltywkRuO+MZ4HGfevk5RTlZa9z6qKdODf3Hr3hGysrTT49PskCLaBot3c7QMk+5JyT65rXnlihiRmwDuP/wCuubtJRYyQlVkYvK6TSfwqrHgAe2AM1f1qdl0pVjdxtmWRghyXX0PHT/CtY1OWLXY4J03Ka8ywsyi45Ynd1BPIp1w0Z3DKs3ZfSsy0uY5BGY54ZyuSSmc4zx19q2INjW8rjYpUcnHP51dOalHR6ETjyMwNatIbiIwyRq4OSNwziuOn0ZNOtvMhRHhik88s5KyDj7mc7dnuRnPevRp7USqzyKq5HC55/OsXUV3NKAu0MrKV7EYxUxTV/M3jNNW7HifjLUIj4mi8lGjZbOLzCGyJDlsN+Qwabq2q3Fq8VjaglRbIGL9FZwHOB68/pWx4y8OP9otrqwthNJCT5gLgZjPOOfvYboOwb0rmIdfsJ0inEiNKeW46nPr24rWL953ZjX01KXl3Wuau0cM7xOhzsAJXjsB+FVtchlsdMklvbG1u/mMUodDGwBx8wyeR0APrnimP4kg0/W/t9vfRNKG+6gwT2+lXvFurWHiuS0iuHRIraELsljG5iTnIbjBGT9eKHKMdtwhPmi0zyO8gRHYxMChPygnOPaqm017pH4R0K90+OOw04BQg3Xdw20BQec85J57UmsfDnw5Y6Nb3CJfXs9yWXzbX5IoSFyR85yQMjnHNdkMcqek9jilgZzd4nhYNFaWtaVPpVyY5QSh5SQDAYVm16VOanHmRwTg4PlY+NGZwFGSa1EtwiAYPPWrPhzTnugXSPe2Gf/gK9atXEBBGBgd8V52LxDb5FsejhMOrc7MiUY+XOB3x3+tQlOPlODWjKijnAwarSAcngcVwXOtxsVCny++euajGQcDp71O7DNRc8HFAmJtxypINXrTU3t9LurP7LbPJM0bC5cHzIghJKoc4w2eeOwqixx7Um4UCTa6msutSGcO1vbqvdVTj9ajm1BLny0lskREXLNGx3EDJJye9ZvelUhvlYAjgjPajQbm7aM0Hm0pIwZPtDZ4KI4zj2OOv51BpFimqXUkD3cNpEqGQyy5PIHCqoyzEnA4Bx1OACar+XEWJZQSe9WkkS1t2jhhIZmDeazHIwCCoHTBz9eOtO6QnzS3NbxFLKsVosSWcFu6faRb2c7vHEz5OCrco4GAR39zWZAS4GPpxVi2vZJkCTgOMYBYZ2e9dr4nvtA1vQYLgaWLXxGXSOSSzh8qAxqMbsKdvIwfug+p6VUZuDDkUlaKOHZACdobA65poq7Dpt28M0kQ8xIVHmbTnAPTI71TPQHsa+py/F+3haW6PBxuF9jK62Cikor0DhFzzSijjiitI7CFpR0pB2p1DEFFFFAhaKQYpatO4D1pfypgPPNOycZ4q0ybC5IooznvRTEJBhY48gZ2Lz+FOJyc01f8AUx/7q/yFJxjmphsinuxc4IzzznFN7U5lwM9qdHtCHPIxjmm7iI/Yc/Sl5xjtU0bRIkgaNmdgNjZxt55471AwIBIqbFAcdqQUD3oGT3qXowGtTeD14pSe3ejnB5qGNDDxR2pT93HT3xR2xWfUoQ5po9ad3pD1oaGJg5qRfeoweetSRg54xntms+YuMWz0P4I+FLXxT4y26mqSaXp8X2q6ibOJT0jTI7FuT6hSO9fQOq6sizR5kd5gS6EthWBzx/8AWPGKyfAMOlaN8LdAi0gsFvlW9mkl++7lSzbsdBxtHbgV5r4p8Uzxu3mMo3LhQDjnt+lfFZnjJVcRZbLb9T67LMIoUed9TD+Inio3d9cRRygF2/eFVzt544ruv2aTBdrr0s1zvuo3gCqyEYVt5LZ75I/8d968y0XwZeeIYJNSlmW1s9/zSOpLSMT/AADvz36V758JfDlhpGlzrYxkbWEMjScNKwGS7cn1wMcda5oQ5Y3e5vXm5vTRI9EaFH2GHZiJ9pIwcuD6VWuLdi8lmzhYpywGGKsp/D+dZ+oTm21C1trRC81wNxSPjao6ufXqOKsecyX3mSTOzhCjYAA98D39vSmnzp90Y+zcbO+5Q0bRbfTi/wDpn2qLIK4X5/8AgZ/iroHWLCqIwrp1yeo6VUW4jYPLFsaPADZ4KnP+fpVFHure+5CJDkecGY/eOTxkev060klFWS0KlzVHzSepsThvO+6WZRnr1qpcbrzJiiKBFARjyOpyce+auSfPBmVcA9R1pmn3hM75ieMAYUtj5xnk1q5pSSuc6uldLY4DxjDNeafJH5aqPmVwwBG0gg59civnPxbokWmavcQxRuAAshBbjDDP5c19LeMJJFQshAjcFiXfcEHTB+np+FfPXjpLqXVZLmSPMLYXzV53EDH9KXtFflLqRvBM5FF8pvO3tFIpxwMgjFV7rZcEzPOzS5y27INSxRSOHJjwRnDs+KhBtgoM7smeBtO7dzW9keddnS+AvDUesfaLt2laO3dVaNAxPVfmOO2WFerRWcWiSalFLcPcT30MVrDZBP3YYscu3GDx8ueOPoK8o8N6w2jn/iXPDPHIMSRTKSAeOfXPToa3NQiOoQLJf6jdefNKSPKTbGgGNpGOo6EZ5qJ0W9kdVLERS1Z1HxK8BRL4Xup9OeONLd43W2LbzEGUEfMOGzk9Onevn/G1iMd8EV9CeBr+a11F7XUbq5v7C/ja3nQEOqhed4J6Hk8d/wAK8q+J/hgeF/FM1rA7SW8hLxsyFcjPbPUc9a6KFV0Z2ezJxNFVKanHdBo0sSaHabQfMQtuwwBzuOMenGK0Z4VlVzuLLnIbGMjtx+VcsdY/0Oxtvs0cYto2RnQYaUl2bc3rgHA9hXV6fNG2nKeSZEUqfTjn+RrPE02nzdHqbYWopx5eqOeuV2OwYYNUJSMnbnFbWpoMqUVix6Aclj6Ad+e1dBpPww1zVNYbTnmsrO5WITOJ3fbGuF3BmVSqld2CCeCpHWsIo1qNJnnb5J5pvt2qSdRHNJGriQKxXcOhweo9qY3AzVGDInzk1EGx1qbHPtTGXnOaaM2mAJPIpFPJzTtoPHrTXX5QB96gaTLFtJGJ4/O3GIMNwXgkZ5A98VrPb2s+oPHHMlrZ5kZZJd8gVRkquVGSTwucdTk4FY8cRzkrirW4mM8nB4zSZtFaO41HO0gErkDIB/n61dsbuaBwEZcehFV7a3eTcI1LBBub2ApZIpI5MOpRhzgjBpq4vQ31vYpg/mRmFeMFe3ryK3PEPh+GfwdaeIrZJ47p5ZFulKgxTKCMzREdApZQynpnI4BrloiJY8YJJG3rXW+CfF174ahkTyhf6RCwlmsZ3AVt/wC6fbkHG5HYEdOh6iunDVXRmpx6GeIg60HFnBkYJo6mnzeX5z+SpWLc3lqTkhM/KD7gYFMr7CE1OKlHY+YnFwk4sXFAGaPrSr3raOxAvQUopMUtAgoooosIQDDE07tRRVoApRSUoGRTEOGM9KKO1FUmIfDn7OhKg5Re/TikI2yBePqKjjb9zFj+4v8AIUooj8KG1qy3cJEqr9nld12ru3Ltw2OQOTkD14+gqmQe3WnAnsefWnyKybS3U8ijoBEGI47ilDf3qQgjnIOaQ881IxXOenSmL05pelOPI4AqGA3g8Y5ppHbOKU5zSHJOKTehSQkmB90nb70zmnspHHer1jpdxdEkJtRWCszcYrmq1YUk5TdkdFHD1K8lCnG7Zn54pDXS2nhiR1d5ZAiouWZsgZxwB6mox4buJcCJW3PwodSDXlSzzCX5VK/yPXXDuNtdx/E5wdAakjb5gPeuhu/CN7bx7neMcZOciqNj4d1S+uI4bS2eR3bC4Bwf0pf2phpRfLNEPKMXBrmps+lfDOnbfhP4adUC3MWkC483IAER5wx+nb1rw+WIarfOs8jmJSQrdkBPJxXufwcS80/wHZaL4gtHn2maNRIS2Ii/yx4P8IGePfiuS8X+AFXUTL4dAEb/ADLAzkqMnorc4HHfivmMRTc6rqR1Pew85RpexmrMp6p4gE9nbW1nEEjjVUGwYUYxjj14rvfhGupPBq9xLKDbK8TFCOjHIJH4Yrx/TbK4MzLNbXNu4yu+aMopOcYGeuT6V6l8LEu9Ju7n+0HmigmhBjhKEKZVPDD32kisVN815s0nD937h6NHDGk0tzDEi3DL97cTkDJA/HvWTfQDzXdGXaejEnNbM1w8dkYxGE8xiGYsS2R16/Wsx4V4Z8gEDbkjr3rtjBRVkcand3ZOyyRQM0SIZE2u+Ojqw4OPb+hpmmzm41CBZRnETFick4zwuOnXnn0oiYI6ArH93BIHLBuRk1heLtUitb61stNid5kQCZ4ZAqqx6DOeuK569RU9V9xrSpur7q3Om1K9lMTQQxOFIGS3GB35qC3uJoLu3VHeQkhSVIPHv6dq4HWBrLQTGytruWWNVfYGwr8gEA5PPOa0tATxVHAsl1psdsIU81NlyrO+RwGBA4qKMakqnNOLHVpRhCykje8V2cM6qs6SDaC8nlYO4Adh655zmvD/ABrPYG3uLS2aR5nIk/d8KOTgMP73B716hcfEJbC5tYNY0SeFZZNrz3ciCJc8cOD65zntXP6pP4TN3f6hFqVnJbyNsaCR1ZowueVI5K9cexFbcqc23p6rY5Zc0Y2aueNR6K8rQFiAsuVO49QaqxeFhcrKti6t5OdyO3T2HFdf44jj09ba6tJUktSjmNWOGU9iVPSua0DXWjSYq8YZwGeNmwGIzhvc8kfjWukfdZy8reqM61t0s5D59s5eM8gcjtitvSvEMAD+XJeRR5EbIuAo9PXNZF7fie9SEEwqQqM5PHXPT05qsGjcJuMQ8xyoIUbv8a2jOSRm1FSPSfCmvxWOqW90kdwiRk7mIUg5GOOB/nvTfi9Jb+KPB8WqxszX+lOIpFByBG5+X37H8q53Qmjimkt2kGzaSjOcDI7c/wAq6DQNXt203xTo88IljvtPaQLs3EPEQQfb5WasZTlZs9CkoO0X1/U8S8zc6tjkda6zSJgmlWynPCEEn6muUlAjmIwCAQcHvXRaJL5tkihQXjduMcdcgfrW8581BLszCjHkru5oG4ubC7tb+zlMV1buJYpBgmNwcgj3FY9/cS3Eskks1xI8jF3Z5CSzMSWJ9csSfxrb1hlARUIweenTjmsy7tJpIUYQsI0iEjNHFuKxk8u2OTjcOvqBx0rlXY6qjs9DFkADkgZqHPOKsTKpdwrh8EgNjGR2OO30qELhgME+tUY2GkZ71G3WpZcLnFNRA4JPb1oRLV3YiXJcDtUmMnPem9CePpVqynEEu9oYpsAjZKCV5BGfqM5HuKBxQqDaygjk1vaX9ltLS5mEV5LqJiEts8MaSwwRklZGlRlJPBG0gjBIPpR4N0WLWrm7W9u47PT7K1kvLq4Zd7qiDACAfeYsy8emT2rpPAGl215bapq2qWlze6RpVlaLexzSfvwTKvEBHAQBScHJIG3jOQJNjnNLQh+Hlgy6H4g1K31O40+6tISUERO6XYpkEeNjBt2wntt2Z5yBV3xP4QkXQbDxFardyG6lCTQ3L78OyecF3DBOIyNxwPmziu0jto7q4ttM0i3bQtAu57+WxeRBA8s6ICVuQWYOi+Z5SkEN1xzW/wCJrcjwtLoRttNthaLcXJt1kZpIo9scxfdMpIl8uTYpIGTnJ4xWqStYx5m5I+eYtsCFwTuYkhccA9sU9HIiZmTO/wCUkdz1olUSqZIztjEgCK7Ddg5IPHXpyRTWZjGQM/Kd1ZxkdnLbYrlcsQeMio8Vs6fYC7vzAqmQkMRtlVAcKTkM3Has26iMMpViCR1xXv5ViLfum/Q8bM6F/wB5FEOM0A8Uh60or31seIOooopiCjFApapLuAUUUVQBTutNFO6UJXEwB5opRjB9qKvRCGp/qYh/sL/IUUJzFFjpsX+QpSKUdlYqW7E7c1JHLtUq43KRjmozQaG7CAjHbjsaaTiik4/iHFZXGBb0pA3IzTtoPTNIBzzSepaQfXkU6NGdwsaliegHU0ijNeneCfBnmWclxerIpABkw2M8nC8duhJ9sV5mYZhDA0/aT36LuepluWzx1TljpFbvsYfgvTrWW31OPULcNdXCJHbOf+WKgkyNx3+6B+Nb2rW40y1gt7doppmwY0Qbn3Aj72Rznj0rU0qBNBl1C2SOSdpjhCmA3A5XnoOetaNjpVvpFi2qXjpJJLh+uTnPAUdeDge9fB4vGzxlV1Zn6HhMDTwNNUqf3vqZtrNd+fHda8kdlbwLhQU/d7ugAAyS57VqNqqbWmsrOS5uBJhi4wqcHA/Om3UN1LBFc30L7ZH/AHcTHGQfQf1P4VtQWjGxdY4xbxKSBJGm6ONsfLju7c5x+ZFcavJ8sUdU3GEeaZyrWF/q+pxxXgWa8cLIlnAoyF9cZ4Hua7iw1LRvBN0kOqahajV3iVxDGc+RGeyjGc8da5eW/ktklttIeWbUhnfMy7GeRhyzMO2eAo4A4ryrxhpLaJK/mT3N3qa4kmvA+QhJOVwecg130cOovmbPCzDHtrkitD1fV/HWp37n/hG7W5lZJArXYVjGo7BTwS31AHpmvQvD15d2XgKNZ7SKHVFBRIGIYsx7E8YBOSB2GetfOngz4h3OkCaC+W4uoGG5IYCE+bPJIbsa9Y8E+ObDWr57jWzGYoZQPtEMTeQjSKzIpIGA4B24PcZFbuMoNOJ5sK0amkj12VLVz5d5bl0WMN5bqHQ9M8HpgjIxWTeSKjmWJIofI+6ztxnoOv1q1Za3bS3DwAM8ruAoXBwTwAD+tYnjjw9Jqlzb6VZXkFvYGBpXQndL97Hne45wB6n0p1YucPd1uKDUJ2loa2l63Za2klxpk8dz5D+VOqctE/GVYH8OelS38yys20fMgxtxyCK8wuPBkmn6haf8I5HPCtyf+PhyVYYIBZx19K9Mt7O10fSYl1K4e8vgo3yFjtdwMkIDyB9a1o89TSw6vJTs77mLfNNHbZT92r53SvyEH8yT29K44XFtpmWMaXCq/meZMMkn/wCvWzrPiq380IysnONh+6K5v+2bW+1BLdoVZ2B2qV4J7Zrf2Mea7eptHGKlT5Yq9zqLXxJf/uRGsccsoDr8pCupPRefm9PrXS+HtXbUdPunY/6QxK+SRh24H4Ac1y81lb2z25eN4vJikjRZiS25XJcjb2yDjPb8av3usQ2HhrU9QtS2fKdsBQM49PUkj9a0VS27OGpHn1ascD8SLDSbq+htta1Qz3Yk3PbwA+RGuMLtHUvngknHoBXA+JI/BMCtHbyXMkgUABFwA2O/t1rI8U32rWRxcwXtr9sjEuLmMo7KSQWXIzjIIrmFspbiDzwdiHnc+a41W5m5SSLnd+5A0jBDcJ9rhv8AzRHl2jnkJc47GvZfih4O0qy8C6Pd29pbxXDRpKXiXazhkB5rzX4T+EJ9b8U2DXOz+zobhHuF3gmRFOSAPQgY59a98+NH2nXNLeCwREWMkhcYJGOgqF710ndgp8iXMrI+TrqUxzF3bcTwCf5VC10ysrI3PcY6Vp3VqwLCQbHVyGjI5FVJdO8zc1ucbeSp61utFqcjV3dF7StWikWSG+OSRmJjjAb3+vr9K9M+EFo9xrGu3zDFta6RIkgbko0joFH4gGvGEEbfI42t65r1z4XXc9l8LfHVxGhImmtIVkPOdu9iPwyv50pKyujSg25xj5nk18wE7j3rc8LHcpAPJfA/IZrnLolpmI7810HhImNGcY4l/pU7U7GlP38Q36mvqIAZVjBO9i2O/YYH5V63oVjc6l8EL7RPD1jfXM/29XkubZBGjxOVkkjaRiMbMbXxkZUdc15JfHfOTGGBUYyB39q0r+8a20NbNLm4YyQrcuIL/bbtIThWEeBllUlHHrk1nFs6K0b2sYJhi1TxDEHsVjtBIkcsOnHqikKWVnJG5uuScZPpWLMj280sciMjqxBVwQRz3q0s8ttcwywOUkhcOCMEZByMg8HnseKj1S9utRumur65muZyqqZZnLsQoCqMn0AAH0qkZPR6FQkEZxz2phcgY5FTxeVGX89C4KELhsbW7H357VUbjkmmS3Yegz1pwPzHHUCkiOGHcDkj1FXrd2WCbzLYy2xUs207SrbWCHdjOAxBx3xRYaasafg7ULWz1uCHUg50u7IgvFQDLIT8v4B9pI7gEV7Homl3trf+N9B0uK6ur7ULiG1tHsm8rbLbYLySoxYRx5dBznOQFGDx4QUjRygkikPy7ZU6AnBzz6dPwNeteHvE0sD6HYrJaW9zYLdyy388u6RpHjk8ti+AdmSCFJblV+lXFqxE4ybuat5d23/CsB4Z8Q2suo6hoskkuoAW67oUVuIlm3fIzO8alwCeTx3Gnqd/oPiWRLbRW1ia4g0BmbUWKETQtGMxTNwWKsyZ4LZjUDOTXHeHtfs/FWj3WjeLNWnt9RvZfOj1AwRrC8qKfJErAbsElyxxk8DtUfhfTT4kk0rwtaW9xatvuGuXVDvMrbmUtkgBAI4z1z8pIB6Uc2ugKn1Zy180dxY295Irx6m080dwAFEOEWMIEXO5SOc5GOmO9ZQG1CWf5TwT1rpL6znm0rU4dPnibTdPe1mu1wTIJpAY2kBZQxUFSCBxlhjPWqGuXBv9Y1O9ggW3Etw6xxIoQIOg+UcDgDOPesup03VrI0vBh0ZPEWnHxCobRIhI11u3bQCu1SdoJADMvas7X4hNcSyQWMlqyki4ikYs0cm48HIBH056VVuEjYEKQYmAOAc4Bxwfxrsb3W7zWvD+n2k11KbCxeO28j7OF3yMpO8yjO4Zxwx3c5xjmuuhJxe+xhVhzb9TzuRTGzIwIZTgikXvV/WLKSxv5reZVDxuVIVg4yD2YcEe9UcY6V9pSqKpBSXU+VqQcJOLClo/CjvVmYoooHSitFsAUUUUAGcA8E+wp1GKQdKcRCjg0UY9qKvRCGRHMEXb5B/KnLyQD0J702IYhj/3B/KlOazh8KKe7HSDazLkMAcZHQ000UY9e1DAQ/nSd6Wk71mhjh0xS4zSfxAY4p5yFYjrg4HvSehcex2PgDw1BqjJe38gETXH2a1hVtrSyjBLng/u14B9SwHrXrunWpsy9vDKtxqTnyza8gRpz85PTrxiuJhhe2u7GWVJU0+1so/smEMYaIjKORnjexdvc5r1rw/YWtz4YM8M3+lY+0XriLlEAO1Vb+En5ScfNivzjNMXLHYh32V0kfpOCw0MuwcbO7na9u/+X6nE6fpt3Zi5uPLW6ePcrO4wiuT0Izk9vzrMubiSG4EMtmCIVCwRF1byzgZLNj5jnPYZJrp9T1KO6iAslVBFtiR4pN7B3OMBByzDgdz8xzW1oGj6botrPd30wnv5WzGJ1EU0aFc/KCc7s9frjgA1w06PPrfQ9Kpi/Yq81eT2Rw6w391Kb3UjPFBEmQzjaOeNkaHuf7x6e+awb7xPNf6VaaVpBuLe1t5GYz5w8obqC3VmyBk4HTFdJe3OqeJNRmvbG4WG3K/JPEmFVPmV0G9cYHyneMZ3YzxxjXUMenWbzWsKSujnTd+AvkeYNwlDbsF8I2M9Pm68VtTjFS0ODGYmc49v0Od1C/ubaVYIJriVZUDDbJt8v3yBk9Kty+BLy8CwwTXLSzK0jNjeoQYySOvUjv3r17wpomhDRbEXBgMiKJGkni53A5xz360a9pNre3BljnjgkiX9y6yADHXIx1z+PSu6NOMPi3PD5uc8aj0W4htl0vVNGe+tbeRpjJbhRKCV25LEE7BgfLzg0zxD4cs9M02zl0u9u/sOopu+ztMSu9Tj5hwMjPGRxmvTILmIX0dnZapaSSCTyZTc4DKAMkkjgL1o1K6s9TltZo7XRLsJLkhLnCbj0JXGT0rGopa8h1KlT0ueP6Drmt+F9dtmMkgRSUMVwWZSGGMjnhhnIPY9jXter+O9Ri1y31Kz0eCzmFiLSP7SA6uDJuCqRgnsccd+9cb4ttNdv/FNmbTTII7+2R9mCrRSLjcfmJ9Aen4V1Fre+JxZBde03w9Z2687ryYluOuE64xVwTkmpaGLppPa50vhDxLres/vdZgQTKuEkWPAdeP0qp4ivriRrsW0Zl8lmMkm/CjjOwe/bAqCyvBZ3Pn23izTGiZQy6dHC00aZ6hXLZT6ZwOwqe/1G616CSGzjsJWyypBa3I37TwXKHkZ9xx1renUlTpuKevyMnSUp3tp81+hh+FdEttfFzqtzOnkRSMiqxyIFT7zOO5OCQBWb8N7KLxL4h1G+giVdMspfs8coQr5nU7m/PsBVDXIdX8MeFbmxEUUU9zctiFYgxWGUgjOR820FsE8jpkYrvdD1nwlpWlnSNKurO2siGRoZZ1VnXPfJyT1NVTqOpF7afmTKnyyVti1q+iWNjrF1c3slxdJdxMphaYoAdgTIHtycepzXCast0LW10dJluLWQ+SvzncAck8ng89vevStbnS6s+FVkjYDK8DJHTP9O9ee+JtTtbXSbn7NMi3SJhGwRg5rnnTfM0jfm927MTxhBaXtpHZ6zcxX1yoaFGcZaM9S0ZGMMOBzkY7Vn+E9J0+yDi5mVbYYGZD9d2RjntgCua8OXkV3e3ba1eO8pbcsgjLH6A9hXsPw9s9NSRdTvkcW+dkbTpwQM5IzXHLnc1Hobw9nyOaR3Hg3w1DDpkd01pFZwSYaGNVAcIOAWI659PeqXj3ZbWRaOIzMzBSIiA369K39O8TW+qarLYWsiSIo37kHAToB71yPxGS7Hh7V/MKWodWSKQ9NpHBBPQ/yruhKNP4df+AefUpTqytLQ+eb5YtZ8U+TbYUOxTHcfX3zUN14fa0YmPcZepGelM8PRx6Yk/8AaMxguHRljMY3kE988jPXmuqt/EemWGl2yXAW9ljTa0rj53Yj+ImuiCUldnNJOLsed67pAFsbuIFSmA4/rXqMED+H/wBnmxW5QRy6vcSXaqerIxUIT/wFQaoabNZeI7eSxs4dtxdt9nCgBipcgAhe+M5/Cu/+P+nCx8GaXYrsSOyBgjUDG5VwBgemAMfjUSejsb0I++pM+XJR+8Oa6bwvEBZCTu8zdewAH+P6VzEpZnJwa9C8PWxTRrYRlVlS3MhJAByz8EdyRkH6D0qZ7Bhleo2Vr+GRD5w/1WdgYHq2M/yNdFHqeneHvDMEMtppWrzarCLpJk+W5024jbYAxbcCNuTjABJPUYrGCfa7/wD0OwSVYFe5kSebhkQFmBPy9h0HJ7VkSsNQntobGyVZ1j2NHAWdpmBJLY5OccY9qyR1VFfRmXN8xJPUnOMYqLaXDbFLYGSAM4A606Vm851ZSNrEYP8AD7VORdTvEG3Z2jDEbSUJxnPGR/SrRlJoplDsG7gH1qWPT2kUFANw5UEjDe35Vrx2MEM7mdzLtGwgoVUHrx68YOenNRXNxFLfXDtNNsYkrsPTPb3FbRjbVnNKV9EZqu28BhGo5bYgCnr29v8ACtGzlcBjbb/OGB85JbockDIGOcYqqsYRjOQWUMR+Hr/9atLTDCZI4WhlnimkU4jOZWVW+ZYwTjdjKgH16ZpNaDi+jH+WkcEl1cW7/a5kR4G3KiKD/EybfmBXpgjnnmr6afZWWky3epXE0l1LBb3Gkx7R5dx+8VZd/JPyEMoBxuwT06x6lZ+br2q/2b9tksLGVitvfuEnCbgixlc5LjOMLk/LT1tmTVLO08mzvRCsbFbabf8AaguJCGYnIJDbMDHTABPWGarQWytxp8lmsEc91cyXHm7GUPDJsXG0RlfmILNz0APSu40DxPqXgfWL2xvNOkm1u7tobWGK6SMyRTYKqWffjgt94jce5UCquiJeab4j1O93/wDCLDTEW6lgtZfPktoJZI42QbtwDBZD1G4YIIpfF2oQ3nhxNOs4YLyWCaS7TWbiUi91NC2Hbbg4AIHyli2IwcCle2w78zs9jmtKtLq907ULjVZJYdOkkW2+2fMIzMXV2LYBL7QrMRnjrnscKSRlGTgsxwO3NX7bWrm20mPT4B5EO+ZriVJG3XKyALsZfu7QoxwM989KnuobE2AthAou7VpJ7u5F2jRyL8oSOMdyM8gEk5PYcTubxfLuZUAfeFCA5PzYr0z4f6DZat4B8Q3up3t2kelXYkgtxKfJUlULyPGAdwCgknjCq1ecWayXEhEKM5P8KjJwBknA9gTWrpH2vSdf09dUtZ4YnuI5ZLe5RollQPggg4+XqCauEmiKsU1ZHVfGHwOfDcouYIpDazXEgjm81WWaPhkdQAMDa6oT/eU+ory5sZIxxX158Z9AW5+EV/t3XM1kyXaXHmF/MGRvYZJwpBJ2g4GBivkeUYJ4r6vKqnPRs+jPmcZH3+YiFFFFeocIUtJSiqiAUoFIKU5qhDqSlFLiqSsIQcCinDoaKYhkeBBFxz5a/wAhSE0kZ/cRf7g/lRWa2Rb3YUGnH6CmmmAh6e1C5ByPwoxxR1FZjQ4dcmpByMZyaiXqas2cohnVyivjs3Sk2XE9PtJ4bzwhZzQ+XLcG4giaXJ3RrEigpyegJ5yMHeuD1r1bS9J1W78GiMTzWkF8y3LR2zDfOhUYjLY+QFcdOc968R+FWmX+qeJJ1htJZ9NED/bwMhBGR8oBwRv3BSo6kr6A19V6TcRrYW0BjkiZY0iVHA7DqMcV8Hj8vp0MRLXR6/efcYfNZ1sJBcuqevyStY8w0vRbrw+Y5tBsGmuIyzpDezlWhYg5KEDaWOcksCeAM15v461i73Wzwzys94xfzWmBYsCu/GDwATgV9Da1IIluhZwiW6hQy7idq7v7ufXj0718vfEuz1K3GhTXsQ2xO4WRWJxllfy8YwMMXIx1B56V53KpPlbvY7HipOLqJa/ien6do91cRww3Lgzlf3ULHKKvcBeg4x+dWtc8Cf20LazggFtfh1HmxsFVfUuOhIBJHfqB1p/hPUEvdNS78tVQSrGsuASPQg54B6c9McV22lX962oyrPMZothZi+N6NnjBH3gefypwdOyXcyqTqXv2OO8VeDdX8N6UF0XUbvVxCoeaGYAZTvswM7vQV4pqfiu5u2t4tOkuorqOUqBGDuZcYCn2z2r6pgnW0vHn2sWYjMhJ3Ejua8B8TWMmpfFDUIPC2nxNeTkyyNt2xoTy0jMucZOM+p+taNR0t1OdOclZ9N33M+DwFfvcJJ431D+y9Iw0jP5iu2cZO7HA7cetbg0vwvHYrcaFPstxwodGL4B+8QBnn2Fb7+DdanELeJtTj1uJP38dkISkW8dT/eYj1NadvqX9nRmCDTorS3eMD7TGAxDY+77dz+NW3Dbp6XNKV4q8UM8K2WqRROws4ZdRlctDdXOVNvFjoq9eR2NVrvw0uu6ix8RXdze3f3lBbhE9gOKuaZ45lec20elyQsqlXcLkY9s+1dHpWrWTyQ3DwFzt+TCDp2DHPA9j6VrB0FbrYdR1ZNuxn6T4Ss7DRphNoVtJPK4ZJGUFxGPud+OSau6KjWGow3b6Ra2YtnA81IwrTrjkcd+h54rs9MvYLzzH+Qxsd8kjOCC2OB6cAVgeMLpLu2QQnK8pE2eMkdfoO9KrZLmizCE5TlyTRcu7/QvECldStoSFAK/awOhPOM/TmueuPh94M1SEQDTtPMmSf3UapuJ7njHpXF2n2yOUwtJJvD4kVjwOnGOR0rpdAi1C8S7tbKRWWJlZmkIUIeSOAM5P9K56eMnezjdlVMLFx92VkcH4o+E/2RJY7CN3t2PyKH2gkewOOPevMtaXV9OY2+pXmoQMq4QOxdCvQc+nHvX07K2qwW//AC6yyKCD8rYcHOT7n/CvAvHdy+q3FwSqxLZZjVBzuO4559Oaaq7d+xLo6N3+aMPwrqlzpV+s7WUOoxOvIYZzz1yP617Pol1onjh4La7vZbVokJfT0+VgoXOVHf8ADNeGeF4Li/umS1Dqw+8fUZ9q9ZXw1ejTBf3Dva6jalZbbUohmWM4x83qMHB9qc1q2lp+A6O2j1O70PTLPw9qQ1O5LeVCpiiSHc3lhgc8dccj9SeK0/GepeH75YJ9SmimtcA4mAMcZB67e7D3FclpHjBptSs3vLNo1YMsmx8xyNjG45wQOvTP3qZaxeGtR8VaXFqjWZAlZ1V5QQ7opKgjOPvAYz3wO9Zxnayi1v8A0zplTjdzkndLoauveEdJ8YaJJqGm2ht0J2xGSPymkXGd208jt1xXz5418K3ul3sttjeg6BiK+on1WCzk8m4tr+K91RZZbZpGRgoPVQMghsAt06DAPavK/iVEuyEuC9yhz5o5Dqeqk13RtKPN1R59aL67HFfs+afcSfFLQySUSF5ZnB77ImOK9U/aNvE/sqOJwjMzbjgjIHABH5Vg/BiH7P44sroJ8sMFzKxHXHlkfzIrG/aA1tLrVEtREVaNeSSOhxjB9Ov502+WNu5z0ov4n0PEmUD5q7rTrjbbRTsTvhgRFAHGNgH51wzAMNq8M52j6nivQNWtktrYiR1TzCHWPBLNlsbRtHUZzzj86ioa4Vatk+i3gt7ApqZ8nRLy+WC/ureQLdMjxOpjUcnaAxcjAB24zzisrVLRtFt7KQ6jJLm0aaxms5kIjkaTLK2MOhCnDA87gccVJ4mu7Z9J0nTINFTTbmxQi8mbd5tzMVQOXVgCpG3p71CNKudZgfUROivK2MSNjO3A+9+GOfTrUxvJcqNJW5ud6GbJpyrDLc6ndMjSKZI9qljI55GW6Hvnmrup3li/2cwMbF9vzosBKADdhRk5xkkU/XrgvZ2UE9zDLIicJAw2xjoAQOB0z1PWsCZlLbpHLsfvbu/41fPyuyIdLnXNc2ZIfMtvPmQPOwRVYKowACMkeuNuO+KqNp+ybLZYY5YIPm+p/oKshZtPW3a9MNxDPAkwVW80JuX5d390gHp6g+hqW7WV1gO6WWFY2aNWixnOORjqM9CfStVLmOdw5dTKch7lolZkTbjJUsFP4VasZorK/wBNeWJLuC2Ks6p8mV8zcwJGCT1BOelMmWSGOWUo+yFN3Ax+OfqePerniTSP7J1L7PDd2t5EbeCYz2wLLl0DlSRnkZwcf/WqblW6MmtL5YdfW+Fmly08zvJBP/qpg3VWwc/e5znsKfIEstL0/wAkWk2IvOJtVIlibzNn749CysAVx0Dist0WZFZowVBB+ckfL0znv2496nllguLhobdZWt1bcvmt8y5HTKjA6dqn0Ltbc1dWEEOlxJpd9ftNfxj+0xMpTc2/cEXB+dSQGLHnIFdTDfXum22rfYPDVqlnqVnLdQXIWaOWOzRfKcqAWO3LFiH6k5JORXn91iWQxxStI7ghVQ7+o4yR6V6h4Z8aOvha/wBB1U20dzK8cdtdnETxxzuscwjGMZ2knkgAAnsaVkkHM0ecjTo7LVIodZiuorNJFjnWHAlVCA2UzxkjkE8VpXrXGpXuqQS2tnp8TQPe2uneb8kLvGu3y+QN/lqGJPHGOpxXT/FTSLqz8TXUE982oyfZVup5nk3JChGECyEDeWVRzjksQOlcXFJaR6HqkU5+0z3ESrEJCR9mdHG184O5thYKOBgt3xUpdjWT5o83cg0DUJrC/l1CONJEgicTBsAeXIPKbC5GT+86Dkde1aM1095prLIkDvZul208rs8twJQEOM8bBwxHUEnrzWVp1tEGYSXECeVDNchjtzuWI7FUsCCSzY245x1BFbHhC8hltptJlsre4uJ93lPMxwSUKqnGOQzbgcnkYwc0KN9BqR9F+FNVg8Q/AHVreKVJpLGzurU5BX5Y1JTg/wCwUr5PmYHBHQjNd/4d1XUdA8O+II001Ip5TLYSX1xJse23AebEIz1YhRnjI4rz1jyMDA6Ae1fTZMmoyvtofP5klGSsJ3pKD1or2zyxRRSUoq0wCnDpTaeKBMUc8DmgnjFHQ8UvXrWhIq55GcDrzRR14zkUUXBkCcQRH/YH8qcPekj/ANRF/uL/ACpQeazWyLe4YpKcxzzikHWmITgnmnbMng0g5brj60uMHOahlLUAvHT8a0dG0y71fUIrLTLae7u5fuwwJvcqPvNj0FUF4NfR37KUVk2neIpmSA6gs0abyB5ghKdM9QpYH8R7VyYuv7Ck6ljooU+efKd14O8N6P4R0y7sNE88ieVZJpZX3uzjC4J4wBjgdsn1roJ4YJEVZApBj2sQcEGvHfEms6vp11d3EUt3FDJcSeXJ5Z2bdzY5HA4A4PXFX/BfxHbULuHStQgNxdyHCXMZAGOdolGPlPGN3Q18D9YdWTdVXufaPBeyivZvY9Ek06J7R4diCHPReCwOM5Pf3ri/iPZWME2lwNG8qMHcbcBQwaNQPfJYYFddNNeG+MaJ5Uh2rtHzhB3PbJAPSszUGhkYG+lFxJAc+Y2AFUZJzjgDIH5D0qZQbTsreoU5NSV2eO6zq/8Awjz2zae3lQXM6RXFt99AAQfMVex5POfavcPCMmmzWii1X7RHJ863HmBxKOxGOmPSvm/xBcafq+t7NMtrx4p5tzCFwUCMw+UKB8oHzd+QR6V9EaVojWEVxJoyfZyqkKijAJxjO3pzxSpvlTkl/XkaV7Ncrdv66jfFOo2difJeQI8y7IY2fDmUngDvj1q94V0DSvDivFCFmvpQHuJd24yv39+vQdhXm3irV7x9SeXXdFup5bciOCND5e1z0YkjJzXW6BF4hutLK6jKunTDaNiIJHIyQWDMSR247HNZ06ilJytr+RFWk4QUb2767m7f3lvOrfZlERTcrSMduO2F9/X2rivGoj0m/gjgsI/OnDEJIMqAMc7fpgDrg4rZ0/RdVDXMTXCNGx3bih2sw/Hr61yNna6trHiOaa/uoZHjUQgzxlE3cElV745HcH8K1hNtR0d2UqUVJ2eiJPDNneX2pR3EiShQcCWXI8wt1Hv0713mjabard3InWO4jf5nUBtpfcAcjpjmsnT9Smnv4rAxw20T5jWaCMMDgZznH+eldNYNLY6mYpwpMaFiyDAZc4BH19K64QSV0ZVJyScRniqa0isV0tLeN3kIIiEYKxp0zjsM15/rd9bjSkt44Wiffg4/i+Y4X8cZrrvFW+7YzQxu7L/FHyVAJIBPbrk1y8eiXQu5JrmOPD7tgkJwp6r+IqZXm2jTDqMIK5lG4lWWW4jAjeQFWaRehwMHH1rZ+FF1dG3v7e7aCK9edXDyfKsuclyo6nAAH41zutyzXFjehxbxsjIoAOSMliT/AOO+npVfRbO9gltrxdXaNFT5ggJ3MR6Zwecda49VPmW5rVSacD1u8wlr+9WTYSWBZMEAnjP0FfLvxUv0GtailqVeJ3KrJG3ysMnkex6iu98XeKfsDeRcXE17Iw3+YkhC5PYgcceleO38s+saqjOpwz4CgdRSjN1J3a0RhUpezptX1ZF4RvtRt9RC6eu+Z8LtIznmvb7Fdev9MhTVpX+zsORGvyoB6+1Z3hvwXElsswXZOqhwyrgn6epr0zwi0b7I5WKEMQRIe/uK63QdXyRy063sfMwbzwuIxEMGOM7cMGOPqp/hNcH4ns9Q0LUZYtSgEqFxJbXTJ8xGc/eHOen44r2LWpA4nj8weWPlG3+A9jj9fwrkHkvJ9BvLXUYY9RbTdtxFcCM4ubdiVdD1wwHI7/lWdWlFaWsehRqOors774eW8OueDNB16+eS5v2tZF82c5OC7Kxx/eKjGfSvPvipZRQu0UIDPvyuDwB3/mK9O8F3Gn2PgDT4dLlIt4kcKN2WUb2PP0zXmvxBuEuNSuAjrIIHO9+2Aa7YTSpaanlzhJzfN3ZB8ILORvFGrzKpFra6T5ZJHWSWUEDPrtiP515R8ZbmCbxGwif5wuCrNlh04Ne8fBlzdeA9Xv1Xy2m1GRFkI/1iIqKP/Ht4/Ovnj4wWCWniWZ0DKZWJKsxbnjPP9Kipq0wg+WnJHN+F7SO81XbO21IY3n+rLjaPxJFdPeX0kWoxucxTWr5Ck4ZHXofrkA1Q8JRRwaa00ke5ptzhwuQoUgAN9TnH0rqfC+iXOpzT6pYm0lm02cSC0uwpF6x5jhRT993CyZGOMCs5a6I1pWhC7Oc8XXmsXepi+18XbXd3GlzvniEZkDDhlA42kDgjriqNxqayaJDYQiVUSRnYHGGySR0+vIruvEWiWEfhrw3dPrNymutcvYaja6ihVbFgm7ZtYHaqZOB/EGBHSuFkuredYTPHbySxqVKhPJB5+U5XGeKURKV1sQrehoo4rmJJ4Q2XJGZAvoH6iq2pWX2UyPbzxXNrvG2VD1B56deOh96nj+zPcJHxEC2GYyAjHrzT54PsasJI0ltZeVZMHkdw3Q47impaajcX9ki00GKGRpyTbzRnEZcoJMHCt74Of1q1bA7VEF7NHCD+8t2k9eoxV4TF7WyC26xwrEy+YpAErByxYDqvBx77arKqzNcBo4knjO1d2W2qeRtP5DJNbJK2hyvmu7lTaJJGNl5TRyLgQEEbjkcEZ5bnpU8Szx3ckZKRKEwGVs+WCOflHfqKkjtZbaP/AEyeEu6K8Lb9rHOcMD+GDUS+ZGpkeIGNgc+X95z1HPqCal7lxehZt1gij5JdDjepILKBx37Zpkc8dnHbOxS6kV43ity/DKHBZWxzhsEH8azru4ctE8rRy7F5hJyF+vr16VZsniO0NAIJAxMhPVhjgKMccZ/OmgktNTUiQFLq8VLaxjk3TCGPJATPEak5JHOMk9utbFmukapNo8uoLP8A2ZpsYOqTSTld8LSttghXGS23e3ByQG6YrmDNDBPF9qDeQwIELliQv1z8pzz0qusyyyoZJAEA25YbS2FOOPQ1MtrFRV3c9t+MemXtzrttHJbaVd6bJYB7G8iDQGwti42PcMD8yKAAC3A3MeteaNZXNh4a1GLUdPufndbpX8tVaJVTYrseuwmaPI+nrxFY63qNrNJNLPcTWk9l9mnE0w3yWrHZ5a784G7+6CcA9s11GgRx6telfDlu82oSCF5dTudkkMC+Un2hbiF/l2M24hu5VdvSpi9dQa5I2PO762e2MMchQmSFJgFOdobkA++MH8RS2Su08YidIpGYBXdwgB9dx6Vb8S3iapr+oahDbLZ29zMZY7YMpWIYAAG0BccdgBVvRrq0s9Ivm+zyyaxdbLayLQiSJUbImOCMb9uNp6jkjB5pPc1TdjpPE2o6N4l8Ji5SJ7DxTp6p9oBUbdSjZsNJnqZRuDMTyQDXnhrYgLTsrD+7s4H8IGAPyrIkVkdldSrKSCD2NfU5NUcqUovo/wAz5/M6ahNNdRuaOwPrQB3pTXsHlgKKBRVoApwoHNLjBFVa5LAHNKM/nQKXBqhAc47UU7Hr3opoVyKI/uo+mNi/yFKRzQv+rjx2Rf5ClqEtEW3qxpGBTQcCn4zSFOcD0qWmG4DnnNLng54pFAFBOeCcVJUR6ivTf2erm6tvinp4swTHJBKl0C2AIiOD7kPswPc15knA5r0/9ny48r4hG2aQot7ZSQjB6upWRfqflNcePusPNpdDqwqTqK59B3Gludb1LSzGs+j6ghlmjJG4FshgCex/T8a8g8cfDXV/D093qXhZWm0+VNlzayTb5FQc7gxxux6DmvfJZJftEjFdoj43t/F7+3aprho5bVQXjZ3XPy9PpXwiSmmmfWRxEoNP0Pnzwj441aWCK31UGWJhshmbKsAoHGe+B3NaXie7tdT0NU8xv9KPmKQ+1WCnJUjqecHnHFd5q/gCy1aW4j+0vbx3C5JhUbvNHRs/04zzXjvjLwdremarDZajdwvDOo+z3CRNtUKcYYdF6dzWbpyjpLY61WhN2huUE8yMJPpcSF1U7w6hQWz/AA57ele5+GNUnutF026u/KjvpI4zMqLtAcjJwB26/lXkPha3t9EW4OqagXMRwotIFkAOf4iMkAd67rw5Jfz6yyMtvJbuFZJmvF2AHvwOvtmtaUVF3avcUqU5x10sanxXvlm0lozIsckbRuGOBu25cjn0AzTPht4vPia5uJXs5LQKu9iZFIfJI4XqBkHr6ikm8I3l/ZS3s8ouHaaVkkI24Q/dKg9BnoMZPGaq6n4S1DTbeW7tEt7KQx7DiQfuwMYJfHzcjPSoVOpzupbTsC9j7NUbq/5bHoEAWe6kxn5RuxnqBnn8qy9dghj02e6LojRHO4AkhWOMcc45rD02XUordpb++spLhYwx6Ic9Pu98+tUbbXr65jm0u5uImf5Q42gjYQCV3dSB0OOfeqclONmt9jL2LjLmUtFuWNE0Q3Ny9wr4BlGDnBDdvw9a2NXu7axvpGTMM6S5ZH5DYHb0zmrHh2W2iWGFbd2+yg+WzEg5PJY8cmobuMXtw93vK72wQgDFueWApyqpWjHcii25Nz2Lsuu26WhuYMq4QM8W3IbI55HuK5fX/EgffJFErRbtsfByH27enfr/AFrXuLWeKYRWMKJG0ZVmkbc7A9SfTPeq2lpZwb1itTHdW8ReSSNfN5B4Jz91fenKtzaN2NowhBcyVzkryys4NI+xys8l7cskx3ny85Jzjd1HH6GudgnQ38Ngt7GrWe9ZiUKLI2TgK3QgDntnPGa2/FlsNSvdzLHNK8rSM5OWf3I7fTtVWx8FS6tJFADBMs7fOz5DqcHkc/5wK4ouU3ypXOrkt+8kzhvFGnXGoanPHGqnyVDOUYEYwCTkdetS+FtHtFn82RJFeMkbn6Zx1r1i78AnRvtFzNOstikaDbFGNytwCpGemOc1vad4Xt0lCWU4EDxrMjtH1yM4wfQYropYWomr7HNiMXScbo42KOQTRz6fG/8Ao8eZDnhQBnv15x0rb0KM3KpqWpDMMmdy5w0fOBnHr613MGnRQwzRKBtyzDjGMgVxV1FPHqkFvAqSq7FNpOFx3z7V6lOmkuZs8epX5vdSHeIobJ4TcI6qYwQSDjdjt/KsDwzd6db+IHczp5DlRKxKgKW4P3uOQe3pU99o7TaXd26sFkkRiA3AHzYHNc7pWkQ2VpLbjpEwMnOdx4OPyyM+9c+JUrrlR3YZx5WnLU9nvdNltNPuJ7FYnuY5W3JJjaUwMjngcCvnfxzqKWr6g7QHeVYt8wwAM17NNqEieH0tbWNxp92VSKSZiZCvC7TzkkcDOfc1wHjLRP7U8Z6RotoBL9rvEjlZI9w8pTudmH90KD3rnkuafNE0lFwpvn1uel6Bo8Xg/wCEWlaXd8PbWqyTlTnMrZdun+0xGa+WvibcSXl6ZJRn5iQ31r6L+NGsyQRRWYKxRSEMW/upjoe/X+dfLD3Z1/WIbNWZbZpQHDH73P6Cqqy97TZbmdGjakoveWxpW2630Cyt037XhLNtXGGzzk9DVaCPzFeMzxQ5ViryOVUEKSCf5D3ruvECw2F1dWluEjHmxRmFog8YBQNy3UZyVGByTyflrH0/xbDa+EdR8P6ro8Gohm/0CWXaj2DbiW+YLubkg4LAcehqIyU4qa6mtWDptwXTQ2PGC6QNGj0/Q5pddk1b7PPLczkRy200YXaCWG7b5XCg9d7E81wGsaeIdQkis0kKZwI2ILqfT345BFS6FC1zPPDJc2sUDJumFxJsDqpHyryPmPTAOetWLu/02C6kitbR5LQxiMFJWDDI+YZPLDdyM/hW65WtTk5JQdkc68ZM5jkUhwcYxzQ6FQuMox5Ge9dXZLDcaWz2Dm7uYWbdA+UY5G7cCc7jweBVKbV59YaEatBJcNHkGVIicZwBwuMYUAd84+tJwSKVR9h2kT28Ngrxw3T3BLbxtLJnGMDHQ89feobzU9saLbl2kUGOMOoClWOTuzySCcDPStl410pLyCKFIxxuiVyTC2zGeeWUk5Lds47VkXMCshl1GS4nZSGZAMk5HBDd8d8VpZxVjO6k7mXPbxFIobbfLcLHvlJOAP8AZAPpTIJkgjQIoDBizMw3DpwB3HU0W8Md3d4jIjjJBO5s4z6etSy6fHDC8jThUU8LkFmBOOMdT3qNWVotGLDO8xBYoMEDJUfKffvSHYkSzxz+Wxb5Q53M+Mdh0A9+tMlktXYkbnCnCrk8/wC03+FOeGGNWud0boeQqjax5Awo7de/1prsS7dSSO3vC0LgM0k77Ykjw7ux4+UDvTrHULiJrqKIASXSG2meVQW2F1JAz905Qc9etUZpY2nIWBojjG0OWwfUk1IUaMBJYnEjAEHuQexFJ9i4nVeFr/RdL0fxFPqLG61S4s3sLG0WH7jSLgzlzwNuMccnJr0XxFPZ+CtA0uXRNZt9Y1a+c3t3LPArRQl4tsW+LB24RpAqnvgkcV4ejgTI8inYrjcBwSM8gelb2mWVq0C3erX02m6TK0otmSI3DvIu0n92GXAOQC/TIx24m3YTim7sinGnp4f3TPLPrU0q+Vtf5beFRhhIDyS2QABwNmc4IpPt1xFpEemRXcn2YzLdmIEgJMAVDc98HHHrWeJPNKmY/NjHXOPbNWI2fZMiHaJcKVzwxByM/Q80r3NFF2ub2hyXeiXFvLBbxTvfWMqQJuDkJIGi3YGcNwwCnkg+4NcvKhikeNlKspKkEYII7EV2eraaNN8MRX5tXtYL357TzZVaefYBG8m1RxHuORk4575riiMAV9Rk1O0JTPBzSabihBSnpQDxig+le0eSHTr1oowaMcDNWmAoODTs0zvTgM1cRMfninIGJxTVXjJ4FP78VSRDFcfTNFNPPPvRVJIQyMfu4/8AdXP5Cg9KVP8AVoM/wD+QpD6dqzjsi3uwoxSjFDj5jjFMEMyAfYUKB1NB689aPQCs7FXHKecelW9Ovp9Pv7W9s5Wiu7aRZopF/hdTkH/PbNUl4P1pwYVEopqzLjK2p9ieA/iFp/jbSpI7WQLq0UKvd2cibcNjBZOuY8kjOcjjOKvXEsEfkJ5X2dS2RsBIz/SvjbT7250+7iurG4ltrqHmKaFyjofYjpX094Y8ULcfD3S9UuNWtzdfZR9sMkqGR3QbXZ1JBzuB9cjB718jmmV+yftIPR9LbH0WX41S92R01te6hHeEska2Yb5SWOW561tGG21KMi7iV4+o3HJHevGNK8YWmv30c41iSO2ll8lTMohTd1wdzccEcml17xjqfhnUmi02+LoDkLdKJlY4B4x90c+prgUfY+7Uv80dtRufvQt8jsbzwjNBq801jDFBCwLLMoUE5HIZeM85rmtV8FarHB9p8LyR2d6jiUWxO2C4xzxnOxsgdCBWx4G+LVp4jl/s/WPslrqTf6rIMaOMHKkk4DdMeueK6y+vlMkSjZGp+UNICoPXgDHU8cfWlKNNq97FU69Y8H1f40eMdMnk08Lb293bny5hPAGZXXrxnmut+GvxZk16zvtL8Qami63MjfZGuUWOFjxxkADPfB9DT/iX4Ct7+0m1W7jjN2M/6VHje+B8qt64rwKXR/tTERYD5KEPVU5XbW7MKq5WpdD0Pxfaa7ass994lju/tExJ2mNG+VeTgDO0E4HPqaq+HtT1PSbpXlWORQc4VxyPUEfhXmlzZvZWylvl+YjCnkV0ngSX7TfQJPqH2SEt+8lByQmCTxg5PAA47iuWtBJ80dDejW5ny9D3rwD46/tee8026UCYY2lWJ2LjnJJwfpXYaatr9sZLXUop3LbRHEQWA65K9QK+V5rjU9MubldGu5svxMdozMQePl74PQkcHkVN4KstaPi+zntYGn1SS4QhHlEbSsTnG79T6CoitLy1Zcp3lZaI+w7S1U2ruxaJXPLvjc1Zk+m2VnffaLJzumHk3Ee8gOrd+O+f51BoVpd6NpEVprNzJd3k53yh/mVGb/lmh/ujBxWhdLIoKRxoAgDY74rSULpaDind66Moa74etLgz3sIbzvvtN1ORjp7etZegra2M7SkOJt/8I6Hv+ddBoF75hntstK23eoxjK9GwD9BUV99lgmm3xxGAhTGSvzA9vwzWjhGMVOOhtGpKLdKd2bUiWupIzx/OUIKkd+KyNRs7zT7Zns1DrDyVZjjZ0/yB6VZ8NwuLD906jcSw4ORziuhcB4+eQwwQe9bQblG+zZwTapz5d0jCtLpL4KwIy3VM8he1Y1/bpDqX2lRhUOAMdxWvFpsOnXTSW2USRyxXtuNUdQdmaWRgqRovBx0NaKpZJT3MalNOV4bHneow6tearLdwvstoH2SIcZ6ZAGBzzUWjwTul/NdImwOFbcQDIcgsSP0zXcxQNLazIZVjGcgg8+tEGhLd2Ic2EfkgExROm0M3B3MOvbIz3xWHslT05m29TeNVSaurFrTJY38H3DR27x3EMklqIwPlL7v5cgZ9uareC9FjsI7vxTej/SZIXW3AfciW/UN0+82Mn2wK2lFro+ny293cW8UEkquftMoRSG++AT34J968z+LfxJcaLJaeF4pJ/NBhE4UiIY4O098VE5xpq8v6ZrCE6zcKaunq/Q8p+L3i6bWJZIUnLSSP5bHGCRjk47elZHgHwos1hNqDyyRy7gkKoQC/97PoCO9c/p/h7VbzUlDBTIwLl5mIDeuTXrmgWN99i8orGhtgDtUHj3J9DXlYvEcseWEtXue5gcK6lT21SNktrlbUtOOo3afZLG8k1i1g+eNirM8JZiSAfldgSMY9cEd68uvY4zJNNErBCS2GGCrE5INeo+K/GGlW5W0ufKkuIwpYbTKFbaCSCvAwc4wfSvPNQ1XTptUjEVyk8E8DxbWVmCEg7TjqGyc+xrTCSmkoSRGOVKTc01fsYcolhwpDR+ZtLqw+8p5U+471ZsZJZLqJUWFpVJwz4BAwe5/rVe5DRuwfcrZwQev40bZFt9z2qmOT5RMy9T14NehF9TyKivozd0gxKlxerG/nOcRfvFTbtPRj3yMj8ail8Ralp2pYjkfyUfzBFvxsbbg4ZevBPr1qKLULQjizFvIDgNFKQpGMcj265q/NKl1YLDcOiWcVwv8ACpyCCGAJ/Bh9PpW121ozmaS3RlPdX+pCVooo7ePAjmfzDlyScAsxzk+ntWY95ex3IKzSCRF8td3UKO1bS6tF5E8WTFGE+zxIFyFI43gfgO3c1mW/mSXcccDotyMnzS23Jx6n2pSve99Qi1a1tijC7rKHiba2MccGp7YQRyEXXC8YZPmGO9REPIJJdykg5LE/MST+tCR+ZG75RUjAzlv5DvUIpj5nVVdN25s5BXABFUiRySMH0py4HstPxkZ4/KmFrjbaYpyqLnOQx6it7SJ1it49Qs2u5dbsrlbsARCSBI0Ibe/fIYLn+HHesHGeW6DnjvSxyPFnynZQw2sAcZHofak9dBLTc09Vv5tTvrm9vEiae5maaR41CDLEk4UYA5PpUEhKjbGrMkY5fB5BOec/dHP40lvMIbjJijlDI6YcZA3KV3fUZyPcCpVvroR3EIuZTDcbBMu84k2HK7h3weR6UMuy6CIqsQT06/Wuw8A+HZ/FPiG30iF1jZ45J9xIHCrnqfy/GuQjXIJ6AdK9E+D10tj4ytLwTBJYorgKFI3MVjDlSDgBWAK5JHfviiKu7Iub5YNmv8f9QB1Dw/pDLCLzT9PRr3y9uUmcLmI7flAUImAOORXkbEE8Vc1XUrnVtQudQv5PMu7qRppWAwCzHPA9KpV9vhKHsKSh16+p8jXqe0nzBSrSUtdaMBaBSUoqhC46U9RhSfwpqjnNOHWqSEOJNKM4zSZO0c9KM9KtEvUQZopfqKKpCGL/AKtR32L/ACFKelIg+RDg/dX+QpfQHtWUdkW92IOo9KM80ppMcA0xCH7optPPNNPFKyGmIOvpS55pMGlGMnNQMaDg0m1C25lUt645pcd6TtUWsVceDkeo61qaXrF3atHCT9ot+FEUnOB6Ke38qyun86VWIIKnBByDWNWjCrFwmro2p1ZQfNF2Z1+nQrqt7dQTRNNCsRuHZFPmRhMEHgHHX3H4V6v4cv8AVobbQktLhm0O4vdumi5k33EsJz5gdlypC4baTjnHGM48K0nVbrS9Ri1C2dvNRsN85G9SeVJHrXsfgDxLbX2o6RaGO1tbKYTLCEXb5Ug/e+WADgk/MOmeRgjpXyGY5fLCSTh8D/Psz6LBYpYhe98S/q6PVPF1lLa+HS0rR2trbS7pCAMLCTgnJPXnPtXzR4m014NZvYnVIJbSVoJCjYOef06H3zXrfxD8V3OqxJbxYW2dYYkTGGYuMEH88fjXHfECfTZ9Ps4LKznttQkZL66ubl1IO+NVIUD5ipKhuTxk+teNVqxlU54aHpxpzUFCZ5Xq08UNj5LAvO3cn7vrWBayiIFlkdJB93AyPx54rrfEGkrLHFFa3VvdO1ul2vkEts3DJRs9CB1HauOaJo4ssrbs8gjpXZTlfc82tCzutjsfCkiXF/5lxeosIdJLi6JYOB/cUFSWcgHGARnrgV778GNAsp/FDXsMdwbS3txPbNKCclsDJbaOOvBANfMmkxJGEme+ggV2/wBWrEvj3Ar6p+B/ifSbfRrm2WWJfLjExkLtmToCPmA6USgoyTeiKpVHKEl1PZhbqxLuAT0/DtXG+IvGtjofiS30q8gmZZ9oNwjKVjLHADDOfxrSuvGmlw3tlZwzRT316VSGAPg7m6Doe2SfYE18u/F3xAt94rup7LKTrKy3I5zFIrYK+/IzSr1paRpM0oU1q6u1j6XvrSW01q1u4OYpCyZGFbORge/epda0CS/tLiBfMjdjvSQPyPUV856b8WvFEwgiurqN7SPKyOIQAdxwBnt7V6d4I8d/YdRSwvUxbSFsTPIWwAODnuM4rNVYN8slZM6WqiSlF3aO+8HpLG0sVyy57YOTmunSHbxuLH37e1ctos6LfxvE6XEEm4xzdQcnJX2I9K6qSRQFaQd8Z9Pc104Zrksuhx4lyc7vqV2hY73ZQrjpzkGsbUAI0ldE3xn0wcVN4i8Q2ej6VqF3fSeUttAZip6t6AfU8D61594b8YzeJ/Dk93caVLZW7zfZgkTecXTHXoO5wT2NVOtGLt1KpUJzXNY7jQhAIxO8kZQt8iofvHPU/jWjrOrw6RavcXMU7qB87Im4L2AJ/GsXRLCeOW1dy6OB/qeygcDI7GuL+KdzHrG+134WxcqIcsFlwwUkgH5iDjg9Bk1zYnFSp03K1mdGFwSr11C+nU4f42xX3jLWLcRfaGs4Bsitom3LvH3mYDjfyB7DHvXH6dO+nQHSbzzre4VgQs2fn6gdenU+3Stq71KOyi8mN2imEm4wRqGJGOoORkVGbq18QsRPdp9oVTJnyAoQDA5wTgdPzrx51atRXnsfW0sLSw9lFK+wafc2z3Yifc5VgzLK23cO6nocHpxU+v6209pqSMiWskygOtv8sfl5DBQCc9VUd+p9a52+uYw4U3Bhfeu0FRuAGejdQevFbOp22knT0lkn+1Jt3vGV2szhgQN5YAZ5y3oMAc06FNe0i2Ti7eyk1uY2s/2MPh9Y298kMWoNGtxpstvPFKzBmIkSYYDKobewAzgEZyQTXn914e1FYvtP2WTyicq64Ye3IqS8Cq7+WmxSeAOSPqafHcRJs8pZonAHzCbgnjJ6fp2r2YM+SqQ6MNP1GRyyyCM3TxNAfMjDlgRjIz0YDv1q5Fqk8Nm1nLBbTIM7POUnbnrjmpLGG1k1CG6RVilib7QoupN0czBh8rEYIGM9Kr6lItzqUpWKKBGkYbUfcijPZu496d2tV1KS51aXQgEVwsRjCDG75tyg4OOxqmJxbyBmRX7gMMr9cVryeS9lIJjKJVDeXg8E568e1YkoWQt8u1R93JzT2M276IJ7meRgHcMoHBxz69etQsW5GMg9jzUi7VIHf3p5AK9cVTd9yOQi7DsB60jtxkkYpZgBGcHn0FQrgx4kGQTmkgbs7Cs3O4fdp6TDdgHFNdQOnAx2pwCsoI64piVyVCGFCxdWGDUcWUI2EVOjMDkYz9Kl3KjZkTOduSOelWzIsltbRRQQo8QZWmUEPLuOfnySOOgwBx61WYYA757VPbqyKQRgEZpjSszRs1KtvC71iUu4xuwAOpq3qd1HHaCxhTBPFwxHJIOQP8aLGSWwthdzSOpw8cUO7YWDLtYn1XB5HpWSzs7FnYsxOSTXv5RgtfbTXoeXmeMsvZQHSJjBHQimU/OY8elMxX0ejPBDtSgZ4pO9PjO0g01YTG0opXx1Uc96RR+BqrAOUU9hyTSAdKce1aJWIbEHSncUxs08D3piGkc9eKKUj1opjBBiNCAfur0PsKQjv6UzBMahWK/KvOPYVIWyO/8AOs4vQpiMwJyFwPTNNJP4U4kEDikPTtQISkIpaD15oAXIAAxUbDFOJ4oIpWHcRR69KQKC2M8UpIx0xSemBzWc4trQpD1Re5ownfNOVkfg/K3b0NGPVT70rBcQ/cOw/XmnwXEkKFFZlQsH+U4KsOjAjkEetNyB/DwaicNkt0BrOrSjUi4zV0aU6kqclKL1PTINSN5o+n6kZpDdxynz1ZQd5DKUcfkeMcY5rL1rUtQWxg0+5eS5t42Nwm87nClWO1WOSFGSdv3eM44rkrHULmxwbO4AVv8AWRuMgjPTH9a3otUSV4b3T7uWyv7Zt0cbN8wXGMK/fqevbNfHY3JqlKUp0leJ9Lh8zhVjGE9JFSeK2sdV8wrJPbqyZMLBdw43jJB7ZGcVzWtWm3y7uNJBFPn73qCRn36fmDXaixkvrWR51Iuk+dmI2l1OAMjvj19DzXK61LcRwfZXLiAsH2k/KGGcHH4n868qnL3tDurQTjqYDDZIN3APU10VlrNzplt5VpK0bSfLKCufl9OelczLMxYjnPQ1f0ZLq4uQIZdhY7dzEACulpNannRk1LQ9DbWbvUNDt1uLvUoyt7uF4yMYLLcir5wdGDbwAV2HjDZ61T1K9bxHdWzXVvPFqUgIuJHkDCYAAK3I3bxg7iSck9qTw5p1xPeQaVc389va3btG0yk+VvIGPMI6LkJknIHXjrWtpyTXk8q/2TaWdus7yowk3yDPAQyk5dR29etcrvbQ74pNq5s21nZxaMqwQQeXFHkLtDM7d8k9T3rc+GvhybWZZ3uJBNaKEZZELIIwc5U4Of4e1c7FLLa3At7eSIuzLtSL52bJ6ccCvb/hvYRaUk89y8HlXA3JIn3UwSCGOcZOePpUqPtHaXzNnL2cW4/ItzQDSIo/7NiWMRElo1JJPH3snvjip9a8baRaxSLe3bbEj3O2THn245zWB4o8QmbUJbexgjW0bEcUzF3ZiePuD3z1NeVeNvBeouY7nTxDcRBQ7QgGMy8nLZYkEkj+lcyxkYScIy0/A6lgpTgpzjr+JT8b69qHj/WF0nwulzNYxP50jzScyOeF5PO0DAC+pzivRfhlBdaboGlaRqdu8c1u80lwrsflJkJQ4H3gRgYzgYJ715T4Z1NtC1WS41JIrEFQvksuw8ejDq1dZffETUr/AE+eLQdRitmjdYY5BglcglnOevbHbOe4rtpuCjzNmPJKVTlS1Z6t4r8aWfh/T7iVtTj+3zxN9lttnPHBY8fz9sd6808Q38CWV9qEeo209vbXQtlEUpd7gbQWZSeSQzqC2P5VwzaiBdzTHMt05zJLNIXeQgdST/IVT1S4a9mGxcBeQTgkew9q4cRVVaSutEe/g8veHV09eunTsV9dja+Mt3FG9vACVUSyb3I6jJ4zwRVPQreU75VLLjgnODirnlNuVpSzLjce44q9aTW824Y2DGOFwCfXNZ87UbI7nRi58z6EerRpcRo8oDsmBuVcED/9dR+HLaG41IRXd40VmrKJP3LSsQzBSQB6AlvwqxqCNFb5Ks3HU8Vz+m7jq1srWj3iNcIZLQMVMqZyyjkdge4rTDXbscOPfJFs1LXS7TWLu10q2S303UoUkiuri4nLR3TrvYuowdnyqBgHBzXLWxYwiJAixygMdyKzA+xPI98Vra/JDLFb+VGRhAJJG/5a4JAOMcYGF75K9axHWRYyVbb83IHX1B/SvRi77HzlSPLoWAknmssajJwqAdzUBLhycYKjkeuaiabzGj2FlIGGcN1PY1dBiCFGJdFx9Vz1I9aozTIZrkOMp8rBdpU9z0z9cVAU3AAY+lSMMysMllHTdxiluJleY+VEkS4GFQnGce9O4kiBo+MnG4dsUjj5RgU5ywwQKQMD159qVx2RA6YIJxjNRyA5G3GKlkU7+vXvUchxgEcGrMpCbcpjnJ96QMA4HT+tP6Y24FRMAxyOtMhjwQMkHGakibkk9ahTOODk+9TQjB5Uce9Fhx7kykEgYrbtreJoxPPgRAYcFskMOQMep/LmszT4BLPvuGK28fzOw9PQVavboThURdkKnOM/eNengMDKvJN7HLisWqMWuoy9uWuZizcIOEXrgdvrVcCgU7BzjrX1kIKKUVsfNzk5Nt7gR8oI7mkFSggxEenNRA1aRIuKVetAFPAxxVcomxAMUtLSVRIvSlP9KSnEc8enpVoQAZ60uMDFAFKVI5yMenvQIVGwSSAfrRTRRVIQxfuIPQD+QpcelCr8i8fwr/IUfTjFZxWhoxB06daD6YpSQTz0pM/pSEJRgHGTilOOvekOOnegBNuelIetLj0oJ+h+tAxDyaT07UGk5HIqGxgaVXZehNN7ijvWYzS0ayutWvfs1t5Z2o00jSMEVI1GXYk9MCqly0Zmbymd4hkJvGCfqKgJ4I4PqPWjJ5oGObCrx1P8qa/bPP1oAGetKvzkdPrUtlpdzptB1QzwfY7icR3a4+zXEjcH1jYngDHQ/hUWuaPKtk13PkIJRDIu7JRsbs464x3rn5VUDCMW9SR1rYs9azZi1vIfPcHCTFiWVcfdI/iFfO5nlXPL21Ba9V3PawOPtH2VXbucvb2Ruzdug2qmMAnmqciSWsgEikYPSuvt7dbNgzR3Eaz/AHd0eEYZzwxPOMj+uKfqOnw3sOfNQ+zAhs9OgyP1r591GpWa0PS+rJx8zlodVngdhBNPFGy7WRZCA2Rg/pV+z1kRCP8Ae3J24/dg8cdAK6Xwr8M5dfZ9t20Sofm2oGwPz6+3pWjefCK9tp7Vbe78+CViGkZNuzAzz26dqfNCRKp146mBpfiRo9ft7sxbYU+9v5JGefxr3bTbi81WS+htQP7PiKs0stwCh6NnsvHY814t4a8MCPXM3UsJsYWIMrplZWH8K+vv6cV2er69AbGz017XNupcq3KGXJ+88YJGRjAJ6DtXm4uomvZ0+p9BlmFq8vtKny/zOrv9VkmSNIJBFtkUvcKd2/a3RV/unjk/hWrpuqyyxT28sjLZsTKsMgBAYgZAI5ABziuV0ySKQT3CAq23aXdjls4OPeqTajd2l3KZVBG3ZGmSRyeW4Ht0zXkOLbcYnvexhLoW/GVlazoTf29vLbE8eY2dp7Ee9ea+XHp7sLNTJDztDEjGenPsT+OK9D1C3l1m3ISXEABwzPtUN/XFczLpNxbxTRRQJcM/AlYn5PoP6munDS5I8rfyCpSg7S+136nNtdq7qTG6HvxxmrcF4sDEp8zH1qpIGE7RyptIOD3FTXltbpC32e9hnfghUVgR+YFd3KmY+1lG+ot/ez3LoYiiqE2E5xxkn8+a1/DfkIql2TeD8yuck++K5AxXYJVQ2enAzmuvtGNz4UXSpDpFtd2jDUGvZJG824EiAC3GF+8ueRnjFa+wvG3Q82WYcs72d2dFewG9tW8tcqfX9K4bWry68OXtpd2txNDqQMiSsuAFjYbRtPfKlga9B0krbaYGdxPLnAXbhR055561zHiy2mv5JraOeZfMCXJVYw4DrnJJ67Qhc8dxz61hhny1bPY6swTqYdpbnO3t2t1DGWcvbxR7Ix12LycD8ST9TWW5kMhiGCrpuyDkgY6GorGRXHly/ICTgf3T6UrRta5Ykb+xB6fSvRWmh89OXMrkCxxiGUFnGVO0bep9DVnKJZIpEe/GQwXLfQ1BKWk8yZyxkc53eh9/anonzgzE8DggZqzKyISwdizOS2elTXJVvnRNicYUHNVmVULMvXOSD6VMsplXaI89xSGrWFB3/OcHFNIKqdozn1p8cLK3zAoT1x3pxYqpUjoetMgq4Kg5yW/lUJ5GDwc96ttzzx0zVd0y3erREkNGCMYpSpcNgDaP1pAu05HBpQS2do57e9MgaiEEZ6Vdt7NnheZiqRhsfMep9h3pY7fYFabIOM7e5/wqWRt5BIwo4VR0UV7GCyydW0qitH8zzsTjo01yw1ZJPPvjSNECQp91B3P94+9Q4496PelHNfSwhGEVGKskeHObm+aT1AUp+tIKWtVsQGKUD0xQCDyKcKtITYncU+g/cB5pBn2qiWKTmkpBS0gFFPpgp9WmuhLHIMn9KdLxgcevFPtVDOFZtvGelMYBuRxzxVdBDPw4opRx170U0BEp4Q/7I/lSknJzTUHyrx2H8qXt796yT0L6hn6UCjafSgA80gEPFJ6U4g9xmmkZHFAIXNGOMCmlTkUgziocilECMdaTnFL82fWlAyPQ9qlsdhnFKAM8nA9aSUhTwOKh8zrxwKzcktylFslLDikDZOBURk5BGMelOdgxBQY+lZuquhfJcm4xg9qRSRnAzmpLeyvLmPzbe1nljJ270jJXPpnpXa+EPBEGr/ZRdXciSSyMrtt2woqjJJbr1BB6cketcGJzShhvjlr26npYTK8Rifgjp3exk+EfDsmszh3tppLfdsURsFMrdwCegHUmuq/saPTLPynhjt5SW+eIjcApA+Ynnv7dK9L8J6UtpdtxBbW0EaoqBRmNnGcn8Bg5/GvOvFV5N/bV8beZRaqETLkNjjOD2Jzn6V8Ljszr4+q1dxj0X+Z95luX4fBR5ElKSWsvXt2RZTRv7SCfbbbzI0H7sKhOM4yc9R0GcViav4bW1VnsFlWTknzOVPtzg/jWrousah9pgt55XLXMwiXyY1Ug5AXr2JPatGaUXM1zFPJcxzRB0Mk6lgFBzt64Bz+Neava03fmPTdGnXupJfqY3h+91nTQF06NLdid5eSRmBPryOOldbc65rep6FFaanLGJzkzywEIkqfwrjHp1OeataZ4claOe4YSSqlsk7BWAVVcZUMScZZew5zgVE+mxXEccS2zIHUI6B2bzG3E8DtgYAA9PenUxVWPu3tcwp4XCt3Svb8NLnBqlzJfubLJt7cHYzL+7VjzlV/zmotD0S61DUHn1FHWIHkuCu8np9a9AtNJXT1KFFkKsRgkAjJz83BwBnr7VUlv2indW8kYYYwC3y/nz9ay9o9kdztL4RdOsfssKjhWAyVx3x/9aqEuoLb6sYEiaYFcbo8HDnkgk+gx+dddpi2l/bqQgQQxuLm4l/1SyEsYuRyflwMdyDWHrejpJHbyCEqs2W84jawXHXPX0FZOm73fUmlWjJuPYoanbzW1uLrS3+x3DfNMjDzFlGOhTkH+dZs8t7dxq8NyCwAjYwx4AcjJ3AdOeK2BaShFjeZShHyvK20AY7n/AArB8Sa1b6aiLozMLpJBmaNiu0rnJ44YNnGG960opytF7Fy5YNyWrMC8wLZmSMNLcdHC/LjuQaz9N0eR5PMy8hJG8AHCj612Phy4fEH23TllYjzRM0QwQeqYIxjtx05ro7W1jEslxKqH5furGFVR7KB+tdM6qoK3UxnTVVqb6HC69C+gyLLGR59wgjQNHnaN33s9AT0H41meG7cT3eoIJ4I7iGN52M3QlSMKv+0ecCvRtYs4NQ0uVrmVY7d0IRgNzcKzAr6DcAMj1PvWDo+k21jHH5cbzySL584ZiCVOcAEHIbg1208TB0bS6Hj1MNN4lyibsmh3mnWt41zPbPBArM8izLJvKlQyqBzu+dTgj1rlfNW9S/1AQyS2dmIw8W4I8hZtm3d9WHy46A5rofE62kdhJLaxZleOPLyHc4l2KGJZsksW5/H2qG1tLXxDpFtY2EVnbPCyyLJPdGJQ7FvMkkP8QJjAAPAGSO1YRUW7o7ZzlGmufd/13PNLbwxdX7xfYy8t2wJkiYbAOC33icfdXPbqKy7gSLLJb3asjRMUYOMMrA969ZnuNHsNPge9FzOJC8k6xqqGZhkIEzgrH0yeuOnWvOpbO4k3TTnczne7OdxYn1zyfxrop120+Y82WBbl7mxkMjBV+bK+gpsm8IOTjvWpDEAxLhQAfTgVNe2dnHZLcXDg72wsUb4fAHJ6YHUY+hrVVk3Yznl04wc7mDI3yEMBkjBqKH5SSxYcABuwrc1bw5JFDZX7XmnSx3cSXDxWcjN9k3kgJICPlbjpk1lIyxzvHcKZIwSvynB9AR/9evRw2GeJuoPVHj163sLSmtGJMJI8FZDIufSo2lkJKuccd6uMyLnYxdD0JGD+IqF1UqXZNyHjA61Lw1SLtyu41iIy15lYijd+AdvA605ufu45pYo0KZO5fbHWrCiNchEAB4y3zH/61dmHyqvW1ei8zmrZhSprR3fkVxbSNg42qejHpU0MQhOUO6T+/wBAPoKfkt1JOOme1L9K+gwuU0qFpS1Z41fMKlXSOiGheaUjrS5JwPSgHrXqKKOC4mKMUv0peKaSAQUcUfypM0bALTgKRec5FOqriY+Mbj3P0pywluFdCc/3qjUkcgkH2pdzddx/GkSDxsjFXGGHUUmKUsWOWJJ96P51aSABUigHGelR96liIz8w4HNCtcTHAgKTnjPSmHgA0E0mO9UxC+lFJg9e2eaKLgRgnCgYGQP5UnTrQD8ox02g/pS4zj3rI0ZYKYIwCNwyPSmshJORxTovmOMc9KnCn6gDNO4rEBjwo5A+po+zsR0HPcEV7R+zTbW1z4z1CO5t4J4xYFgJYw4UiReRkcHmvpaFDEjKtnFFjOAijB54ryMbmf1ao6fLf5/8A7aOF9pHmufAJs2Zfvp/31mpotKvJj+6t5pc/wDPOJm/kK+9ZJJku7eNY0AkBJBUdARnn6GnO10bqWON1QLGGUbAckse+fQCuF50+kPx/wCAbrBJdT4Xi8I6/MV8jRdUcn+7Zy//ABNacPw08Y3Kgx+HNTwehaAr/PFfZ6Nfu11FHdxs6BSjCLjljkdeelR38Wqi3EkV9GjBiX3RLgLgnqT2rKWcVOkUV9Uj1Z8LeJ/DOq+HLpbTWrV7O4aMSiKQjO0kgHj3U1z7KByDzXs/7RnnSeOFFzJ50qWSIJMBdwEsuDgcdK8ckXpivUjUdSnGo1q0czjyycUQ855wBXU+DfC0+uXPmz5isIyDIWyGk9l9j69q2/hZ4VtNSujq+uecmmWsqrGIkDebLnoQeqglc/8A1q9PubeC3voZJLuaKPPmsJIgzygoSOF4xkAHsO/avmM1zeVFujQ+Lq+x9RlGUwqJVsRtulbf+uxiXujRQ2sOnWiLbgKhyhztB9h0JHrW9oFhFDqFpGXQQMUWNLcFi2TymeAG4+br+NQXVzG12kixLEsjokEEb5I8z5huHZcEHIrY1K6lElvFMYgljZ7VtVb92CfvSc5+Ykkd/wCdfIcjbbm/+CfZznLlUIaafd6DJBbSahqVxbo7WTW8dudxyQwbPHqMjPuK838Upps3inUYdqRJPP5izSLuEe8KTuA7DLcAdQK6zSlkdZt5TDJvRV4K/N/hXI+KtPk/ta3ugzyv5RGQFGMHGQO/Xn8KuFROp/XcU6KhHR67fh/wBfhzoc0+qA3jwSW1vdKot2yHmzn7hHRVGGJB4471114kM8ksGmCNio3bI5NzIBtwWyAcfMOSO9cb4Sa+eykhVS1vHLty7YUEkDI/TpXpPh2K31LV7KDW7f7c8caKm5xAY5dp+Xd/GBg/N3yKqs1UlyszgnQj7V7W2/rT8hLG5htbQJcW9w8pK5L3AKkBR8vr1Bx6ACqEGrSzzy2tsBCN2ZViG5uRwd3fjPOav3OnrPKsd0iL5OZCVk3gHnqe+O9JbxRxwzW5tkiY7pXuFlG6SPgJtX8enpzXJHmvK3Q1vTST3uU7+w1S/wDD6/2HCtxY36or7DtcSRzMCxBwcEY+gBzmsOXw1eQQ3H2y88pJHwYYpAcbeMn09sdq9D8PzW6Wc+jrBDDayIzXV1jLqhByAD9Og+tZep2MD+cIr6CaHcCrkiIEfQ9q6akvcThpf0MaFVxqSpz2vf17Xe1zj1VLG0SKCRmaIBQhY/Mo6A+oA6VnaaFF0n228lihQlmQO0gOOgHpz+GBVnUXt0YpCP3m4hwjbc8cH3H+RWW1zIg3xQQLG7M6Ec5YdePzrOF76npJKMbota3bbyF01CBkZa3ZiHBHGax9P8MXc16Y5lZGGc7s4Q9iSPfniiXWHM9sbwmVEG0IkhG7246c81tW1xY7IpSs8LSNtKuzFj35bPP1rZXjt1M27rlZasNMltQscUHkofklj3ksy4OdrHoTkcjGM1pxXSLaCzisZ/tAYQqoGRwMkgg/McA/rSeGdQS+e3gjlUSgGHZKeWYE4GSc9NoB7803xe0ez7AYkMjk+bubIHQcehHPNc0m3UtNaCv9nqc9rWrfa7BXQLiX93En9wFRwPyrotJkhXSoQkatJLHwzDLZZeTn0GOPrXJ6pp7NFcyQneYIyUQkKAvTA9W79ziuRl8UX2ialc6ZcNHNHExiZkJ9OcH8cV10qM6kfdOHFYylh7KXU9M8S3Wl6l5NjoUF8moyOBdM/wA6uMfei/utuwAMfxD0qtcy217qyaxe21m1zGYbaKDzMxPJGoDRGFR8w+ZR2G5hk4NYOmavZx+HTAkebqd1Y5+ZHjBz85ByASeenAFaKa8lhod9axOZtRvY1t490QMIjJYySKmMKVARVz1znqox2U9LxehzzhKylHXovn5mNeLFeW8szFAz3YjXPzPhFwdrA42E5PHXima3p72wSSQELs4Utnj+lX9G0SacidgsTAKsaMP4R6+lb93pUl5YWMscm681CY6XDCynhyR5jg91C4Ge24+lc3Nzz5Y9D1G40Ye89zgLUpY28V+x/eCfEcfGGAGST+JAxWXaB9V1cqyld54AQYznjAJAAq/4pA055bCRFaaKRkz5m7BzgnI47duKyNK1m70u6+0WsjrLgDO7qB0Fe1hMrrV6PtoW8j5zMc3pUMQqEnotWehw6V/ZlnMNU0uM2kKiW5lF18+0EEsAM8+3PWvM9WmiuNRuZrZWSB5CUDnLAds+9bOq+LL/AFCwNlxDA7EyhSWMn1J7ewrnmHPNe9k+WzwilOr8T/I+dzvNKeMcYUfhX5jVGfrUg4HWmrwOlPC5Ne7bsfPtj1XNPUAGkAp1dEY6GTYHvjpQKUUp5xWlhXGnv6UDpS4/KlxQK42l7Y7UpWgCiwXE69KMZp3fpRTC4dzQKUHg/lSnpTsTcQ03k9Dz9KcKDQwAE45GDSn+dHQ4pC3NPoAo4wPepl4RselQjgdanAGxTTSEyPjpig5PWk/i9qXoe9Ah2R0FFG4tjceg4op3AgHCrj+6P5U4deOnvSY4XP8AdH8qBwayNGToTnjoOasA8HnvVZMtJxjBIGaehOCGySR69/ahgeyfs2ySR+Lr8RorynT3wrNtBw6d6+jL6wvLi6nMbvGkrxkstww+RSCVAHTODkjB5PWvjr4deNJfBeuS6pFYrfSG2kgWJpfLG5iCCTg8fLXqUP7Qt7cxsx8O2kbpg4+1sdxPYfLx7189mOBr167nTjdWR6NCvCELSZ7zcwXX220ukihZ4UeIqZT91tuD09Vq15l2v30t19MOx/pXzq37Qmr+Y7Dw9pi8YAa5fd/LmopP2gteZwh0LR+hH+vkb/CuH+ysT1j+KN/rNLufRNvFNDcS+UlsofDFAW65JY9O+abqkgFlcpfi1+yGFzKHJwV6EHjpjivnVvj74iaNg+iaL8y7T88vIx9fSmj4/a/BZnbouiqka5C7pSOB9aP7KxPb8UL61T7nP/HQFvGkg+QIlqqoE6BBLLt/TFeZWlobzULO0BKtczJEGAztDNgtj2GT+Fdf4/8AElx4n1zUbu+hggmi3WwWDIUoDuBOe/z/AKVX+H1jc3OvRT2qAm3gkUk9S7hlUD35JH0r1KtR4TBc8t4r8egYaj9ZxSpx6v8A4c9T0/T7S10+10+ynEBWWJLO1ll+WCJmZnd2IwDyTgnJP4Vd1H7JeaYbm5YLtEuyQEDIbJVsDjBx+tO1Cxm1fxZq1gbKCwnVHLgSYwyqWViDx8wZTz1xxWXYxBN6ar9otiLZ8FlwJJE3FSQeADx93jp61+azlK7ctW+r6+p+l0nBRTi7WSdlbS/a2/8ATM+Oa6ttQtVks1EwCxCRGVZJI+OAf4cYH9OtSC/k1KRLe4MVzPAQMkhR5QGDz35IH1zSXkUuoWlolq8ayvACQrDKpubDEc88g/jUFjfx6dHP58zPCsca28mRuGwuSme6Hfux/eFZpprlZ2TuveSVyzpaTw3bvcEKHt/kU9c7h/SuZ1WEavrf2O4u/ssLQmVXMeVaRQSFz2J7Vo2HiGzs7jUmvZorKI2iqhU7EkYuXwR3bHYV54PFFvP4qN7MjJZlgFbbllAGMkf0row+Bq1HKdOOiX4nBiswo0moVJJNu3/BfkezeH3s7P8A0SW3hjthhiTCWKSHAzuHTrn07VcihD3sLzWyTwIQ7Ij8gEjKg9sgfoK41L+4ngW4W4ZrZJMxSRyFVYEfwnkEcHitDTb+S2aO4srqKTzXUzxsux0Y9duODj0/GuGcPvR3eybvKL3+7/gGnr/im00q8iitrZ7USqZE3IXYKeoBA9a46XxjD9rVUs5TNvKpLI2xFTgcjGePQV1WqeJra2tmtrs70KtlTINpH0zXF2d9dy3sken26pZ7RcRAooBDNglScZBPHGa1oxUlflMmvZq17P8AE6lL+4JXyNkzyNgvKwOPnYISRkYZFDD/AHhjIGaS58yeOMSb9hjeNUkJjWWXuQSMELlcg+tJap/xLbmG78lTaLM8QSL52kbagG4cEAqMDsGNU7G3aaaWKaO7VVkQeUyKARICowrHrvKDPY49q0VOMpe7EcXyRbcnp/X+RVn1C8EMNz5kLrOrqvz7mG0hQMnsBjHtXKzalJIkrXc0jkqEGAAI0XoeB78jHOBnNb+pRq1kbS3ZInQ7lIk+8TjcPY56j2rKGjX+mbkeUw78EtH8x8sYbp0xkKfyp0mk3fQ0qRfKrFOzsNls928sCrvVMmQAvu5IVSOPlyckjoa19X13Wr6S5y0QtIkWKFXhUbUVQqjGOTtUZ5xmobq6tZLWC3Z455o2B86JfLJfp8xzj8feuts9MS30wPqm2IysJTp/39sYy+WzyB0yM5OfStpPr0OaPJdX3RmCxaLYsF7bv5u24VIcL5ZUEABuozzn3Hpiob2aeSOzuIraafUJHdLmJfmBQDIkGDz/ABZHYV0uu6Z9oEeoafaRWP2qNZ2jQZCKqlfLyeccfkfpWHBqOl31/p2n+bEtrCxe4lWMypgjAG0csFxzg8ZNYJqVS1ro0lU/dXvr+P8AwfkcLrPipbd76xsYrJmeVgL0jzF2kBSUGOCeu6uOSwZr+WONjNGhz5oDBWXOA/IBwe2a9C1XwvNfXhW6ghjRBsDwoFEig4EgGB16/QioL3wZquxQkk93BHCpjViSViztXA/u54Hb0r0aOIpU1yrRngYrL8RVmqk3ddCXRovsdtIYIzHpqSKlxOF3DzsFlB9TgHjpxWijWTaJeySWarfXsiR2e0n5IoyTK57c8L75OMY55a0fZAY1BVBwy/3mHT8ua6p9R1LVdDsxBp0ZsdIiW3aa2iIKlyzbpD6tg+3FZT1k2j1aC5YRjLv/AF97Oo0W4trWwTMnyYyW7qO9ZniXWgLHTPmiWT7HNNGYrrd5LSy7mXb/AAtxjAPQ5xxg8gruHEk9w/kMwkEav2B5B9CcflWb4m1MXupXjQQx20c0rSGCIfJFk/cX2GBW+W5fLE1HGL06vyMc0zCOEgqk1qtvN7GXfziebCDESDag9BVVhSnHvSAA5r9Bp0o0oqENkfmlevKtOVSbu2JTwKM0prVLqYMBTk60xCTncMc+vWng84q4sTJeppQM00U/HFdUTNgRQRQc4pfrTEItLR0oOaBCd+RS0UuM9KAFx2pKTpSrwTQIF60Gl7U0A45pgOxikxzSUvSi4Cjp70UmfwpCDnrTuA7g1Mu7ygFxxUA5PFS5wgB6UIQg4BzUTSEHpUg796Y6ggilIETQyRgNuj35UgfNjaex9/pRVQE4/wAKKlTtuU4skH3Fzn7opemMdaaMYH0FLQMkXI3DuakPJLkY3c4Hpio04J5zUhAJIHvgUxMVQSqc8sen41d07/lq25VEYDYbvz0qhH95cdhVywVmjuyRwsSknHI+ZR/WlcaJbnKSOXC9c4Xn9agyQemR0B6ilkGUKohOc4980+7uFuZpHjXYjHcqg56AAc1LeoCYKMFbJ46Hng9DSzsBZzhicBG3Y+lJEfMBV8/KpwQehp03zW8iJtXcpBLdPrSvbUEXdZ2rqupHG4Fic+uYYmx+ZrsvhItsmka3dXa3IFtJBNE8DAfvP3uA/cp8mTj+tcPrzvFquoRblbPl/MOc/wCjxcj9K2vhvqc1teTaZFcGAapAQhbGwSxsWUt3+6XAx3YV4eZQdXL5el/usz28rmoY6F3ZN2+/Q7rXLu+FyLhrmO6jmIBPzcqePnYj5iBgZPpVaCGfxDKbeFZ1jj+d5HGUSMA5YkHhRj9PSkFxJpLXdqr7WhwCJF+YK4wU2nrg55rUudRktdPtW0ixDTmE2TyoFdrpBukLr1G1VA7k4PavzjkvLmlqfp8puEFGml5Pt/XkJZXMC6WbextrUPvIjljcucDI5k4+XIOAAeucmuF1nVLXwiyXCLBqeoSo4jjuYhLADwDlePuEsM564x3q8Vu5ZZWV/Le4JZYpC0ZAx06Yri/HUzy2trbJGskNi7gzpHjaZWLLGW6no2AfQ4ruy2nGpiP3h5ubzlh8K3S3/wAzk7q6nu333EryNknLHOM+np+FMhR5JESJWd2OAq9SaR42Q4ZSpPqMV13hTTXXQp9YEKsiziDzi4GxiMhQDySeTx2FfTYjExw9JzWp8hgcHLGV1Tbtfd/11H+HdOvbCZZ5ZGMCkqIg58ssVPDds9+nbrXV3mn3P9labfpaXVvayMVmcnYJnwDmM4wBjdg4PQ9cVlQSySWXlhS3k5ckDOAeCSa6XRJrdpbZNQSIwCRBL5bkN5DDa0agnGfmPIGeeDXytXEOtPnnufeUsHHC0lCley83qVry00ua0S3juENvDbvdTSybHlLsVVI1fAJ+bjB6LlgMkgTxaVanw9MoW3E8dtFdpE8hzKmQxKEDqcng4IAz9dyHTbC91LV59L054g8JuYLV5/LSzwDhnbBBBw2Bwc4zisfUtbhsbuZJ7Wexu2ZLhUeHYdpUcejKRxxwevtUTTaTRNNpycVo/Oxp6fdSTlFnl+zwRERzyLKHlfaQchskEkHOfXFWYbWRLua90XVohNaXSvAt3IxeZPU4G0ADt3/KvOb3Vv7S1Qx2lvEkjybxtGBxz0xwPauy1y01PULO5uPsS+RdbpZbhTsWfn5ig4z84J4zjHasvZyTbj1NXOMvdb/yM95b26nCWsaXF6svnGQAFi4+Y5J4bjJwffrSWotre4hn1GznLRv5Zt2dfm69QegwCeQQcVS0/Vriy0rUtPkikNzcGJmut+JIwgbCrnHJ3de+MVf1bStKt5J47a9a7meTC3QnKoFwcgkDnBJGeCfQVbglrct1JN8rVr/l/TM27s7u5uLOadI7WSGBYYkgRYBheQ/HUnOc/wBK7bR5dN1GIalOs00aLHZMjElXKxrkbjwSTycc815dqdsfKgjRJowpYM7SE7umMA9AB+dLb3epadps2n2swW2mmW4IYZYOoIGD2HJ470Thzx+Iw5HF+5G3+R32t6jbaraN9nurloo8pDCGbYUBBk3LnAH3guM9e1ccqWOk6drUzxXAluJU+zSIPlgA3bjwQecr7EdRwKxY5tUZDBFcM27JIK5x/EcelZ95Pf3RH2q4LpjGOgI9MVpSpuGl9DCs7xtyu56d4d1WIeH9Mu9euWlDwtsutwbeNzKqMSSc8HqOOKwtd16TUmtLbS3nijgQDzIFMckmOAp29VHUZ5yxrilYoAvAUHgdhV20kmVwYZXiOQSUYjH5U/ZpSci6b5oKD1aO58C/DzVvFlvc3Om/Y4bezkCSm5kMe04ycgAnAHWtOXUNN8P6sRHqMWp/JJcXllDAosJ7tlAjVRgZjjILDcOo4HJrI0vUr3w7pb6jZ30cd5LHNCqtIk3mAuiMoQcBwpJy2eDxiqGltEvieGCWJ3t4rhDJAJQ4YpweQAp/i7YANW3ybEKg69SXO7xWyWnqc/q1w1vO00qqZZCSibcKB6hew9K5xmJJJ5J5JNWb+6e7upJpWDMx6jpjtVY5IPGK+7y7BRwlJLq9z4DNswljqzl9lbCAZOTSjA70Z4pABXoHkCqKcOlItLVLYQUq+tNx2qVBjFaQWomSDtTqZS9K6bGQp5oJ6Un0o5oAcaKKKQgpc4FJ3oJ/GgBe1GPyozxQeuBVCDkmlHvRjvkUUWAaOtDdqPSikMXtQOaBSYwQKYhe4qT+AYplPHMf41SExoGKRjjrTgMUxlPNS0NajJBnp0opO9FZ2vsWtAH3V+g/lTxnFN6D26D8qAeaoQ4cVOx+UNznP6VEp+Yep4qSJQVbnk9PrQARZByOcDP5Vq6OilNT5+ZbYFOeM+YnXP1qhEB+8GOTjFe4/Cf4Raf4k8IW/iDU9SvY/tocJBbBAEUSFcknOSdoOOMZrmxGKhh4qUzSnTlP4UeNEZVWDAn5sDODwOP8Kj2BcFhjIHGea+nLX4K+EYZ40mvNWmd2wqvMi78cnAC8++K04fg74DTz91vLJ9nP73det+74DYbB44IPPauGeb0F0f3GkcLUZ8mqjHPKgkdSO9E4kMEoJ2qQSSa+un+Gvw3ggtbiXTrIQ3TotvJJePtmZvuhTvw2e2OtS2vw2+HS6nJYxaJpr30aCWSBpGd1QnhipY4BrGWb0+kWaxwk/I+RvF0TR65Oit/rIrU4x/etYqzba8e2ubSeMAm2kEignqQ4bH6V75+0v4b0nRz4futK0+C0kuDLBM8S43hI02A/QKQK+eXP7pyeu6qo1FVop9DSScKlz23xZqrX8FyllarDpEywXCR4QsA6Fhh8b8DY3HTms/SLlp4ILe0M00pkC/KpZiCAoPPoNoJBBII9KwvCfjaM+HU0bVpzA9qCLSfYGJBbJUnHB6DJyMelGraqkV2Lu3vQ4WMqWaRQPmJBACsSRjvj8K+CxODq0arhJO3R9GfpWDx1GthlODV/x+fX+uu5reMbO407U3hmkEo882jiMEZdHOTzk/ka5jXb21XULiayhEsqnKRKMhQON2MY6k8n1rqrm9i8RaHcS2c+/wCyyRQRQRxSMct1ZWxjJOeCck+1Yuj2GnGwuYkiaHV0lDbXG9RBjkE54b5gaxiuXWStY2knViop79fPuZGiaZcanqM1/qMsixW+JmhiCuY0zhR87AHkgY569D0q1c6U0T+VFFLFF/rVSUjKg98DjuBnHPtWy+nQvHI9ukHlR/KZfOHzP1xsyTx71nXUI+0I9zIsrbizp9w88nkjGDz0yBTlXdRJPobUcJTw7bjq39/zMx4pbe48lkmS5RgzqTxjGRwPqDWnpOoC3uVYhxKh3RyByCj9Awx3GavaaNNuJrRJ3a2YRAySCIyOfm5O5iAcKMjjkgCr2p6JHqGq3N4mowb7mUzAsFjPzcgbOikflWcrXNoSbdmjotHuZ7O30+PSFgW+umlaWJEDPuDPGCzk/dKvjnjv1OayvEV6dcurj7cTOYiyx3skeCwAPykjIPPPrnvWn4Utp7C4QXc8kdsy7C4ZQJMEHb15BIq1dtpsbTBA1w2TiOJQkcRPpjr+ArOd0rszjTjGo2lfz6/eeZXXha93yz2e+OWGWEbSOY45Au2RjnG0kkd8bTnFaOo6ncLBplrc3Ek8dr5iR/NiIHfkOozweWzwMg9xXXNK0X2eCNbeaFmMwiGQ1qy/K3sQ69Rk464BrjPF/kta/bbF4YYZJGkEXzZQlvugsBnGa0U3JpImFNQvOS/r+v6e76W70Wxv5Gk0+V7iVnX5XyoIPBycjPQMMf3sHkVhTQzabqDLeQADqMnt6itPw/Lb3kcN8YEMzArKsc5Uqe3B5OP85FWbhZWtJ1DGa4bDqg2YI5yDknABxzVSpuUtxwlaK6mTcrBewGSRSowNrBveo4IbO42wySRs69h2B6Grawi2e1a8sXltgwEwyEL9eQMYwCR78VNP4cie5ZlliViCpEcoCnb0J7ZPoD9ay5LaXLde3Q5HVbU27kbRtJwpzy/I+6Ovcf5zWdLaSDBlQxJgElxjAJx0rrvF9tGINOWB4pI7SLySyPt3lmLb8HksM4Jxj7vJyawftNm3lC5y7Ipd3LhixzwoAPH411RjoczrOT1VhthotvPBHJcRyNvYFcHl1B5wAfbHNSbUmuTHYWbi2eTKxcsxA7FuuP0qWxuXupmllZorcsMomCzHoBk4/KrdzI9tHtuIBHOhaHYuRtweh54P0qW31NYQS2WpTstRurpIdML28Fh9q+1jzYVKq6pzk4yRgD5enTistryS3huLyORI5uUQgfxPnOB2wCxqWWea7jhhcs4gTy4kVegJzjjqcnqeazfEXlxSQWq4MkSlpWU5+Zv4fqAMV6WV4f6xiIprRas8zNsT9Tws5rRvRfP/AIBjn9BSc0pOaTFfdpH5m2KB60d6OacP1q0raiFxijvQMdqWmSIDzUoBApqjjpTwe1bQRLY6ik70tbECU4d6Q+1HIoAUZNHNIKdQACiigUhAfelBppoyOlMB/elI9DTQeeacBgjrt6n1p3YmNYHqKTGOOtPBxjPShhxmiwXGgDPNBHrSY7DmnfXrQgCpUx5R9ai9akQkLiqExpHPNNP604GkA7/pSAjGBnIzkHHPein8k4HWis2ikyLrigUueARzkUijnPUUdSiQDLVKDkEjt8xqFc59qkXjIHTGKGCRaRdsKk4O4n68f/rr62/Z6BT4P6UpPSa6H/kd6+S0JaNASTjIUe5OTX1b8Crgp8IbZI4mMsFzOhTuSZS38mrx83jelH1X6nZhJWk/Q2vFY0qPxh4MutSuLmK8W7mhsUiXKSu8ZBDn+Ec9e/Q1a0yy0OHUfHRhiu3eeVW1NHUlXP2deI/UFD+ZNZ+t3Oqi70aW00NL1hd4aSVgptIyBukUnPOMj9O9dW9/Ol3eJHbIYwoMUu8ASuR0I7c4Gf8ACvEqRkkrdu673/r/ACOiFWLvqjmmPhu68F+FLo6Vc3GnRTWp06KVNssDD5UcgkdAMn+ta1vNpi/EW8gj0mWPV205JJdR8vCSxbyBHuzyQeelULrU/Fsnhy2NrYaPFrvnJ50b3DGBYt/zbTtyW2gcYxycE45urc68fFcc262Tw99jKPbNgzfaN+Q4I427eOT+HelJSafz6/1/wSlVgnuec/tWRg+FdAm7pqOz8Ghk/wABXyncHMbgHo1fW37S22++Gscy8NbalASPQkMuP/Hq+RpySs3b5un416WBv7HlfdmVZpyuiAZ/ClBxTA2M+ppSe/6V0paEKR3mg6/bR+EItIiuLlbpZ2maFn2xyEsCMYGSeBwSPu981JoMFwftFxD9nnYwMZB2jQtg9RyckdPX2rz8MRzWnpmsXFnhFy6L91S2Mc5/L2rwsdlMqspVaTu30f6f18z6fLM9hSjGjWVkuq/Vf16Hb30819paS3tyi3EjebFI0WMqp2H5+OmBgYOR3rJv9agSGwlitVe5hLPJK6hllyThdnQADFU9W8T6lqdukE1xIsARYvKDfLtXlQBjAAz2rFLuwC7jtHQelOhw5OSUqkreW/4muK4mpxbhSV9N9vw7HS6nrEGp35eytp7XzI1RIWlDKn94KeuDjoe5p1hNNNHIHkKqpwct0GORzXKhyDwcVZW9L5ZiWLDr15p47IFZPDb9mZ5dxLJNxxP3o9T0XX5f7Ma3jmQiNgUUqCBnHI9D1rKuprqO9NtDM8aSHc3z8EepNcB9tnV/3bsq4A9KedWvTkC5cAjbgelcNPhyu378kvxPQq8U4eK9yLb+47a11SHT7h2kkdk2lfk5JJ+p/wAamsJbCO9knaGG9tJVaMKULgBVyT355zntXG+Grya016zuFSOfy33Mk3KkDnPIPP4V6hc2zafodmYNNjsVvbULJdWs7N5SE/IkjLwVI27QcexNcmOy+OBny819LnXl+ZzzBfDZeb/ruZhsI9L8tLKa1byVQSkSKAxIz8pGdx55I6dO1OF5El9F9lL7wvzS+TwWIyV98jvS3Hhy3Om2+ovqQjMspyTcBwV/2sD5G7Yycg5OKq2NtDHfiQ3VzJpjuA7BB58SkcEqcDv1z6V5/Mm731PUjde6lojoL172ezd1kjIC7jvGArd/bsDms6w1V5pILC/GZo284GJhmbJJ8sk424HetG2V7S7SB7kTQlGPnQp5mPlJG7B2kYIyQTjB4Fc3r2kLqEhW4QrfxMBvjVj5IJONxwMEgcdq0pzjf31oYYmnKa/cvVDNYniFtNd2k8isPmhJXcVkU/dYdh0Oe9Yus2w/tKG4jtorWG/T7WkESfJCrOVCjnkDaT0GOnNaGi2qpr5uoJI7OK2jZJkPzNcbvlAVSSCeQTjtzWdrDPDqMk5kyrJ5aRRNkKoxxnBwQAe3Ga3ailZdTjhOpJ+0nunYtQRxQXEaXALeSPNIY8FuMNgD0xxTdQ1IXAjRBIFBZsn1Pf8AlUj6U0OmXF5YQvJpLyER3coXIOMlWweDnOAQCRg8ZxWaiyTyw2+8BCcGQ8Ko6kk/SslScnZHd7dKHM9CxZ3A0rT5NTPMpYxQDuXx1+g5Nce5JZmY5ZiWJ9SeTWlr2prqNxGIE8q1gXy4k6ZGeWI7E8Vmda+4yzBrC0rPd7n57nGYPGVtH7q2Ex6UooxzinAYr00eOH60etB/U09Vq0riuNAPYU4KaeAO1LWihYi4g44pcc5oxTlFaxRLYCl7DFBGOaD0BqhCUHmil6e9ACnA4opRRtwOTmkK4lHSgfWkIpgHUUnX604DFIR6UDCpFPygdx3pmcCl6d6LiYu7J/Cl9RnrUZODTsjOadxWFIxSDHegHjrSkDNFgFOMD1/nQudpo6AccUnSmIUGjPWlHammgBQR6UU09faikFhnQDPcUAnPFKOmaT0qCxw7cVItMHWkD5OMChjTL0Rwo2k8ZP619Lfs6zFvh1doWOU1dwcnsYk/rmvmQ5AIzxnFfQ37M0hbw54iiP3Y9QhYfjEP8K8zM1ej80bUXv6M9kJJAxScgDHFPQc/hWV4e1c6zZ3ExgEPlXUtuFDbshDjOfevAc0pKPczjByi5dEacZy5znNPYADPpUTybWjXH3m2/Tgn+lOY5+X1qhPY81+LqyXXw18ZiZiy2Wo27oD0UbYG/m5/Ovk2f70/pu/rX158UU8j4YfEN4jgvcQufqUta+R5V3G6bONp6YruwMvca8/0R2S0jH0KKgZFPAz6VGOc04Gu6KIY0jn+lOX7woYdKVeSKOWzC5bQ5FL07UIPlFFd3Q53uNI46Um0AcdKf0/KkPak0tx3YKMCk2gHp3ox70oqdGhpu5oRRS2ul/bhFKDLKEt5QnylkZWcZPfGOn49a7/wh4iaSwml1e9mnthNFbJauTveEZdQxwcRqwABAJGfSvPLW6mitpoo2AXryMjnAORTQZS0U0k0jPwMDCjr6V8tmOWYjE15SSVt/kj6zLswoYajDV32a8zpP9Ji1O5tbh3ubCMZuFhJWOeQjO7IHGCQOAMBcVr3c0Vtp6XUV1CYXzC0KsS4QpkNnpjIYdeqngVymsKdOYSwSSgsFJAbHDdR+teheKU/s7w1pWqJjzLkfYr5EG0XUTxRT49EPRSQMnGc9q+ZqU1uz6qjX9nPlW7ZhRfa9I1J4by2ijtzt/cqp2ycBic9OQRk+9N1TUFeeQK08DdAqjlV7BvX61lXRaWB1jJjAYSqSSxAA4XOegB/SmauzzyGdnYHbnA68HHWojT5ndHTOq6SafQW/g1AEPbMJ3GT+6TB5/iGPaqHh23uk1LM0g8oAs8crHD47fWqV74gu1cwvtb5yCwyCRnmutu7WJPD+m3UYI8/duU4PPsfSt2p01r1OCPscRUag3pqRXOp3Vq1xZ6fJJaW14m24jHyiQDkA461zWpX5GbW0ci3UbWP/PQ9z9PajVL2W4ht0cniPBPcjceKza+ryzLVRiqtRe8fJZtmjqN0aTfL+Y3g0u33oxg0or3Ej55sAOBTwuetCjkCn4xW0YdyGxAmDk06iitUrEhRQetAoAUU7tSKM0ZzWiViRQPekI4pR2p1FwGDmnooJPpS4penShCbEbqfak7fX1pc5pDy/NDEhKOc8UpGCRTR1pDF/nSZ7Uvb8aX0oAbik+tP7Unp+VADTRnilPUUh5pjFU08dM0zpSqcmmtxMcTmlxTR1p5JCkimSFDYyB1BHNIeQDR1TNADO/t0opW7e9FJgf/Z);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Gross appearance of a mucinous cystadenoma of the pancreas and attached spleen.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Michael L Steer, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f27_45_28373=[""].join("\n");
var outline_f27_45_28373=null;
var title_f27_45_28374="Ileal J pouch construction by securing loop of ileum to ileum";
var content_f27_45_28374=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=SURG%2F83914&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=SURG%2F83914&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Ileal J pouch construction by securing loop of ileum to ileum",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 377px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f27_45_28374=[""].join("\n");
var outline_f27_45_28374=null;
var title_f27_45_28375="Anatomy of the presacral venous plexus";
var content_f27_45_28375=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=SURG%2F52520&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=SURG%2F52520&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 551px\">",
"   <div class=\"ttl\">",
"    Anatomy of the presacral venous plexus",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 531px; height: 538px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This figure illustrates the relationship of the presacral venous plexus with the sacral aperatures. The veins are vulnerable to injury with pelvic dissections.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f27_45_28375=[""].join("\n");
var outline_f27_45_28375=null;
var title_f27_45_28376="Pathophysiology, clinical features, evaluation, and management of acute mitral regurgitation";
var content_f27_45_28376=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Pathophysiology, clinical features, evaluation, and management of acute mitral regurgitation",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?27/45/28376/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?27/45/28376/contributors\">",
"     Catherine M Otto, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?27/45/28376/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?27/45/28376/contributors\">",
"     William H Gaasch, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?27/45/28376/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?27/45/28376/contributors\">",
"     Susan B Yeon, MD, JD, FACC",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?27/45/28376/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Dec 5, 2011.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with acute mitral regurgitation (MR) are often gravely ill with significant hemodynamic abnormalities that require urgent medical and usually surgical treatment [",
"    <a class=\"abstract\" href=\"UTD.htm?27/45/28376/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The pathophysiology, clinical features, and management of acute MR will be reviewed here. The changes that occur in chronic MR are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/2/36901?source=see_link\">",
"     \"Pathophysiology and stages of chronic mitral regurgitation\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/30/9705?source=see_link\">",
"     \"Etiology, clinical features, and evaluation of chronic mitral regurgitation\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     ETIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although there are many causes of acute mitral regurgitation (MR), many of which can, under other circumstances, also cause chronic MR, there are only three basic mechanisms of acute native valve acute MR (",
"    <a class=\"graphic graphic_figure graphicRef79932 \" href=\"UTD.htm?5/22/5476\">",
"     figure 1",
"    </a>",
"    ):",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Flail leaflet due to myxomatous disease (mitral valve prolapse), infective endocarditis, or trauma.",
"     </li>",
"     <li>",
"      Chordae tendineae rupture due to trauma, spontaneous rupture, infective endocarditis, or acute rheumatic fever.",
"     </li>",
"     <li>",
"      Papillary muscle rupture or displacement due to acute myocardial infarction or severe ischemia or trauma. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?38/19/39225?source=see_link\">",
"       \"Mechanical complications of acute myocardial infarction\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?17/55/18297?source=see_link\">",
"       \"Ischemic mitral regurgitation\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Different mechanisms are responsible for acute MR in prosthetic valves:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Tissue valve leaflet rupture due to degeneration, calcification, or endocarditis.",
"     </li>",
"     <li>",
"      Impaired closure of mechanical valve occluders due to valve thrombosis, infection, or pannus formation. With older generation mechanical valves, there were instances of strut fracture and disk escape, but these have not been reported with currently implanted valves.",
"     </li>",
"     <li>",
"      Paravalvular regurgitation due to infection or suture rupture (often related to a calcified or scarred annulus).",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     PATHOPHYSIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The hemodynamic changes in acute MR are more severe than those in chronic MR due in part to the lack of time for the left atrium and left ventricle to adapt to the mitral regurgitation. This is in contrast to chronic MR where these adaptations have time to develop and typically preserve hemodynamic stability. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/2/36901?source=see_link\">",
"     \"Pathophysiology and stages of chronic mitral regurgitation\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The degree of hemodynamic deterioration in acute MR depends upon the etiology and degree of MR, which is often dramatic and rapid in onset. An important factor is left atrial compliance, which is usually normal unless the acute regurgitation is superimposed upon chronic MR. Since the normal left atrium is not compliant, the sudden and marked increase in left atrial volume in acute MR results in an abrupt elevation in pressure within the left atrium. This is immediately reflected back into the pulmonary circulation, often leading to pulmonary edema.",
"   </p>",
"   <p>",
"    In addition, because the left ventricle is not dilated and most of the blood ejected by the ventricle goes backward across the mitral valve, effective forward flow is limited. Despite a compensatory increase in heart rate, cardiac output falls, possibly precipitating cardiogenic shock. The neurohumoral response to the reduction in cardiac output is an increase in vascular resistance, which exacerbates the regurgitation. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?3/41/3737?source=see_link\">",
"     \"Hemodynamics of valvular disorders as measured by cardiac catheterization\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    If the degree of regurgitation is limited and left atrial compliance increases, the pressures within the left atrium and pulmonary circulation fall and hemodynamics improve. However, this does not occur in most cases because the amount of regurgitation is large and the left atrium does not accommodate well. Thus, urgent surgical intervention to repair or replace the valve is usually essential.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     CLINICAL MANIFESTATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Acute mitral regurgitation typically presents as a cardiac emergency with the sudden onset and rapid progression of pulmonary edema, hypotension, and signs and symptoms of cardiogenic shock. In some cases, the pulmonary hypertension leads to acute right-sided heart failure. In clinical practice, acute mitral regurgitation often is not recognized at presentation because the clinical history mimics an acute pulmonary process (such as infection or acute respiratory distress syndrome) and the physical examination findings often are subtle. Primary care physicians should include acute valve regurgitation in the differential diagnosis of any patient presenting with pulmonary decompensation and consider echocardiography early in the disease course to exclude or confirm this possibility.",
"   </p>",
"   <p>",
"    The presentation may not be as dramatic if acute MR is superimposed upon chronic MR or the patient is younger and physically fit. Such patients may present subacutely in the office or clinic, rather than in the Emergency Department. However, they may note a sudden and marked increase in symptoms of heart failure and a low output state, with increasing shortness of breath, dyspnea on exertion, fatigue, and weakness.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Physical examination",
"    </span>",
"    &nbsp;&mdash;&nbsp;The patient with acute MR is often in pulmonary edema and there is evidence of poor tissue perfusion with peripheral vasoconstriction, pallor, and diaphoresis. The arterial pulse is often rapid and of low amplitude or thready due to the reduction in forward output. When there is an associated increase in right-sided pressure, the neck veins become distended; they may also become pulsatile with a marked \"v\" wave if the elevated right ventricular pressure leads to tricuspid regurgitation. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/15/33013?source=see_link\">",
"     \"Examination of the arterial pulse\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/59/33719?source=see_link\">",
"     \"Examination of the jugular venous pulse\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The cardiac impulse is hyperdynamic but is usually normal in location because left ventricular size is normal. If, however, acute regurgitation is superimposed upon chronic MR, the cardiac impulse may be displaced due to the underlying left ventricular enlargement. There is often a hyperdynamic precordium with a right ventricular lift due to the acute increase in pressure within this chamber and the development of tricuspid regurgitation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Cardiac auscultation",
"    </span>",
"    &nbsp;&mdash;&nbsp;The murmur of acute mitral regurgitation may be early systolic, midsystolic, or holosystolic. However, since the pressure within the left atrium markedly increases during ventricular systole and the pressure gradient between the left atrium and ventricle diminishes or disappears by the end of systole, the systolic murmur is often soft, low pitched and decrescendo, ending before A2. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/37/26202?source=see_link\">",
"     \"Auscultation of cardiac murmurs\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/56/22410?source=see_link\">",
"     \"Auscultation of heart sounds\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    When present, the murmur is often best heard along the left sternal border and base of the heart, generally without a thrill, and may radiate to the back. It can be confused with an acute ventricular septal defect which, like acute MR, is a complication of an acute myocardial infarction.",
"   </p>",
"   <p>",
"    An S3 is commonly heard but may be difficult to appreciate if tachycardia is present. With the development of pulmonary hypertension, P2 is increased in intensity and the murmurs of pulmonary and tricuspid regurgitation may be appreciated. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/56/22410?source=see_link\">",
"     \"Auscultation of heart sounds\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h3\">",
"     Silent MR",
"    </span>",
"    &nbsp;&mdash;&nbsp;Approximately 50 percent of patients with moderate to severe MR have no audible murmur, particularly those with acute ischemic MR [",
"    <a class=\"abstract\" href=\"UTD.htm?27/45/28376/abstract/2-7\">",
"     2-7",
"    </a>",
"    ]. As an example, a community-based series of 773 patients who underwent echocardiography within 30 days of an MI found that 89 had moderate to severe MR; 28 of these patients (31 percent) had no murmur [",
"    <a class=\"abstract\" href=\"UTD.htm?27/45/28376/abstract/2\">",
"     2",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/55/18297?source=see_link&amp;anchor=H6#H6\">",
"     \"Ischemic mitral regurgitation\", section on 'Presentation'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The presumed mechanism of silent MR is a relatively low pressure gradient in systole between the left ventricle and left atrium due to the combination of a low systemic blood pressure and elevated left atrial pressure. In addition, acoustic transmission of the murmur may be obscured by obesity and respiratory distress. Thus, the absence of a systolic murmur does not reliably exclude the diagnosis of acute severe MR.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     TESTING",
"    </span>",
"    &nbsp;&mdash;&nbsp;Testing in patients with acute MR consists of an electrocardiogram, chest radiograph, echocardiography, and, in some patients, coronary angiography.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Electrocardiogram",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are generally no electrocardiographic abnormalities specifically associated with acute MR. There may, however, be changes that reflect the etiology, such as an acute myocardial infarction, left ventricular hypertrophy, or P-mitrale reflecting underlying chronic MR.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Chest radiograph",
"    </span>",
"    &nbsp;&mdash;&nbsp;The chest radiograph usually shows a normal size cardiac silhouette, with severe left-sided congestive heart failure and pulmonary edema. An enlarged left ventricle and atrium may be present if chronic MR has been present prior to the acute event.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Echocardiography",
"    </span>",
"    &nbsp;&mdash;&nbsp;The echocardiogram, including Doppler studies, should establish the diagnosis, mechanism, and etiology of acute MR. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/41/32409?source=see_link\">",
"     \"Echocardiographic evaluation of the mitral valve\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/3/42040?source=see_link\">",
"     \"Transesophageal echocardiography in the evaluation of mitral valve disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    With transthoracic echocardiography:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Left atrial size may be normal",
"     </li>",
"     <li>",
"      Left ventricular size is normal",
"     </li>",
"     <li>",
"      Systolic function is normal or hyperdynamic",
"     </li>",
"     <li>",
"      The duration of aortic valve opening may be reduced",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Other findings are related to the etiology of acute MR:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      There will be evidence of a flail mitral leaflet when the etiology is papillary muscle or chordal rupture. With papillary muscle rupture, the ruptured head is seen in the left ventricle and usually prolapses back into the left atrium (",
"      <a class=\"graphic graphic_movie graphicRef73295 \" href=\"UTD.htm?27/19/27952\">",
"       movie 1",
"      </a>",
"      and",
"      <a class=\"graphic graphic_movie graphicRef77752 \" href=\"UTD.htm?33/17/34065\">",
"       movie 2",
"      </a>",
"      ). Chordal rupture with rheumatic disease more often affects the anterior leaflet, while chordal rupture with myxomatous disease more often involves the posterior leaflet [",
"      <a class=\"abstract\" href=\"UTD.htm?27/45/28376/abstract/8\">",
"       8",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Vegetations on the leaflets may be seen in patients with endocarditis.",
"     </li>",
"     <li>",
"      The severity of regurgitation is evaluated with Doppler studies. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?31/41/32409?source=see_link&amp;anchor=H21#H21\">",
"       \"Echocardiographic evaluation of the mitral valve\", section on 'Determination of severity'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Transthoracic echocardiography can underestimate the severity of MR due to inadequate imaging of the color flow jet. Thus, when transthoracic echocardiography is nondiagnostic in patients with suspected acute native valve MR (eg, acute heart failure with a hyperdynamic left ventricle), transesophageal echocardiography provides improved images of the mitral valve and assessment of regurgitant severity [",
"    <a class=\"abstract\" href=\"UTD.htm?27/45/28376/abstract/9,10\">",
"     9,10",
"    </a>",
"    ]. For prosthetic mitral valves, transesophageal imaging is almost always necessary and may be performed before transthoracic imaging when the clinical likelihood of valve dysfunction is high.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h3\">",
"     Exercise echocardiography",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most patients with acute severe MR have hemodynamic compromise and exercise testing is not appropriate. However, in patients with ischemic MR, regurgitation that is trivial at rest may become severe with exercise. Detecting significant MR under these circumstances may require exercise echocardiography.",
"   </p>",
"   <p>",
"    The mechanism of worsening MR with exercise may be papillary muscle displacement (previously known as papillary muscle dysfunction) or alterations in papillary muscle orientation due to hypokinesis of the underlying left ventricular wall. However, worsening of MR with exercise can occur in the absence of detectable ischemia, as evidenced by the absence of chest pain or typical ECG or echocardiographic findings [",
"    <a class=\"abstract\" href=\"UTD.htm?27/45/28376/abstract/11\">",
"     11",
"    </a>",
"    ]. Such patients can present with acute pulmonary edema and have a worse prognosis. These issues are discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/55/18297?source=see_link&amp;anchor=H7#H7\">",
"     \"Ischemic mitral regurgitation\", section on 'Effect of exercise'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/55/18297?source=see_link&amp;anchor=H8#H8\">",
"     \"Ischemic mitral regurgitation\", section on 'Association with acute pulmonary edema'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Cardiac catheterization",
"    </span>",
"    &nbsp;&mdash;&nbsp;In selected patients with acute MR who are hemodynamically stable, coronary angiography may be warranted before surgical intervention to detect significant coronary obstruction. Although data supporting efficacy are limited, these lesions are usually revascularized at the time of mitral valve surgery since concurrent bypass surgery typically adds little morbidity or mortality to the procedure [",
"    <a class=\"abstract\" href=\"UTD.htm?27/45/28376/abstract/9\">",
"     9",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/53/36697?source=see_link&amp;anchor=H4#H4\">",
"     \"Surgical procedures for severe chronic mitral regurgitation\", section on 'Predicting coronary disease'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The 2006 American College of",
"    <span class=\"nowrap\">",
"     Cardiology/American",
"    </span>",
"    Heart Association",
"    <span class=\"nowrap\">",
"     (ACC/AHA)",
"    </span>",
"    guidelines on the management of valvular heart disease included recommendations for coronary angiography prior to valve surgery (",
"    <a class=\"graphic graphic_table graphicRef66360 \" href=\"UTD.htm?29/4/29772\">",
"     table 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?27/45/28376/abstract/9\">",
"     9",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Coronary angiography should",
"      <strong>",
"       not",
"      </strong>",
"      be performed before valve surgery in patients who severely hemodynamically unstable.",
"     </li>",
"     <li>",
"      Coronary angiography was recommended in patients who have or are suspected to have coronary disease (and who may have ischemic MR) and those at risk for coronary disease. At risk was defined as men &ge;35 years of age, women &ge;35 years of age with coronary risk factors, and postmenopausal women. A higher age threshold of &ge;45 years was recommended in patients without ischemic symptoms or coronary risk factors in whom MR is due to mitral valve prolapse. This is based upon data from a large observational series in which only 3 of 220 such patients (1.3 percent) had coronary disease and all had single-vessel disease [",
"      <a class=\"abstract\" href=\"UTD.htm?27/45/28376/abstract/12\">",
"       12",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      The weight of evidence",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      opinion was considered in favor of the usefulness of coronary angiography solely for acute MR in patients undergoing emergency valve surgery.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Contrast angiography of the left ventricle is generally avoided at the time of catheterization because of the contrast load in an already compromised patient. Furthermore, ventricular angiography is rarely needed with the availability of transthoracic and transesophageal echocardiography.",
"   </p>",
"   <p>",
"    If contrast angiography is performed, the left ventricle and left atrium are often normal in size (unless there is preexisting chronic MR) and the left ventricle is hyperdynamic. There is immediate, complete, and usually persistent opacification of the left atrium on the first beat after ventricular injection. Opacification of the pulmonary veins is also frequently seen due to the high atrial pressures during systole. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?3/41/3737?source=see_link\">",
"     \"Hemodynamics of valvular disorders as measured by cardiac catheterization\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h1\">",
"     TREATMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Acute MR is a medical and surgical emergency, as the patient typically presents in acute pulmonary edema or cardiogenic shock. In most cases, the definitive treatment is surgical intervention. However, medical therapy may be needed to support the patient while the diagnosis is made and in the interval until surgery can be performed.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Medical stabilization",
"    </span>",
"    &nbsp;&mdash;&nbsp;The primary goal of medical therapy in acute MR is to stabilize the patient in preparation for surgery. Intravenous",
"    <a class=\"drug drug_general\" href=\"UTD.htm?20/51/21302?source=see_link\">",
"     nitroprusside",
"    </a>",
"    can reduce MR, both by reducing systemic vascular resistance and by improving mitral valve competence as the left ventricular size falls [",
"    <a class=\"abstract\" href=\"UTD.htm?27/45/28376/abstract/13-15\">",
"     13-15",
"    </a>",
"    ]. The decrease in MR severity increases forward cardiac output and diminishes pulmonary congestion. This may be associated with an improvement in ventricular systolic performance and a reduction in myocardial oxygen consumption",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"UTD.htm?20/51/21302?source=see_link\">",
"     Nitroprusside",
"    </a>",
"    should not be given as monotherapy in patients who are hypotensive at presentation. Some benefit may initially be achieved by concurrent administration of an inotropic agent such as",
"    <a class=\"drug drug_general\" href=\"UTD.htm?24/57/25494?source=see_link\">",
"     dobutamine",
"    </a>",
"    but an intraaortic balloon pump (IABP) is often inserted [",
"    <a class=\"abstract\" href=\"UTD.htm?27/45/28376/abstract/9\">",
"     9",
"    </a>",
"    ]. The IABP can be continued into the early postoperative period until hemodynamics stabilize.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Surgery",
"    </span>",
"    &nbsp;&mdash;&nbsp;The risk of surgery is high is acute MR, with mortality rates as high as 50 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?27/45/28376/abstract/16-19\">",
"     16-19",
"    </a>",
"    ]. However, the exact timing and risk of surgical intervention depend upon the etiology of the MR.",
"   </p>",
"   <p>",
"    In a multicenter study of surgery for acute severe mitral regurgitation in 279 patients, overall 30-day mortality was 23 percent, but 15-year survival was 67 percent. All 279 patients were hemodynamically unstable before surgery. Valve repair was performed in 27 percent with valve replacement in the remainder. The cause of regurgitation was ischemic in 45 percent, myxomatous mitral valve disease in 26 percent, and endocarditis in 28 percent. Multivariate predictors of 30-day mortality were acute myocardial infarction, acute endocarditis, shock, left ventricular dysfunction, and coronary disease [",
"    <a class=\"abstract\" href=\"UTD.htm?27/45/28376/abstract/20\">",
"     20",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h3\">",
"     Chordal rupture",
"    </span>",
"    &nbsp;&mdash;&nbsp;Spontaneous chordal rupture often can be treated early with mitral valve repair [",
"    <a class=\"abstract\" href=\"UTD.htm?27/45/28376/abstract/21\">",
"     21",
"    </a>",
"    ]. Compared to valve replacement, mitral valve repair is associated with a lower operative mortality, improved preservation of left ventricular function, and better long-term survival. In addition, the risks of a prosthetic valve and anticoagulation are avoided.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h3\">",
"     Endocarditis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most centers advocate early surgical intervention in patients with acute MR due to endocarditis that results in heart failure; the goals are to prevent progressive valve damage and perivalvular abscess formation. It is not clear that delaying surgery decreases the risk of recurrent infection. The European Society of Cardiology guidelines for infective endocarditis recommend emergency surgery for acute mitral regurgitation due to endocarditis if refractory heart failure or an intracardiac fistula is present [",
"    <a class=\"abstract\" href=\"UTD.htm?27/45/28376/abstract/22\">",
"     22",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/49/22297?source=see_link\">",
"     \"Surgery for native valve endocarditis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Urgent surgery is recommended if there is persistent heart failure or echocardiographic signs of hemodynamic compromise, including pulmonary hypertension and early mitral valve closure. Elective surgery is appropriate for acute severe regurgitation due to endocarditis, even in the absence of heart failure. In a recent propensity-matched study of early versus late surgery for endocarditis, the absolute risk reduction in mortality with surgery was 5.9 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?27/45/28376/abstract/23\">",
"     23",
"    </a>",
"    ]. Subgroups benefiting most from early surgery included those with paravalvular abscess, systemic embolism, and infection with Staph aureus (",
"    <a class=\"graphic graphic_figure graphicRef82107 \" href=\"UTD.htm?14/63/15358\">",
"     figure 2",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Valve repair is preferred but is not always possible depending upon the extent of tissue destruction. The efficacy of mitral valve repair can be illustrated in the following observations:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In a review of 53 patients with MR due to endocarditis, the valve could be repaired in 40 percent with an operative mortality of 0 percent; in contrast, the operative mortality was 13 percent in those who required valve replacement [",
"      <a class=\"abstract\" href=\"UTD.htm?27/45/28376/abstract/24\">",
"       24",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Similar outcomes were noted in a series of 78 patients with endocarditis and MR: valve repair was feasible in 81 percent and operative mortality was only 3 percent [",
"      <a class=\"abstract\" href=\"UTD.htm?27/45/28376/abstract/25\">",
"       25",
"      </a>",
"      ]. However, 60 percent of patients had healed endocarditis and may therefore have been at lower risk than patients with active infection.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In a meta-analysis of 24 studies of surgery for endocarditis, a total of 470 (39 percent) patients underwent valve repair and 724 (61 percent) underwent valve replacement. Valve repair was associated with a lower early (2.3 versus 14.4 percent) and long term (7.8 versus 40.5 percent) mortality, lower rates of early and later reoperation, and lower rates of recurrent endocarditis (1.8 versus 7.3 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?27/45/28376/abstract/26\">",
"     26",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The 2006",
"    <span class=\"nowrap\">",
"     ACC/AHA",
"    </span>",
"    guidelines recommended that, in the setting of active infection, mitral valve repair should be performed, if possible; mitral valve replacement is associated with a risk of infection of prosthetic materials [",
"    <a class=\"abstract\" href=\"UTD.htm?27/45/28376/abstract/9\">",
"     9",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h3\">",
"     Ischemic MR",
"    </span>",
"    &nbsp;&mdash;&nbsp;In patients with acute ischemic MR, treatment depends upon the exact etiology of valve dysfunction [",
"    <a class=\"abstract\" href=\"UTD.htm?27/45/28376/abstract/27\">",
"     27",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Among patients with acute MR due to myocardial ischemia, percutaneous revascularization may lead to resolution of the MR [",
"      <a class=\"abstract\" href=\"UTD.htm?27/45/28376/abstract/28,29\">",
"       28,29",
"      </a>",
"      ]. In these patients, medical therapy and an IABP may be used during the acute episode with weaning of these modalities as myocardial function improves. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?17/55/18297?source=see_link\">",
"       \"Ischemic mitral regurgitation\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      In contrast, surgical intervention is needed with papillary muscle rupture [",
"      <a class=\"abstract\" href=\"UTD.htm?27/45/28376/abstract/16-19\">",
"       16-19",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?38/19/39225?source=see_link\">",
"       \"Mechanical complications of acute myocardial infarction\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?6/31/6649?source=see_link\">",
"       \"Natural history of chronic mitral regurgitation in mitral valve prolapse and flail mitral leaflet\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The risk of surgery is high in such patients, with an operative mortality rate of about 50 percent; however, the outcome is worse with medical therapy with a mortality of 75 percent at 24 hours and 95 percent within two weeks after complete papillary muscle rupture [",
"    <a class=\"abstract\" href=\"UTD.htm?27/45/28376/abstract/30,31\">",
"     30,31",
"    </a>",
"    ]. Risk factors for worse outcomes after surgery include older age, female gender, and poor left ventricular systolic function [",
"    <a class=\"abstract\" href=\"UTD.htm?27/45/28376/abstract/32\">",
"     32",
"    </a>",
"    ]. In some patients, the risk of surgical intervention may be so high as to be futile.",
"   </p>",
"   <p>",
"    In a study of 54 patients undergoing surgery for papillary muscle rupture between1980 and 2000, 10-year survival was only 35 percent and 10-year survival free of heart failure was only 23 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?27/45/28376/abstract/33\">",
"     33",
"    </a>",
"    ]. These patients had a mean age of 70&plusmn; 8 years, were predominantly male (74 percent) and 91 percent presented with cardiogenic shock, pulmonary edema or cardiac arrest. Operative mortality (overall 18.9 percent) was high but decreased over time with an operative mortality of 8.7 percent in patients operated after 1990 with coronary artery bypass grafting.",
"   </p>",
"   <p>",
"    With the use of echocardiography, partial papillary muscle rupture can be recognized. The prognosis in such patients depends upon the extent of myocardial damage and severity of mitral regurgitation.",
"   </p>",
"   <p>",
"    With partial papillary muscle rupture, some surgeons prefer to stabilize the patient and delay surgery for six to eight weeks after myocardial infarction to avoid operating on the necrotic myocardial tissue. However, many patients cannot be stabilized and acute intervention must be considered. Valve repair is preferred, but myocardial necrosis may necessitate valve replacement.",
"   </p>",
"   <p>",
"    The outcomes after surgery were illustrated in a report of 55 patients with acute ischemic MR who underwent urgent surgery: 25 had complete papillary muscle rupture; 12 had partial papillary muscle rupture; and 18 papillary muscle dysfunction (or papillary muscle displacement) without rupture [",
"    <a class=\"abstract\" href=\"UTD.htm?27/45/28376/abstract/34\">",
"     34",
"    </a>",
"    ]. The valve could be repaired in only four patients, with the remaining patients requiring mitral valve replacement. The overall operative mortality was 24 percent with a higher mortality in those who did not undergo coronary revascularization compared to those who did (34 versus 9 percent).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      There are only three basic mechanisms of acute native valve acute mitral regurgitation (MR) (",
"      <a class=\"graphic graphic_figure graphicRef79932 \" href=\"UTD.htm?5/22/5476\">",
"       figure 1",
"      </a>",
"      ) (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Etiology'",
"      </a>",
"      above.):",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Flail leaflet due to myxomatous disease (mitral valve prolapse), infective endocarditis, or trauma.",
"     </li>",
"     <li>",
"      Chordae tendineae rupture due to trauma, spontaneous rupture, infective endocarditis, or acute rheumatic fever.",
"     </li>",
"     <li>",
"      Papillary muscle rupture or displacement due to acute myocardial infarction or severe ischemia or trauma.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Acute MR is often misdiagnosed as a primary pulmonary process or as heart failure due to LV dysfunction. Echocardiography is diagnostic but a high level of clinical awareness is needed. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Clinical manifestations'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Approximately 50 percent of patients with moderate to severe MR have no audible murmur. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Silent MR'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Immediate therapy of acute MR includes urgent surgical consultation. Most patients require urgent mitral valve surgery. Despite a high operative mortality, the outcome is even worse with medical therapy (See",
"      <a class=\"local\" href=\"#H14\">",
"       'Treatment'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The primary goal of medical therapy in acute MR is to stabilize the patient in preparation for surgery. Vasodilator therapy with",
"      <a class=\"drug drug_general\" href=\"UTD.htm?20/51/21302?source=see_link\">",
"       nitroprusside",
"      </a>",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      placement of an intraaortic balloon pump may be helpful while awaiting surgical intervention. (See",
"      <a class=\"local\" href=\"#H15\">",
"       'Medical stabilization'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Spontaneous chordal rupture often can be treated early with mitral valve repair. (See",
"      <a class=\"local\" href=\"#H17\">",
"       'Chordal rupture'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Most centers advocate early surgical intervention in patients with acute MR due to endocarditis that results in heart failure (See",
"      <a class=\"local\" href=\"#H18\">",
"       'Endocarditis'",
"      </a>",
"      above.).",
"     </li>",
"     <li>",
"      In patients with acute ischemic MR, treatment depends upon the exact etiology of valve dysfunction (See",
"      <a class=\"local\" href=\"#H19\">",
"       'Ischemic MR'",
"      </a>",
"      above.):",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Among patients with acute MR due to myocardial ischemia, percutaneous revascularization may lead to resolution of the MR. In these patients, medical therapy and an IABP may be used during the acute episode with weaning of these modalities as myocardial function improves.",
"     </li>",
"     <li>",
"      In contrast, surgical intervention is needed with papillary muscle rupture.",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/45/28376/abstract/1\">",
"      Stout KK, Verrier ED. Acute valvular regurgitation. Circulation 2009; 119:3232.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/45/28376/abstract/2\">",
"      Bursi F, Enriquez-Sarano M, Nkomo VT, et al. Heart failure and death after myocardial infarction in the community: the emerging role of mitral regurgitation. Circulation 2005; 111:295.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/45/28376/abstract/3\">",
"      Tcheng JE, Jackman JD Jr, Nelson CL, et al. Outcome of patients sustaining acute ischemic mitral regurgitation during myocardial infarction. Ann Intern Med 1992; 117:18.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/45/28376/abstract/4\">",
"      Lehmann KG, Francis CK, Dodge HT. Mitral regurgitation in early myocardial infarction. Incidence, clinical detection, and prognostic implications. TIMI Study Group. Ann Intern Med 1992; 117:10.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/45/28376/abstract/5\">",
"      Barzilai B, Gessler C Jr, P&eacute;rez JE, et al. Significance of Doppler-detected mitral regurgitation in acute myocardial infarction. Am J Cardiol 1988; 61:220.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/45/28376/abstract/6\">",
"      Stone GW, Griffin B, Shah PK, et al. Prevalence of unsuspected mitral regurgitation and left ventricular diastolic dysfunction in patients with coronary artery disease and acute pulmonary edema associated with normal or depressed left ventricular systolic function. Am J Cardiol 1991; 67:37.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/45/28376/abstract/7\">",
"      Goldman AP, Glover MU, Mick W, et al. Role of echocardiography/Doppler in cardiogenic shock: silent mitral regurgitation. Ann Thorac Surg 1991; 52:296.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/45/28376/abstract/8\">",
"      Kaymaz C, Ozdemir N, Ozkan M. Differentiating clinical and echocardiographic characteristics of chordal rupture detected in patients with rheumatic mitral valve disease and floppy mitral valve: impact of the infective endocarditis on chordal rupture. Eur J Echocardiogr 2005; 6:117.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/45/28376/abstract/9\">",
"      Bonow RO, Carabello BA, Chatterjee K, et al. 2008 Focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. Circulation 2008; 118:e523.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/45/28376/abstract/10\">",
"      Moursi MH, Bhatnagar SK, Vilacosta I, et al. Transesophageal echocardiographic assessment of papillary muscle rupture. Circulation 1996; 94:1003.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/45/28376/abstract/11\">",
"      Pi&eacute;rard LA, Lancellotti P. The role of ischemic mitral regurgitation in the pathogenesis of acute pulmonary edema. N Engl J Med 2004; 351:1627.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/45/28376/abstract/12\">",
"      Lin SS, Lauer MS, Asher CR, et al. Prediction of coronary artery disease in patients undergoing operations for mitral valve degeneration. J Thorac Cardiovasc Surg 2001; 121:894.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/45/28376/abstract/13\">",
"      Chatterjee K, Parmley WW, Swan HJ, et al. Beneficial effects of vasodilator agents in severe mitral regurgitation due to dysfunction of subvalvar apparatus. Circulation 1973; 48:684.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/45/28376/abstract/14\">",
"      Harshaw CW, Grossman W, Munro AB, McLaurin LP. Reduced systemic vascular resistance as therapy for severe mitral regurgitation of valvular origin. Ann Intern Med 1975; 83:312.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/45/28376/abstract/15\">",
"      Sasayama S, Takahashi M, Osakada G, et al. Dynamic geometry of the left atrium and left ventricle in acute mitral regurgitation. Circulation 1979; 60:177.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/45/28376/abstract/16\">",
"      Rankin JS, Hickey MS, Smith LR, et al. Ischemic mitral regurgitation. Circulation 1989; 79:I116.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/45/28376/abstract/17\">",
"      Tepe NA, Edmunds LH Jr. Operation for acute postinfarction mitral insufficiency and cardiogenic shock. J Thorac Cardiovasc Surg 1985; 89:525.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/45/28376/abstract/18\">",
"      Hickey MS, Smith LR, Muhlbaier LH, et al. Current prognosis of ischemic mitral regurgitation. Implications for future management. Circulation 1988; 78:I51.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/45/28376/abstract/19\">",
"      Replogle RL, Campbell CD. Surgery for mitral regurgitation associated with ischemic heart disease. Results and strategies. Circulation 1989; 79:I122.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/45/28376/abstract/20\">",
"      Lorusso R, Gelsomino S, De Cicco G, et al. Mitral valve surgery in emergency for severe acute regurgitation: analysis of postoperative results from a multicentre study. Eur J Cardiothorac Surg 2008; 33:573.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/45/28376/abstract/21\">",
"      Roberts WC, Braunwald E, Morrow AG. Acute severe mitral regurgitation secondary to ruptured chordae tendineae: clinical, hemodynamic, and pathologic considerations. Circulation 1966; 33:58.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/45/28376/abstract/22\">",
"      Habib G, Hoen B, Tornos P, et al. Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009): the Task Force on the Prevention, Diagnosis, and Treatment of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and the International Society of Chemotherapy (ISC) for Infection and Cancer. Eur Heart J 2009; 30:2369.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/45/28376/abstract/23\">",
"      Lalani T, Cabell CH, Benjamin DK, et al. Analysis of the impact of early surgery on in-hospital mortality of native valve endocarditis: use of propensity score and instrumental variable methods to adjust for treatment-selection bias. Circulation 2010; 121:1005.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/45/28376/abstract/24\">",
"      Mihaljevic T, Paul S, Leacche M, et al. Tailored surgical therapy for acute native mitral valve endocarditis. J Heart Valve Dis 2004; 13:210.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/45/28376/abstract/25\">",
"      Iung B, Rousseau-Paziaud J, Cormier B, et al. Contemporary results of mitral valve repair for infective endocarditis. J Am Coll Cardiol 2004; 43:386.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/45/28376/abstract/26\">",
"      Feringa HH, Shaw LJ, Poldermans D, et al. Mitral valve repair and replacement in endocarditis: a systematic review of literature. Ann Thorac Surg 2007; 83:564.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/45/28376/abstract/27\">",
"      Iung B. Management of ischaemic mitral regurgitation. Heart 2003; 89:459.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/45/28376/abstract/28\">",
"      Le Feuvre C, Metzger JP, Lachurie ML, et al. Treatment of severe mitral regurgitation caused by ischemic papillary muscle dysfunction: indications for coronary angioplasty. Am Heart J 1992; 123:860.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/45/28376/abstract/29\">",
"      Lehmann KG, Francis CK, Sheehan FH, Dodge HT. Effect of thrombolysis on acute mitral regurgitation during evolving myocardial infarction. Experience from the Thrombolysis in Myocardial Infarction (TIMI) Trial. J Am Coll Cardiol 1993; 22:714.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/45/28376/abstract/30\">",
"      Wei JY, Hutchins GM, Bulkley BH. Papillary muscle rupture in fatal acute myocardial infarction: a potentially treatable form of cardiogenic shock. Ann Intern Med 1979; 90:149.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/45/28376/abstract/31\">",
"      Manning WJ, Waksmonski CA, Boyle NG. Papillary muscle rupture complicating inferior myocardial infarction: identification with transesophageal echocardiography. Am Heart J 1995; 129:191.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/45/28376/abstract/32\">",
"      DiSesa VJ, Cohn LH, Collins JJ Jr, et al. Determinants of operative survival following combined mitral valve replacement and coronary revascularization. Ann Thorac Surg 1982; 34:482.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/45/28376/abstract/33\">",
"      Russo A, Suri RM, Grigioni F, et al. Clinical outcome after surgical correction of mitral regurgitation due to papillary muscle rupture. Circulation 2008; 118:1528.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/45/28376/abstract/34\">",
"      Chevalier P, Burri H, Fahrat F, et al. Perioperative outcome and long-term survival of surgery for acute post-infarction mitral regurgitation. Eur J Cardiothorac Surg 2004; 26:330.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 8170 Version 7.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-61.55.141.10-1AFF26D322-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f27_45_28376=[""].join("\n");
var outline_f27_45_28376=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H20\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      ETIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      PATHOPHYSIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      CLINICAL MANIFESTATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Physical examination",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Cardiac auscultation",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      - Silent MR",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      TESTING",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Electrocardiogram",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Chest radiograph",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Echocardiography",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      - Exercise echocardiography",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Cardiac catheterization",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      TREATMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Medical stabilization",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Surgery",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      - Chordal rupture",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      - Endocarditis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      - Ischemic MR",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"CARD/8170\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"CARD/8170|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?5/22/5476\" title=\"figure 1\">",
"      Mitral valve structure",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?14/63/15358\" title=\"figure 2\">",
"      Early surgery and native valve endocarditis mortality",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"CARD/8170|MOV\">",
"      <a href=\"#\" title=\"MOVIES\">",
"       MOVIES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_movie\" href=\"UTD.htm?27/19/27952\" title=\"movie 1\">",
"      Ruptured papillary muscle post MI 2-chamber view",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_movie\" href=\"UTD.htm?33/17/34065\" title=\"movie 2\">",
"      Ruptured papillary muscle post myocardial infarction long axis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"CARD/8170|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?29/4/29772\" title=\"table 1\">",
"      Coronary angio valve disease",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/37/26202?source=related_link\">",
"      Auscultation of cardiac murmurs",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/56/22410?source=related_link\">",
"      Auscultation of heart sounds",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/41/32409?source=related_link\">",
"      Echocardiographic evaluation of the mitral valve",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?9/30/9705?source=related_link\">",
"      Etiology, clinical features, and evaluation of chronic mitral regurgitation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/15/33013?source=related_link\">",
"      Examination of the arterial pulse",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/59/33719?source=related_link\">",
"      Examination of the jugular venous pulse",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?3/41/3737?source=related_link\">",
"      Hemodynamics of valvular disorders as measured by cardiac catheterization",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/55/18297?source=related_link\">",
"      Ischemic mitral regurgitation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/19/39225?source=related_link\">",
"      Mechanical complications of acute myocardial infarction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/31/6649?source=related_link\">",
"      Natural history of chronic mitral regurgitation in mitral valve prolapse and flail mitral leaflet",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/2/36901?source=related_link\">",
"      Pathophysiology and stages of chronic mitral regurgitation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/49/22297?source=related_link\">",
"      Surgery for native valve endocarditis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/53/36697?source=related_link\">",
"      Surgical procedures for severe chronic mitral regurgitation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/3/42040?source=related_link\">",
"      Transesophageal echocardiography in the evaluation of mitral valve disease",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f27_45_28377="Strongyloides life cycle";
var content_f27_45_28377=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F87284&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F87284&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 611px\">",
"   <div class=\"ttl\">",
"    Strongyloides life cycle",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 591px; height: 480px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <strong>",
"     Causal agent:",
"    </strong>",
"    The nematode (roundworm)",
"    <em>",
"     Strongyloides stercoralis",
"    </em>",
"    . Other",
"    <em>",
"     Strongyloides",
"    </em>",
"    include",
"    <em>",
"     S. f&uuml;lleborni",
"    </em>",
"    , which infects chimpanzees and baboons and may produce limited infections in humans.",
"    <br>",
"     <strong>",
"      Life cycle:",
"     </strong>",
"     The",
"     <em>",
"      Strongyloides",
"     </em>",
"     life cycle is more complex than that of most nematodes with its alternation between free-living and parasitic cycles, and its potential for autoinfection and multiplication within the host. Two types of cycles exist:",
"     <br>",
"      <strong>",
"       Free-living cycle:",
"      </strong>",
"      The rhabditiform larvae passed in the stool",
"      <strong>",
"       (1)",
"      </strong>",
"      (see \"Parasitic cycle\" below) can either molt twice and become infective filariform larvae (direct development)",
"      <strong>",
"       (6)",
"      </strong>",
"      , or molt four times and become free living adult males and females",
"      <strong>",
"       (2)",
"      </strong>",
"      that mate and produce eggs",
"      <strong>",
"       (3)",
"      </strong>",
"      from which rhabditiform larvae hatch",
"      <strong>",
"       (4)",
"      </strong>",
"      . The latter in turn can either develop",
"      <strong>",
"       (5)",
"      </strong>",
"      into a new generation of free-living adults (as represented in",
"      <strong>",
"       [2]",
"      </strong>",
"      ), or into infective filariform larvae",
"      <strong>",
"       (6)",
"      </strong>",
"      . The filariform larvae penetrate the human host skin to initiate the parasitic cycle (see below)",
"      <strong>",
"       (6)",
"      </strong>",
"      .",
"      <br>",
"       <strong>",
"        Parasitic cycle:",
"       </strong>",
"       Filariform larvae in contaminated soil penetrate the human skin",
"       <strong>",
"        (6)",
"       </strong>",
"       , and are transported to the lungs where they penetrate the alveolar spaces; they are carried through the bronchial tree to the pharynx, are swallowed, and then reach the small intestine",
"       <strong>",
"        (7)",
"       </strong>",
"       . In the small intestine they molt twice and become adult female worms",
"       <strong>",
"        (8)",
"       </strong>",
"       . The females live threaded in the epithelium of the small intestine and by parthenogenesis produce eggs",
"       <strong>",
"        (9)",
"       </strong>",
"       , which yield rhabditiform larvae. The rhabditiform larvae can either be passed in the stool",
"       <strong>",
"        (1)",
"       </strong>",
"       (see \"Free-living cycle\" above), or can cause autoinfection",
"       <strong>",
"        (10)",
"       </strong>",
"       . In autoinfection, the rhabditiform larvae become infective filariform larvae, which can penetrate either the intestinal mucosa (internal autoinfection) or the skin of the perianal area (external autoinfection); in either case, the filariform larvae may follow the previously described route, being carried successively to the lungs, the bronchial tree, the pharynx, and the small intestine where they mature into adults; or they may disseminate widely in the body. To date, occurrence of autoinfection in humans with helminthic infections is recognized only in",
"       <em>",
"        Strongyloides stercoralis",
"       </em>",
"       and",
"       <em>",
"        Capillaria philippinensis",
"       </em>",
"       infections. In the case of",
"       <em>",
"        Strongyloides",
"       </em>",
"       , autoinfection may explain the possibility of persistent infections for many years in persons who have not been in an endemic area and of hyperinfections in immunodepressed individuals.",
"       <br>",
"        <strong>",
"         Geographic distribution:",
"        </strong>",
"        Tropical and subtropical areas, but cases also occur in temperate areas (including the South of the United States). More frequently found in rural areas, institutional settings, and lower socioeconomic groups.",
"        <div class=\"footnotes\">",
"        </div>",
"        <div class=\"reference\">",
"         Reproduced from: Centers for Disease Control and Prevention. Parasites and Health: Strongyloidiasis. Available at:",
"         <a href=\"file://www.dpd.cdc.gov/dpdx/HTML/Strongyloidiasis.htm\" target=\"_blank\">",
"          file://www.dpd.cdc.gov/dpdx/HTML/Strongyloidiasis.htm",
"         </a>",
"         .",
"        </div>",
"       </br>",
"      </br>",
"     </br>",
"    </br>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f27_45_28377=[""].join("\n");
var outline_f27_45_28377=null;
var title_f27_45_28378="Treatment of Langerhans cell histiocytosis";
var content_f27_45_28378=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"7\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Treatment of Langerhans cell histiocytosis",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?27/45/28378/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?27/45/28378/contributors\">",
"     Kenneth L McClain, MD, PhD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?27/45/28378/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?27/45/28378/contributors\">",
"     Laurence A Boxer, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?27/45/28378/contributors\">",
"     Julie R Park, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?27/45/28378/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?27/45/28378/contributors\">",
"     Rebecca F Connor, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?27/45/28378/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Mar 29, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H42642367\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Langerhans cell histiocytosis (LCH) is a rare histiocytic disorder most commonly characterized by single or multiple osteolytic bone lesions demonstrating infiltration with histiocytes with &ldquo;bean-shaped&rdquo; nuclei on biopsy with or without histiocytic infiltration of extraskeletal lesions (most notably the skin, lungs, and central nervous system).",
"   </p>",
"   <p>",
"    Histiocytic disorders are thought to be derived from mononuclear phagocytic cells (macrophages and dendritic cells) or histiocytes. This group has generally been divided into Langerhans cell histiocytosis and non-Langerhans histiocytosis. LCH is so named because the morphology and immunophenotype of the abnormal cells is similar to that of Langerhans cells, which are specialized dendritic cells found in the skin and mucosa. Gene expression array data on LCH have shown that the skin Langerhans cell is not the cell of origin for LCH. Rather, it is a myeloid dendritic cell that expresses the same antigens (CD1a, CD207) as the skin Langerhans cell. In contrast, non-Langerhans histiocytoses are thought to be derived from other dendritic cells that ultimately produce the monocyte-macrophage lineage.",
"   </p>",
"   <p>",
"    For now, \"Langerhans cell histiocytosis\" remains the preferred nomenclature, although new terminology may evolve when the precise origin of the CD-207+ cells in LCH is fully understood. The historical terms histiocytosis-X, Letterer-Siwe disease, Hand-Sch&uuml;ller-Christian disease, and diffuse reticuloendotheliosis should be abandoned. The term &ldquo;eosinophilic granuloma&rdquo; is sometimes used to describe the pathology of an individual lesion, particularly isolated lytic processes in bone.",
"   </p>",
"   <p>",
"    The management of LCH in children and adults will be presented here. The epidemiology, clinical manifestations, pathologic features, diagnosis, and differential diagnosis of LCH are presented separately, as is additional detail regarding solitary LCH involving either the lung or bone. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/53/21338?source=see_link\">",
"     \"Clinical manifestations, pathologic features, and diagnosis of Langerhans cell histiocytosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/48/35592?source=see_link\">",
"     \"Pulmonary Langerhans cell histiocytosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/50/32551?source=see_link\">",
"     \"Langerhans cell histiocytosis (eosinophilic granuloma) of bone in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H452652744\">",
"    <span class=\"h1\">",
"     PRETREATMENT EVALUATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;While all aspects of a complete history and physical examination are important, some elements of this evaluation are particularly relevant to complications that might arise due to the disease or its management. The evaluation should pay particular attention to signs or symptoms that may reflect involvement of the central nervous system (eg, excessive thirst and urination, abnormal growth velocity, abnormal findings on neurologic exam) or risk organs (eg, hepatosplenomegaly, symptoms due to cytopenias).",
"   </p>",
"   <p>",
"    In addition to a history and physical examination, it is our practice to perform the following pretreatment studies:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The pathologic diagnosis of LCH should be confirmed by biopsy of involved tissue prior to initiating treatment. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?20/53/21338?source=see_link&amp;anchor=H452648918#H452648918\">",
"       \"Clinical manifestations, pathologic features, and diagnosis of Langerhans cell histiocytosis\", section on 'Diagnosis and differential diagnosis'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Laboratory studies for all patients include a complete blood count with differential, chemistries with liver and renal function and electrolytes, albumin, and urinalysis. Patients with hepatomegaly, jaundice, abnormal liver enzymes, or a low albumin should also be evaluated with a prothrombin time (PT) and activated partial thromboplastin time (aPTT). A water restriction test should be performed if diabetes insipidus is suspected. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?23/47/24312?source=see_link&amp;anchor=H10#H10\">",
"       \"Diagnosis of polyuria and diabetes insipidus\", section on 'Water restriction test'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Unilateral bone marrow aspiration with trephine biopsy is indicated for all patients with multi-system disease and for those with multi-site single system disease who have unexplained cytopenias. This sample should be sent for histologic review that includes staining for anti-CD1a",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      anti-CD207 (langerin) and anti-CD163 immunostains to detect LCH cells. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?20/53/21338?source=see_link&amp;anchor=H452652235#H452652235\">",
"       \"Clinical manifestations, pathologic features, and diagnosis of Langerhans cell histiocytosis\", section on 'Pathologic features'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Radiographic evaluation should include a skeletal survey, skull series, bone scan, and chest radiograph for all patients. If available, we also suggest obtaining a pretreatment positron emission tomography (PET) scan [",
"      <a class=\"abstract\" href=\"UTD.htm?27/45/28378/abstract/1\">",
"       1",
"      </a>",
"      ] to use as a baseline measure of disease extent. Additional radiographic testing depends upon patient characteristics:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Computed tomography (CT) is used to further assess involvement of the orbit, mastoid, vertebrae, or pelvis suspected based upon initial radiographic studies or symptoms. CT is also used to better define lung abnormalities seen on chest radiograph (eg, interstitial pulmonary infiltrates, cystic changes, or nodules).",
"     </li>",
"     <li>",
"      Magnetic resonance imaging (MRI) of the brain with gadolinium contrast should be performed for all patients with diabetes insipidus, those with",
"      <span class=\"nowrap\">",
"       signs/symptoms",
"      </span>",
"      suggestive of central nervous system (CNS) involvement, and those thought to be at risk for CNS involvement [",
"      <a class=\"abstract\" href=\"UTD.htm?27/45/28378/abstract/2\">",
"       2",
"      </a>",
"      ]. The following populations are thought to have an increase risk for CNS involvement: patients with multisystem disease and those with craniofacial involvement at the time of diagnosis, particularly of the ear, eye, and oral region.",
"     </li>",
"     <li>",
"      Patients with hepatic",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      splenic enlargement should undergo further assessment of these organs with ultrasound, CT, or MRI.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Patients with lung involvement should undergo pulmonary function testing. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?34/48/35592?source=see_link&amp;anchor=H11#H11\">",
"       \"Pulmonary Langerhans cell histiocytosis\", section on 'Physiologic testing'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H42641518\">",
"    <span class=\"h1\">",
"     INITIAL TREATMENT",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H42641525\">",
"    <span class=\"h2\">",
"     Risk stratification",
"    </span>",
"    &nbsp;&mdash;&nbsp;LCH is an extremely heterogeneous disease with certain subsets of patients having a clinically indolent course limited to involvement of a single organ system (&ldquo;low risk disease&rdquo;) and others having disseminated multisystem disease with acute and chronic morbidity and mortality (&ldquo;multisystem disease with risk organ involvement&rdquo;) [",
"    <a class=\"abstract\" href=\"UTD.htm?27/45/28378/abstract/3\">",
"     3",
"    </a>",
"    ]. At the time of diagnosis, patients are risk stratified based upon the extent of disease and whether or not \"risk\" organs are involved (ie, bone marrow, liver, or spleen). The risk stratification schemas used to determine treatment in prospective studies have changed over the years and continue to evolve.",
"   </p>",
"   <p>",
"    Using information from the pretreatment evaluation, we stratify patients into three groups that help guide therapy: single system LCH, low-risk multisystem LCH, and multisystem LCH with risk organ involvement.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Single system LCH &mdash; Patients typically do not have systemic symptoms (eg, weight loss or fever). Unifocal or multifocal involvement can be found in one of the following",
"      <span class=\"nowrap\">",
"       organs/systems:",
"      </span>",
"      bone, skin, lymph node (excluding draining lymph node of another LCH lesion), lungs, central nervous system, or other rare locations (eg, thyroid, thymus).",
"     </li>",
"     <li>",
"      Multisystem LCH &mdash; Two or more",
"      <span class=\"nowrap\">",
"       organs/systems",
"      </span>",
"      are involved with or without involvement of &ldquo;risk organs&rdquo;. Risk organs include the hematopoietic system, liver,",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      spleen and denote a worse prognosis. Although the lung has been considered a &ldquo;risk organ&rdquo;, more recent studies have suggested that it has less of an effect on prognosis [",
"      <a class=\"abstract\" href=\"UTD.htm?27/45/28378/abstract/4-6\">",
"       4-6",
"      </a>",
"      ]. In contrast to the term &ldquo;risk organs&rdquo;, the term &ldquo;CNS-risk&rdquo; areas include the sphenoid, orbital, ethmoid, or temporal bones and denote an increased risk of involvement of the central nervous system [",
"      <a class=\"abstract\" href=\"UTD.htm?27/45/28378/abstract/7\">",
"       7",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    This stratification is based upon data gathered from studies of patients with multisystem disease. An initial risk stratification scheme was suggested based upon data from the LCH-I randomized study that demonstrated similar patient outcomes in patients with multisystem disease after treatment with either",
"    <a class=\"drug drug_general\" href=\"UTD.htm?4/3/4152?source=see_link\">",
"     vinblastine",
"    </a>",
"    or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?29/57/30617?source=see_link\">",
"     etoposide",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?27/45/28378/abstract/8\">",
"     8",
"    </a>",
"    ]. In this study, a &ldquo;low risk&rdquo; population was identified that had significantly better survival. These patients were age two years or older and had no evidence of LCH in the lung, bone marrow, liver, or spleen. The subsequent LCH-II study determined that age at diagnosis was not an independent prognostic factor, but confirmed that involvement of the lung, bone marrow, liver, or spleen resulted in significant disease-related mortality [",
"    <a class=\"abstract\" href=\"UTD.htm?27/45/28378/abstract/9\">",
"     9",
"    </a>",
"    ]. Since these publications, the prognostic value of lung involvement has been questioned. At least two studies have suggested that pulmonary involvement does not affect the outcome of patients with otherwise low risk disease [",
"    <a class=\"abstract\" href=\"UTD.htm?27/45/28378/abstract/4,5\">",
"     4,5",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6814315\">",
"    <span class=\"h3\">",
"     Single system disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;There is a paucity of data to guide the management of patients with unifocal or multifocal involvement of one organ or system (eg, skin, lymph nodes, bone). The choice of therapy is generally made based upon the site of involvement and number of lesions with an aim to minimize toxicity. Treatment options include single agent",
"    <a class=\"drug drug_general\" href=\"UTD.htm?37/43/38585?source=see_link\">",
"     prednisone",
"    </a>",
"    , the combination of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?4/3/4152?source=see_link\">",
"     vinblastine",
"    </a>",
"    and prednisone, curettage of bone lesions, and topical therapy for skin lesions. Alternatively, a subset of patients may select close observation with treatment upon progression. None of these management options has been directly compared in prospective trials in this patient population.",
"   </p>",
"   <p>",
"    The following is a description of common single system disease presentations and available therapy:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Single skull lesions in the frontal, occipital, or parietal bones (non-CNS-risk) and other single bone lesions &mdash; Children with a single non-CNS-risk skull lesion have a low recurrence rate following curettage [",
"      <a class=\"abstract\" href=\"UTD.htm?27/45/28378/abstract/10\">",
"       10",
"      </a>",
"      ]. Intralesional injection of glucocorticoids at the time of biopsy may help control pain and improve range of motion in children with solitary lesions in the axial or appendicular skeleton. This is discussed in more detail separately. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?31/50/32551?source=see_link&amp;anchor=H10#H10\">",
"       \"Langerhans cell histiocytosis (eosinophilic granuloma) of bone in children\", section on 'Solitary bone lesions'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Single skull lesions of the orbit, mastoid, temporal, or sphenoid bones (CNS-risk) &mdash; Patients with lesions in these bones are at increased risk of developing LCH involvement of the CNS and resultant endocrine abnormalities (eg, diabetes insipidus), morbidity, and mortality [",
"      <a class=\"abstract\" href=\"UTD.htm?27/45/28378/abstract/7\">",
"       7",
"      </a>",
"      ]. More intensive therapy is given in an attempt to prevent this progression. As such, these patients are generally treated with a combination of",
"      <a class=\"drug drug_general\" href=\"UTD.htm?4/3/4152?source=see_link\">",
"       vinblastine",
"      </a>",
"      and",
"      <a class=\"drug drug_general\" href=\"UTD.htm?37/43/38585?source=see_link\">",
"       prednisone",
"      </a>",
"      such as that used for low risk multisystem disease, as described in the following section. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?20/53/21338?source=see_link&amp;anchor=H452648890#H452648890\">",
"       \"Clinical manifestations, pathologic features, and diagnosis of Langerhans cell histiocytosis\", section on 'Diabetes insipidus and other endocrinopathies'",
"      </a>",
"      and",
"      <a class=\"local\" href=\"#H42641532\">",
"       'Multisystem disease'",
"      </a>",
"      below.)",
"     </li>",
"     <li>",
"      Spinal or femoral bone lesions at risk for collapse &mdash; Involvement of the spine or femoral bones can result in bone pain,",
"      <span class=\"nowrap\">",
"       fractures/vertebral",
"      </span>",
"      collapse, and spinal cord compression. Such lesions often require intervention for stabilization and may benefit from radiation therapy. Management of these lesions is described in more detail below. (See",
"      <a class=\"local\" href=\"#H6872801\">",
"       'Bone lesions at risk of collapse'",
"      </a>",
"      below.)",
"     </li>",
"     <li>",
"      Lymph node &mdash; If a single lymph node with LCH is surgically removed, observation until progression is reasonable. If there are two or more nodes involved or if there are additional sites of disease, patients are usually treated with 12 months of chemotherapy as given for multisystem disease. (See",
"      <a class=\"local\" href=\"#H42641532\">",
"       'Multisystem disease'",
"      </a>",
"      below.)",
"     </li>",
"     <li>",
"      Pulmonary lesions &mdash; Pulmonary LCH is most commonly seen in adult smokers. The initial focus of any therapeutic regimen in patients with pulmonary LCH is cessation of smoking. The management of pulmonary LCH is presented in more detail separately. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?34/48/35592?source=see_link\">",
"       \"Pulmonary Langerhans cell histiocytosis\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Skin only &mdash; A subset of patients will have spontaneous regression of cutaneous LCH (ie, &ldquo;self-healing cutaneous LCH&rdquo;). As such, close observation is an option for patients with skin only disease. However, a significant percentage (up to 40 percent of infants) will progress to develop multisystem involvement [",
"      <a class=\"abstract\" href=\"UTD.htm?27/45/28378/abstract/11,12\">",
"       11,12",
"      </a>",
"      ]. We commonly administer oral",
"      <a class=\"drug drug_general\" href=\"UTD.htm?23/38/24170?source=see_link\">",
"       methotrexate",
"      </a>",
"      to patients with skin only LCH. Small retrospective studies and case reports have described responses to topical corticosteroids, topical nitrogen mustard, oral methotrexate, and oral",
"      <a class=\"drug drug_general\" href=\"UTD.htm?28/62/29673?source=see_link\">",
"       thalidomide",
"      </a>",
"      [",
"      <a class=\"abstract\" href=\"UTD.htm?27/45/28378/abstract/13-16\">",
"       13-16",
"      </a>",
"      ]. As an example, a retrospective study of 14 patients with cutaneous LCH treated with topical nitrogen mustard reported responses in 13 patients [",
"      <a class=\"abstract\" href=\"UTD.htm?27/45/28378/abstract/16\">",
"       16",
"      </a>",
"      ]. Although eight patients achieved a complete response after a median of 12.3 months, six ultimately relapsed.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    All patients with single system disease are at risk for both local and distant recurrence. As such, these patients should be watched carefully for evidence of disease in other organs. (See",
"    <a class=\"local\" href=\"#H6872159\">",
"     'Monitoring for recurrence'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H42641532\">",
"    <span class=\"h3\">",
"     Multisystem disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;Given the rarity of LCH, there are limited data regarding the best treatment for patients with multisystem LCH, and all patients should be encouraged to participate in a well designed clinical trial. For patients who are not candidates for a clinical trial or for those who choose not to participate in a clinical trial, we suggest an initial six-week induction (or &ldquo;intensive&rdquo;) chemotherapy phase with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?4/3/4152?source=see_link\">",
"     vinblastine",
"    </a>",
"    plus",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/48/33536?source=see_link\">",
"     prednisolone",
"    </a>",
"    . Subsequent therapy is dependent upon disease response at six weeks and whether &ldquo;risk organs&rdquo; (ie, hematopoietic system, liver,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    spleen) were involved at the time of diagnosis (",
"    <a class=\"graphic graphic_algorithm graphicRef83046 \" href=\"UTD.htm?23/1/23568\">",
"     algorithm 1",
"    </a>",
"    ). Patients with an adequate response proceed with &ldquo;continuation&rdquo; chemotherapy until a total treatment duration of 12 months is completed. &ldquo;Continuation&rdquo; chemotherapy consists of vinblastine and prednisolone with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?36/43/37559?source=see_link\">",
"     mercaptopurine",
"    </a>",
"    added for patients with risk organ involvement. Patients without an adequate response undergo a second induction phase or proceed to second-line chemotherapy regimens.",
"   </p>",
"   <p>",
"    This approach is based upon the results of prospective trials conducted by the Histiocyte Society, described in more detail below.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H932497\">",
"    <span class=\"h4\">",
"     Induction chemotherapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Initial induction chemotherapy (sometimes called &ldquo;intensive&rdquo; chemotherapy) is given to all patients with the goal of achieving complete resolution of signs and symptoms. With modern induction chemotherapy, approximately 70 percent of patients with &ldquo;risk organ&rdquo; involvement and greater than 90 percent of patients without &ldquo;risk organ&rdquo; involvement will demonstrate a response to therapy by six weeks [",
"    <a class=\"abstract\" href=\"UTD.htm?27/45/28378/abstract/9\">",
"     9",
"    </a>",
"    ]. The most common side effects of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?4/3/4152?source=see_link\">",
"     vinblastine",
"    </a>",
"    are constipation, mild cytopenias, and, rarely, alopecia. All patients should be carefully monitored for peripheral neuropathy, which is more common in teenagers and adults than in younger children.",
"    <a class=\"drug drug_general\" href=\"UTD.htm?37/43/38585?source=see_link\">",
"     Prednisone",
"    </a>",
"    causes excessive appetite and weight gain in nearly all patients, mood changes, and sometimes hypertension, diabetes mellitus, osteoporosis, and myalgias. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/32/43530?source=see_link&amp;anchor=H22#H22\">",
"     \"Neurologic complications of non-platinum cancer chemotherapy\", section on 'Other vinca alkaloids'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The combination of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?4/3/4152?source=see_link\">",
"     vinblastine",
"    </a>",
"    plus",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/48/33536?source=see_link\">",
"     prednisolone",
"    </a>",
"    is the most commonly used induction regimen and is administered over six weeks, as follows [",
"    <a class=\"abstract\" href=\"UTD.htm?27/45/28378/abstract/9\">",
"     9",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?32/48/33536?source=see_link\">",
"       Prednisolone",
"      </a>",
"      (40",
"      <span class=\"nowrap\">",
"       mg/m",
"       <sup>",
"        2",
"       </sup>",
"       /day",
"      </span>",
"      orally for four weeks, and then tapered over two weeks)",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?4/3/4152?source=see_link\">",
"       Vinblastine",
"      </a>",
"      (6",
"      <span class=\"nowrap\">",
"       mg/m",
"       <sup>",
"        2",
"       </sup>",
"      </span>",
"      weekly intravenous bolus for six weeks)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The preference for this combination is largely based upon its use as a backbone in the largest prospective trials. These trials have demonstrated no apparent benefit to adding additional agents (ie,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?29/57/30617?source=see_link\">",
"     etoposide",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?23/38/24170?source=see_link\">",
"     methotrexate",
"    </a>",
"    ) to induction, but have not prospectively examined the role of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/48/33536?source=see_link\">",
"     prednisolone",
"    </a>",
"    in this combination. Although",
"    <a class=\"drug drug_general\" href=\"UTD.htm?4/3/4152?source=see_link\">",
"     vinblastine",
"    </a>",
"    and etoposide appear to be equally effective single agents, the combination of vinblastine plus prednisolone has been generally adopted due to concerns of secondary leukemia after etoposide exposure. The following is a summary of the largest organized prospective trials in LCH:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      The DAL-HX 83 trial &mdash; In this nonrandomized trial, 28 patients with multifocal bone disease and 57 patients with soft tissue involvement but without organ dysfunction received an initial six-week treatment with",
"      <a class=\"drug drug_general\" href=\"UTD.htm?29/57/30617?source=see_link\">",
"       etoposide",
"      </a>",
"      ,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?37/43/38585?source=see_link\">",
"       prednisone",
"      </a>",
"      , and",
"      <a class=\"drug drug_general\" href=\"UTD.htm?4/3/4152?source=see_link\">",
"       vinblastine",
"      </a>",
"      , followed by one year of vinblastine, prednisone, and 6-",
"      <a class=\"drug drug_general\" href=\"UTD.htm?36/43/37559?source=see_link\">",
"       mercaptopurine",
"      </a>",
"      (with etoposide added for patients with soft tissue involvement) [",
"      <a class=\"abstract\" href=\"UTD.htm?27/45/28378/abstract/17\">",
"       17",
"      </a>",
"      ]. Complete resolution was achieved in approximately 90 percent of patients. Recurrence developed in 12 and 23 percent of patients with bone and soft tissue involvement, respectively. An additional 21 patients with organ dysfunction were treated with the same induction, followed by one year of etoposide, vinblastine, prednisone,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?23/38/24170?source=see_link\">",
"       methotrexate",
"      </a>",
"      , and 6-mercaptopurine. Complete resolution was achieved in 14 patients, with recurrence in 42 percent, and eight deaths.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      The Histiocyte Society LCH-I study &mdash; In this study, 143 previously untreated patients with multisystem LCH were randomly assigned to receive a single initial dose of corticosteroids plus 24 weeks of treatment with either",
"      <a class=\"drug drug_general\" href=\"UTD.htm?4/3/4152?source=see_link\">",
"       vinblastine",
"      </a>",
"      (6",
"      <span class=\"nowrap\">",
"       mg/m",
"       <sup>",
"        2",
"       </sup>",
"      </span>",
"      intravenously once per week) or",
"      <a class=\"drug drug_general\" href=\"UTD.htm?29/57/30617?source=see_link\">",
"       etoposide",
"      </a>",
"      (150",
"      <span class=\"nowrap\">",
"       mg/m",
"       <sup>",
"        2",
"       </sup>",
"      </span>",
"      per day intravenously for three consecutive days every three weeks) [",
"      <a class=\"abstract\" href=\"UTD.htm?27/45/28378/abstract/8\">",
"       8",
"      </a>",
"      ]. The two treatment arms were equivalent in all of the study endpoints, including response at six weeks (49 to 57 percent), survival (76 to 80 percent), probability of disease reactivation (55 to 61 percent), and development of diabetes insipidus (22 to 23 percent).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      The Histiocyte Society LCH-II study &mdash; In this study, 193 patients with previously untreated multisystem LCH and risk organ involvement were randomly assigned to receive",
"      <a class=\"drug drug_general\" href=\"UTD.htm?4/3/4152?source=see_link\">",
"       vinblastine",
"      </a>",
"      plus",
"      <a class=\"drug drug_general\" href=\"UTD.htm?32/48/33536?source=see_link\">",
"       prednisolone",
"      </a>",
"      with or without",
"      <a class=\"drug drug_general\" href=\"UTD.htm?29/57/30617?source=see_link\">",
"       etoposide",
"      </a>",
"      [",
"      <a class=\"abstract\" href=\"UTD.htm?27/45/28378/abstract/9\">",
"       9",
"      </a>",
"      ]. Induction was followed by continuation therapy for 24 weeks. When compared with vinblastine plus prednisolone alone, the three-drug combination resulted in similar rates of response at six weeks (71 versus 63 percent), rate of survival at five years (79 versus 74 percent), and disease reactivation (46 versus 46 percent). A controversial comparison of patients from the LCH-I study suggested that more intensive treatments as in LCH-II led to earlier responses and reduced mortality.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      The Histiocyte Society LCH-III study &mdash; In this study, 234 patients with previously untreated multisystem LCH and risk organ involvement were randomly assigned to received",
"      <a class=\"drug drug_general\" href=\"UTD.htm?4/3/4152?source=see_link\">",
"       vinblastine",
"      </a>",
"      plus",
"      <a class=\"drug drug_general\" href=\"UTD.htm?37/43/38585?source=see_link\">",
"       prednisone",
"      </a>",
"      with or without",
"      <a class=\"drug drug_general\" href=\"UTD.htm?23/38/24170?source=see_link\">",
"       methotrexate",
"      </a>",
"      [",
"      <a class=\"abstract\" href=\"UTD.htm?27/45/28378/abstract/3\">",
"       3",
"      </a>",
"      ]. Induction was followed by maintenance therapy for a total of 12 months. In addition, 260 patients without risk organ involvement were treated with vinblastine plus",
"      <a class=\"drug drug_general\" href=\"UTD.htm?32/48/33536?source=see_link\">",
"       prednisolone",
"      </a>",
"      with subsequent randomization to 6 or 12 months of continuation therapy. The LCH-III study was closed in 2009 and results are still being analyzed. Unpublished preliminary results demonstrate no significant improvement in response, survival, or reactivation rate with the addition of methotrexate to induction, but suggest a decrease in relapse rates among patient with low risk disease receiving longer continuation.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      The JLSG-96 protocol &mdash; This nonrandomized trial employed more intensive treatment with various combinations of cytosine arabinoside,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?1/29/1498?source=see_link\">",
"       vincristine",
"      </a>",
"      ,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?32/48/33536?source=see_link\">",
"       prednisolone",
"      </a>",
"      ,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?23/38/24170?source=see_link\">",
"       methotrexate",
"      </a>",
"      , adriamycin, and",
"      <a class=\"drug drug_general\" href=\"UTD.htm?9/20/9546?source=see_link\">",
"       cyclophosphamide",
"      </a>",
"      , for a longer treatment (30 weeks) [",
"      <a class=\"abstract\" href=\"UTD.htm?27/45/28378/abstract/18\">",
"       18",
"      </a>",
"      ]. The recurrence rate following attainment of remission was 28 percent in those with multiple lesions in a single organ and 45 percent in those with multiple lesions in several organs, suggesting that more intensive treatment may not necessarily result in better outcomes.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Together, these studies have demonstrated a gradual improvement in the outcomes of patients with multisystem LCH. The majority of patients will respond to initial therapy. Patients without &ldquo;risk organ&rdquo; involvement have very good outcomes. Patients with multisystem disease and risk organ involvement (ie, liver, spleen, bone marrow) can be more difficult to treat and appear to require intensified treatment [",
"    <a class=\"abstract\" href=\"UTD.htm?27/45/28378/abstract/9\">",
"     9",
"    </a>",
"    ]. Importantly, disease response at six weeks is an important predictor of outcome and is used to determine subsequent management.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H932504\">",
"    <span class=\"h4\">",
"     Response evaluation and selection of subsequent management",
"    </span>",
"    &nbsp;&mdash;&nbsp;Response to therapy is first assessed after the end of the initial six-week course of induction (or &ldquo;intensive&rdquo;) therapy and determines further management. The response to treatment should be documented by history, physical examination, and imaging studies. The post-treatment imaging study of choice is controversial and, in practice, depends upon the site(s) of involvement and the imaging studies performed at the time of diagnosis. Magnetic resonance imaging (MRI) and positron emission tomography (PET) can be used to evaluate disease in the central nervous system (CNS) [",
"    <a class=\"abstract\" href=\"UTD.htm?27/45/28378/abstract/19\">",
"     19",
"    </a>",
"    ]. PET scans often show a decreased isotope uptake in bone or soft tissue lesions before such responses are apparent on bone scan or plain films [",
"    <a class=\"abstract\" href=\"UTD.htm?27/45/28378/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Using these studies, disease response is categorized as one of the following:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      No evidence of active disease &mdash; complete resolution of all signs and symptoms",
"     </li>",
"     <li>",
"      Continuous regression &mdash; signs",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      symptoms are less prominent with no new lesions",
"     </li>",
"     <li>",
"      Stable disease &mdash; persistence of signs",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      symptoms",
"     </li>",
"     <li>",
"      Progressive disease &mdash; progression of",
"      <span class=\"nowrap\">",
"       signs/symptoms",
"      </span>",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      appearance of new",
"      <span class=\"nowrap\">",
"       signs/symptoms",
"      </span>",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Prospective trials have identified response to treatment at six weeks and the presence of &ldquo;risk organ&rdquo; involvement as independent prognostic markers. In the LCH-I trial, all children &ge;2 years of age without risk organ involvement survived [",
"    <a class=\"abstract\" href=\"UTD.htm?27/45/28378/abstract/8\">",
"     8",
"    </a>",
"    ]. When risk organs were involved (liver, lungs, hematopoietic system, spleen), lack of rapid response (ie, within six weeks) indicated a poor prognosis, predicting a mortality rate of 66 percent. Similarly, in the LCH-II study, patients with &ldquo;risk organ&rdquo; involvement and no evidence of response or progression at six weeks had a significantly lower predicted survival at five years than those who demonstrated a response at six weeks (49 and 27 percent versus 88 percent, respectively) [",
"    <a class=\"abstract\" href=\"UTD.htm?27/45/28378/abstract/9\">",
"     9",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Information regarding disease response at six weeks and the involvement of &ldquo;risk organs&rdquo; is used to guide subsequent management (",
"    <a class=\"graphic graphic_algorithm graphicRef83046 \" href=\"UTD.htm?23/1/23568\">",
"     algorithm 1",
"    </a>",
"    ):",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      No evidence of active disease &mdash; All patients who achieve this level of response proceed to continuation therapy, regardless of &ldquo;risk organ&rdquo; status at the time of diagnosis. Continuation therapy is an essential part of the management of these patients and decreases the risk of relapse. (See",
"      <a class=\"local\" href=\"#H932511\">",
"       'Continuation therapy'",
"      </a>",
"      below.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Continuous regression &mdash; Patients with evident but incomplete response who did not have &ldquo;risk organ&rdquo; involvement at diagnosis proceed to continuation therapy. For patients with &ldquo;risk organ&rdquo; involvement at diagnosis, another six-week induction is used with",
"      <a class=\"drug drug_general\" href=\"UTD.htm?37/43/38585?source=see_link\">",
"       prednisone",
"      </a>",
"      only given for three days each week. (See",
"      <a class=\"local\" href=\"#H932497\">",
"       'Induction chemotherapy'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Stable disease &mdash; For patients with stable disease who did not have &ldquo;risk organ&rdquo; involvement at diagnosis, another six-week induction is used with",
"      <a class=\"drug drug_general\" href=\"UTD.htm?37/43/38585?source=see_link\">",
"       prednisone",
"      </a>",
"      only given for three days each week. Patients with &ldquo;risk organ&rdquo; involvement proceed with second-line treatment. (See",
"      <a class=\"local\" href=\"#H932497\">",
"       'Induction chemotherapy'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H6873611\">",
"       'Relapsed or refractory disease'",
"      </a>",
"      below.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Progressive disease &mdash; All patients with progressive disease at six weeks should be changed to a second-line therapy, regardless of &ldquo;risk organ&rdquo; status at the time of diagnosis. (See",
"      <a class=\"local\" href=\"#H6873611\">",
"       'Relapsed or refractory disease'",
"      </a>",
"      below.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H932511\">",
"    <span class=\"h4\">",
"     Continuation therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Attainment of a response is the first step in the treatment of LCH. However, relapse can be expected in the following months to years if no further therapy is given [",
"    <a class=\"abstract\" href=\"UTD.htm?27/45/28378/abstract/8\">",
"     8",
"    </a>",
"    ]. Continuation therapy is an essential component of the treatment of LCH. During continuation therapy, chemotherapy consisting of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?4/3/4152?source=see_link\">",
"     vinblastine",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/48/33536?source=see_link\">",
"     prednisolone",
"    </a>",
"    are administered for a total treatment duration of 6 to 12 months.",
"    <a class=\"drug drug_general\" href=\"UTD.htm?36/43/37559?source=see_link\">",
"     Mercaptopurine",
"    </a>",
"    is incorporated for patients originally presenting with &ldquo;risk organ&rdquo; involvement. One of the Histiocyte Society LCH-IV study aims is to compare six and 12 months of continuation therapy. Until further data are available, we suggest the use of continuation therapy to a total treatment duration of 12 months.",
"   </p>",
"   <p>",
"    The combination of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?4/3/4152?source=see_link\">",
"     vinblastine",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/48/33536?source=see_link\">",
"     prednisolone",
"    </a>",
"    most commonly used for continuation is administered in three-week cycles for a total of six to 12 months of therapy, as follows [",
"    <a class=\"abstract\" href=\"UTD.htm?27/45/28378/abstract/9\">",
"     9",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?32/48/33536?source=see_link\">",
"       Prednisolone",
"      </a>",
"      (40",
"      <span class=\"nowrap\">",
"       mg/m",
"       <sup>",
"        2",
"       </sup>",
"       /day",
"      </span>",
"      orally on days 1 through 5), repeated every three weeks",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?4/3/4152?source=see_link\">",
"       Vinblastine",
"      </a>",
"      (6",
"      <span class=\"nowrap\">",
"       mg/m",
"       <sup>",
"        2",
"       </sup>",
"      </span>",
"      intravenously on day 1), repeated every three weeks",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    For patients who had &ldquo;risk organ&rdquo; involvement at the time of diagnosis, we administer daily",
"    <a class=\"drug drug_general\" href=\"UTD.htm?36/43/37559?source=see_link\">",
"     mercaptopurine",
"    </a>",
"    (50",
"    <span class=\"nowrap\">",
"     mg/m",
"     <sup>",
"      2",
"     </sup>",
"     /day",
"    </span>",
"    orally) during continuation until completion of therapy.",
"   </p>",
"   <p>",
"    The use of continuation therapy has not been subject to investigation in a randomized trial. The following prospective studies offer insight into the role of continuation therapy for patients with LCH:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      In the Histiocyte Society LCH-I study, patients with multisystem LCH received a single initial dose of corticosteroids plus 24 weeks of treatment with either",
"      <a class=\"drug drug_general\" href=\"UTD.htm?4/3/4152?source=see_link\">",
"       vinblastine",
"      </a>",
"      or",
"      <a class=\"drug drug_general\" href=\"UTD.htm?29/57/30617?source=see_link\">",
"       etoposide",
"      </a>",
"      and no further therapy [",
"      <a class=\"abstract\" href=\"UTD.htm?27/45/28378/abstract/8\">",
"       8",
"      </a>",
"      ]. After a median follow-up of 4.9 years, disease reactivation occurred in 55 to 61 percent.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      In the nonrandomized DAL-HX 83 trial, patients with multifocal bone disease or soft tissue involvement received induction followed by one year of",
"      <a class=\"drug drug_general\" href=\"UTD.htm?4/3/4152?source=see_link\">",
"       vinblastine",
"      </a>",
"      ,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?37/43/38585?source=see_link\">",
"       prednisone",
"      </a>",
"      , and",
"      <a class=\"drug drug_general\" href=\"UTD.htm?36/43/37559?source=see_link\">",
"       mercaptopurine",
"      </a>",
"      [",
"      <a class=\"abstract\" href=\"UTD.htm?27/45/28378/abstract/17\">",
"       17",
"      </a>",
"      ]. This continuation regimen was modified by risk with the addition of",
"      <a class=\"drug drug_general\" href=\"UTD.htm?29/57/30617?source=see_link\">",
"       etoposide",
"      </a>",
"      for patients with soft tissue involvement and",
"      <a class=\"drug drug_general\" href=\"UTD.htm?23/38/24170?source=see_link\">",
"       methotrexate",
"      </a>",
"      for patients with organ dysfunction. After a median follow-up of 6.75 years, recurrence developed in 12, 23, and 42 percent of patients with multifocal bone disease, soft tissue involvement without organ dysfunction, and with organ dysfunction, respectively.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      In the Histiocyte Society LCH-II study, patients with previously untreated multisystem LCH and risk organ involvement received induction with",
"      <a class=\"drug drug_general\" href=\"UTD.htm?4/3/4152?source=see_link\">",
"       vinblastine",
"      </a>",
"      plus",
"      <a class=\"drug drug_general\" href=\"UTD.htm?32/48/33536?source=see_link\">",
"       prednisolone",
"      </a>",
"      with or without",
"      <a class=\"drug drug_general\" href=\"UTD.htm?29/57/30617?source=see_link\">",
"       etoposide",
"      </a>",
"      followed by continuation therapy for six months [",
"      <a class=\"abstract\" href=\"UTD.htm?27/45/28378/abstract/9\">",
"       9",
"      </a>",
"      ]. Continuation consisted of",
"      <a class=\"drug drug_general\" href=\"UTD.htm?36/43/37559?source=see_link\">",
"       mercaptopurine",
"      </a>",
"      ,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?37/43/38585?source=see_link\">",
"       prednisone",
"      </a>",
"      , and vinblastine, with or without etoposide. After a median follow-up of 7.5 years, disease reactivation occurred in 46 percent.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      The JLSG-96 protocol uses more intensive treatment with various combinations of cytosine arabinoside,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?1/29/1498?source=see_link\">",
"       vincristine",
"      </a>",
"      ,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?32/48/33536?source=see_link\">",
"       prednisolone",
"      </a>",
"      ,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?23/38/24170?source=see_link\">",
"       methotrexate",
"      </a>",
"      , adriamycin, and",
"      <a class=\"drug drug_general\" href=\"UTD.htm?9/20/9546?source=see_link\">",
"       cyclophosphamide",
"      </a>",
"      , administered over six weeks of induction followed by six months of continuation therapy [",
"      <a class=\"abstract\" href=\"UTD.htm?27/45/28378/abstract/18\">",
"       18",
"      </a>",
"      ]. After a median follow-up of five years, the recurrence rate following attainment of remission was 28 percent in those with multiple lesions in a single organ and 45 percent in those with multiple lesions in several organs.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Together, these studies suggest that continuation therapy appears to decrease the rate of disease recurrence. It is unknown whether longer continuation therapy (ie, 12 months) results in lower rates of recurrence than shorter continuation (ie, six months). This is subject of the LCH-IV study. When",
"    <a class=\"drug drug_general\" href=\"UTD.htm?4/3/4152?source=see_link\">",
"     vinblastine",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?37/43/38585?source=see_link\">",
"     prednisone",
"    </a>",
"    were used for at least 12 months (the DAL HX-83 study), the percentage of recurrences was less than 20 percent. In the LCH-I study, in which treatment was stopped after six months, the recurrence rate was as high as 50 percent. For most patients who achieve a response to induction therapy, we suggest the use of continuation therapy to complete a total treatment duration of 12 months. Six months of therapy is a reasonable alternative, especially for patients with significant side effects.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6872190\">",
"    <span class=\"h2\">",
"     Special populations",
"    </span>",
"    &nbsp;&mdash;&nbsp;The general treatment principles described above apply to most disease presentations of LCH in children. However, involvement of certain organs has unique therapeutic implications. Importantly, adults with LCH require special consideration because toxicity rates are unacceptably high when these patients are treated with regimens usually offered to children.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H42641546\">",
"    <span class=\"h3\">",
"     Central nervous system LCH",
"    </span>",
"    &nbsp;&mdash;&nbsp;Involvement of the central nervous system (CNS) may manifest as mass lesions in the white or grey matter, endocrine abnormalities (eg, diabetes insipidus) or as neurodegenerative syndrome. Patients with CNS involvement require therapy directed at their CNS lesions. Treatment options include chemotherapy that crosses the blood brain barrier, resection, radiation therapy, or a combination of these. These options have not been compared directly in a prospective trial.",
"    <a class=\"drug drug_general\" href=\"UTD.htm?19/22/19815?source=see_link\">",
"     Cladribine",
"    </a>",
"    is effective for CNS mass lesions [",
"    <a class=\"abstract\" href=\"UTD.htm?27/45/28378/abstract/20\">",
"     20",
"    </a>",
"    ].",
"    <a class=\"drug drug_general\" href=\"UTD.htm?19/53/20314?source=see_link\">",
"     Cytarabine",
"    </a>",
"    can reverse the symptoms and signs of the neurodegenerative syndrome [",
"    <a class=\"abstract\" href=\"UTD.htm?27/45/28378/abstract/21\">",
"     21",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/53/21338?source=see_link&amp;anchor=H452662508#H452662508\">",
"     \"Clinical manifestations, pathologic features, and diagnosis of Langerhans cell histiocytosis\", section on 'Central nervous system'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Case reports have demonstrated remissions following the resection of solitary mass lesions with or without subsequent low dose radiation therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?27/45/28378/abstract/22\">",
"     22",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Mass lesions of the white or grey matter, hypothalamus, and pituitary have been effectively treated with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?19/22/19815?source=see_link\">",
"     cladribine",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?27/45/28378/abstract/20,23\">",
"     20,23",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Three treatments for the neurodegenerative syndrome of LCH have been published.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Retinoic acid was used for 10 patients with MRI findings remaining stable, but clinical efficacy was difficult to judge as only one-year follow-up was reported [",
"      <a class=\"abstract\" href=\"UTD.htm?27/45/28378/abstract/24\">",
"       24",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Another study, which used intravenous immunoglobulin and oral",
"      <a class=\"drug drug_general\" href=\"UTD.htm?37/43/38585?source=see_link\">",
"       prednisone",
"      </a>",
"      with or without",
"      <a class=\"drug drug_general\" href=\"UTD.htm?4/3/4152?source=see_link\">",
"       vinblastine",
"      </a>",
"      &nbsp;",
"      <a class=\"drug drug_general\" href=\"UTD.htm?23/38/24170?source=see_link\">",
"       methotrexate",
"      </a>",
"      in five patients, reported most remained stable over a mean follow-up period of 30 months [",
"      <a class=\"abstract\" href=\"UTD.htm?27/45/28378/abstract/25\">",
"       25",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      A study using",
"      <a class=\"drug drug_general\" href=\"UTD.htm?19/53/20314?source=see_link\">",
"       cytarabine",
"      </a>",
"      with or without",
"      <a class=\"drug drug_general\" href=\"UTD.htm?1/29/1498?source=see_link\">",
"       vincristine",
"      </a>",
"      reported improvement in the clinical",
"      <span class=\"nowrap\">",
"       (6/8)",
"      </span>",
"      and MRI findings",
"      <span class=\"nowrap\">",
"       (5/8)",
"      </span>",
"      [",
"      <a class=\"abstract\" href=\"UTD.htm?27/45/28378/abstract/21\">",
"       21",
"      </a>",
"      ]. Seven of these patients have been followed for more than three years after stopping therapy and all but one have stable neurologic and radiographic findings.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Treatment of the pituitary damaged by LCH has not been shown to reverse the DI [",
"    <a class=\"abstract\" href=\"UTD.htm?27/45/28378/abstract/26\">",
"     26",
"    </a>",
"    ], although some patients have reported a need for lower doses of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?5/24/5511?source=see_link\">",
"     antidiuretic hormone",
"    </a>",
"    (",
"    <a class=\"drug drug_general\" href=\"UTD.htm?9/60/10184?source=see_link\">",
"     desmopressin",
"    </a>",
"    , DDAVP) after receiving chemotherapy.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6872801\">",
"    <span class=\"h3\">",
"     Bone lesions at risk of collapse",
"    </span>",
"    &nbsp;&mdash;&nbsp;While bone involvement occurs in the majority of patients with LCH, only a minority of these patients will have lesions of the vertebrae or femoral neck that are at risk of collapse. Such lesions require special consideration and directed therapy.",
"   </p>",
"   <p>",
"    Radiation therapy (RT) is able to obtain in-field disease control in most patients with LCH, but is generally avoided due to concerns regarding damage to endochondral ossification centers and other toxicities [",
"    <a class=\"abstract\" href=\"UTD.htm?27/45/28378/abstract/27\">",
"     27",
"    </a>",
"    ]. However, RT should be considered for patients with bone lesions of the vertebrae or femoral neck, which are at risk of collapse. Studies of RT for LCH demonstrated radiographic and symptomatic response in greater than 90 percent of children and 70 percent of adults [",
"    <a class=\"abstract\" href=\"UTD.htm?27/45/28378/abstract/28-31\">",
"     28-31",
"    </a>",
"    ]. LCH-related bone pain generally resolved within four months. Long term control was documented in the majority. While diagnostic biopsy and RT are usually sufficient therapy, orthopedic intervention or bracing may be necessary for severely unstable bone lesions.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6872370\">",
"    <span class=\"h3\">",
"     Adults",
"    </span>",
"    &nbsp;&mdash;&nbsp;There have been no clinical trials to inform practitioners of the optimal therapy of adult patients. Thus, if there is a clinical trial open, patients should be referred, whenever possible, for enrollment. Adults with a single bone lesion are usually treated with curettage with or without intralesional corticosteroids or radiation therapy. However, there is no agreed upon management plan for multisystem disease in adults. Our current approach is to administer low dose",
"    <a class=\"drug drug_general\" href=\"UTD.htm?19/53/20314?source=see_link\">",
"     cytarabine",
"    </a>",
"    (100",
"    <span class=\"nowrap\">",
"     mg/m",
"     <sup>",
"      2",
"     </sup>",
"    </span>",
"    over 60 minutes, daily for five days, repeat monthly for 12 months) for patients with multiple bone or any other lesions except skin alone. Some patients tolerate this well with healing of skin and bone lesions as well as decrease in their pain. Others have surprisingly great hematologic toxicity, fatigue, and lack of response in lesions.",
"   </p>",
"   <p>",
"    Several major reviews of LCH in adults have been published [",
"    <a class=\"abstract\" href=\"UTD.htm?27/45/28378/abstract/32-37\">",
"     32-37",
"    </a>",
"    ], with the largest series including pediatric patients seen at the Mayo Clinic and material from the Armed Forces Institute of Pathology [",
"    <a class=\"abstract\" href=\"UTD.htm?27/45/28378/abstract/34-36\">",
"     34-36",
"    </a>",
"    ]. Adult LCH can be considered to be an \"orphan disease\" for two reasons:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Adults with a single lesion may present to a specialist (eg, dermatologist or pulmonologist), who may be unaware that the lesion in question is part of a more generalized systemic disorder.",
"     </li>",
"     <li>",
"      For those physicians who are aware that LCH can be a systemic disorder, no organized treatment protocols have been in place to define optimal treatment and natural history of the disease.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    This section summarizes what is known about LCH in adults from the medical literature and the author's own experience. The Histiocytosis Association of America is developing a list of physicians who are especially knowledgeable about LCH and who can be of assistance to adult patients and their physicians. (See",
"    <a class=\"local\" href=\"#H452650173\">",
"     'Clinical trials'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    A wide diversity of treatments includes:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?19/22/19815?source=see_link\">",
"       Cladribine",
"      </a>",
"      &mdash; Case reports have reported responses in patients with LCH who responded to cladribine (2-CdA) [",
"      <a class=\"abstract\" href=\"UTD.htm?27/45/28378/abstract/38,39\">",
"       38,39",
"      </a>",
"      ]. Since these reports were published in the early 1990s, this drug has been successfully used in many patients and for some is considered the standard of care for patients with multifocal bone disease. There seems to be variable response of skin lesions. (See",
"      <a class=\"local\" href=\"#H6873611\">",
"       'Relapsed or refractory disease'",
"      </a>",
"      below.)",
"     </li>",
"     <li>",
"      Bisphosphonates &mdash; Anecdotal reports describe the successful use of the bisphosphonate",
"      <a class=\"drug drug_general\" href=\"UTD.htm?2/62/3048?source=see_link\">",
"       pamidronate",
"      </a>",
"      in controlling severe bone pain in patients with multiple osteolytic lesions [",
"      <a class=\"abstract\" href=\"UTD.htm?27/45/28378/abstract/40,41\">",
"       40,41",
"      </a>",
"      ].",
"      <a class=\"drug drug_general\" href=\"UTD.htm?9/1/9241?source=see_link\">",
"       Zoledronic acid",
"      </a>",
"      and other bisphosphonates have been effective in reducing pain and improving functional status in a series of 12 patients [",
"      <a class=\"abstract\" href=\"UTD.htm?27/45/28378/abstract/42\">",
"       42",
"      </a>",
"      ]. There was radiographic evidence of response in 75 percent.",
"     </li>",
"     <li>",
"      MACOP-B &mdash; A retrospective analysis evaluated the use of MACOP-B (",
"      <a class=\"drug drug_general\" href=\"UTD.htm?9/20/9546?source=see_link\">",
"       cyclophosphamide",
"      </a>",
"      ,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?35/37/36440?source=see_link\">",
"       doxorubicin",
"      </a>",
"      ,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?1/29/1498?source=see_link\">",
"       vincristine",
"      </a>",
"      ,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?23/38/24170?source=see_link\">",
"       methotrexate",
"      </a>",
"      ,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?38/15/39159?source=see_link\">",
"       bleomycin",
"      </a>",
"      and",
"      <a class=\"drug drug_general\" href=\"UTD.htm?37/43/38585?source=see_link\">",
"       prednisone",
"      </a>",
"      ) in seven patients with single-system multifocal or multisystem LCH [",
"      <a class=\"abstract\" href=\"UTD.htm?27/45/28378/abstract/43\">",
"       43",
"      </a>",
"      ]. There were five complete responses and two partial responses. Three patients relapsed from 5 to 62 months after this intensive treatment.",
"     </li>",
"     <li>",
"      Tyrosine kinase inhibitors &mdash; Responses to the tyrosine kinase inhibitor",
"      <a class=\"drug drug_general\" href=\"UTD.htm?17/1/17434?source=see_link\">",
"       imatinib",
"      </a>",
"      were reported in three adults with LCH involving the skin, lung, bone,",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      CNS [",
"      <a class=\"abstract\" href=\"UTD.htm?27/45/28378/abstract/44,45\">",
"       44,45",
"      </a>",
"      ]. Another adult LCH patient did not respond to imatinib [",
"      <a class=\"abstract\" href=\"UTD.htm?27/45/28378/abstract/46\">",
"       46",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Other treatments &mdash; A survey of 30 adults with LCH involving the bone was compiled from five Rare Cancer Network centers [",
"      <a class=\"abstract\" href=\"UTD.htm?27/45/28378/abstract/47\">",
"       47",
"      </a>",
"      ]. Patients were treated with various combinations of surgery, radiotherapy, and corticosteroids. With a median follow-up of 58 months, 30 percent had recurrent disease with the lowest recurrence number in those who had surgery and radiotherapy. Patients with skin-only LCH have responded to oral",
"      <a class=\"drug drug_general\" href=\"UTD.htm?23/38/24170?source=see_link\">",
"       methotrexate",
"      </a>",
"      20",
"      <span class=\"nowrap\">",
"       mg/m",
"       <sup>",
"        2",
"       </sup>",
"      </span>",
"      weekly, but sometimes need the addition of",
"      <a class=\"drug drug_general\" href=\"UTD.htm?36/43/37559?source=see_link\">",
"       mercaptopurine",
"      </a>",
"      50",
"      <span class=\"nowrap\">",
"       mg/m",
"       <sup>",
"        2",
"       </sup>",
"      </span>",
"      nightly [",
"      <a class=\"abstract\" href=\"UTD.htm?27/45/28378/abstract/13,14\">",
"       13,14",
"      </a>",
"      ].",
"      <a class=\"drug drug_general\" href=\"UTD.htm?28/62/29673?source=see_link\">",
"       Thalidomide",
"      </a>",
"      is effective for skin disease and topical nitrogen mustard is worth trying for refractory lesions of limited size [",
"      <a class=\"abstract\" href=\"UTD.htm?27/45/28378/abstract/15\">",
"       15",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    It is clear that protocols used for LCH in children are not generally applicable to adults. In 2004, as an example, the Histiocyte Society initiated a protocol for treatment of adult LCH patients, with treatment similar to that used for children (ie,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?4/3/4152?source=see_link\">",
"     vinblastine",
"    </a>",
"    plus",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/48/33536?source=see_link\">",
"     prednisolone",
"    </a>",
"    ). However, this protocol was closed because of excessive neurotoxicity from vinblastine. In addition, a single institution retrospective review of 58 adult patients with LCH with bone lesions found that low dose monthly",
"    <a class=\"drug drug_general\" href=\"UTD.htm?19/53/20314?source=see_link\">",
"     cytarabine",
"    </a>",
"    was more effective and less toxic than the combination of vinblastine plus",
"    <a class=\"drug drug_general\" href=\"UTD.htm?37/43/38585?source=see_link\">",
"     prednisone",
"    </a>",
"    or cytarabine [",
"    <a class=\"abstract\" href=\"UTD.htm?27/45/28378/abstract/48\">",
"     48",
"    </a>",
"    ]. Of the patients treated with vinblastine plus prednisone, 84 percent either did not respond or relapsed within a year of starting treatment. Vinblastine plus prednisone resulted in severe (grades",
"    <span class=\"nowrap\">",
"     3/4)",
"    </span>",
"    neurotoxicity in 75 percent. In comparison, in patients treated with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?19/22/19815?source=see_link\">",
"     cladribine",
"    </a>",
"    , 59 percent either did not respond or relapsed within a year of starting treatment. Severe (grade",
"    <span class=\"nowrap\">",
"     3/4)",
"    </span>",
"    hematologic toxicity was seen in 37 percent of the patients treated with cladribine and 20 percent of those who received cytarabine.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3864598\">",
"    <span class=\"h3\">",
"     Lung involvement",
"    </span>",
"    &nbsp;&mdash;&nbsp;Lung involvement is seen in approximately 10 percent of cases and is much more common in adults than in children. Management of pulmonary LCH in adults is presented separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/48/35592?source=see_link&amp;anchor=H15#H15\">",
"     \"Pulmonary Langerhans cell histiocytosis\", section on 'Treatment'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/53/21338?source=see_link&amp;anchor=H452648876#H452648876\">",
"     \"Clinical manifestations, pathologic features, and diagnosis of Langerhans cell histiocytosis\", section on 'Lungs'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    A",
"    <span class=\"nowrap\">",
"     cystic/nodular",
"    </span>",
"    pattern within the lung leads to the destruction of lung tissue. Ultimately, widespread fibrosis and destruction of lung tissue leads to severe pulmonary disability. However, in some young children with diffuse disease, therapy can halt progress of the pathology, and normal repair mechanisms may restore some function [",
"    <a class=\"abstract\" href=\"UTD.htm?27/45/28378/abstract/49\">",
"     49",
"    </a>",
"    ]. Lung and",
"    <span class=\"nowrap\">",
"     lung/heart",
"    </span>",
"    transplantation have been successfully accomplished in some adolescents and adults with LCH [",
"    <a class=\"abstract\" href=\"UTD.htm?27/45/28378/abstract/50\">",
"     50",
"    </a>",
"    ]. A review of 39 LCH patients who had lung or",
"    <span class=\"nowrap\">",
"     lung/heart",
"    </span>",
"    transplants in France revealed a survival rate &gt;50 percent at five and 10 years with 20 percent recurrence of the LCH if extra-pulmonary disease was present at the time of the transplant [",
"    <a class=\"abstract\" href=\"UTD.htm?27/45/28378/abstract/50\">",
"     50",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/20/26953?source=see_link\">",
"     \"Lung transplantation: General guidelines for recipient selection\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/31/34297?source=see_link\">",
"     \"Indications and contraindications for cardiac transplantation\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6872130\">",
"    <span class=\"h1\">",
"     POST-TREATMENT SURVEILLANCE",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6872159\">",
"    <span class=\"h2\">",
"     Monitoring for recurrence",
"    </span>",
"    &nbsp;&mdash;&nbsp;Following the completion of therapy, patients are seen at periodic intervals to be monitored and assessed for possible relapse. The frequency and extent of these visits depends upon the comfort of both the patient and physician. There have been no trials comparing various schedules of follow-up. Our approach to monitoring for recurrent disease is consistent with that proposed by the Histiocyte Society.",
"   </p>",
"   <p>",
"    As described above, response to therapy is first assessed after the end of the initial six-week course of therapy. The response to treatment should be documented by history, physical examination, and imaging studies. Patients with no evidence of active disease or with continuous regression are considered to be responding to therapy. Responders continue with treatment and are assessed periodically for response at 12, 18, and 24 weeks of therapy, then every three months for two years, every six months for two years, and then yearly. All other patients are considered non-responders and are candidates for second-line (salvage) therapy. (See",
"    <a class=\"local\" href=\"#H932504\">",
"     'Response evaluation and selection of subsequent management'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    Patients with diabetes insipidus",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    skull lesions in the orbit, mastoid, or temporal bone are at high risk of CNS involvement both at the time of initial diagnosis and at the time of relapse. These patients should have MRI with gadolinium contrast at the time of diagnosis and every one to two years for the next 10 years [",
"    <a class=\"abstract\" href=\"UTD.htm?27/45/28378/abstract/51\">",
"     51",
"    </a>",
"    ]. Although radiologic changes may be present, treatment for relapse in the CNS is not indicated until there is associated clinical neurodegeneration. In addition to MRI, brain stem auditory evoked responses should be performed at regular intervals to define the onset of clinically significant disease [",
"    <a class=\"abstract\" href=\"UTD.htm?27/45/28378/abstract/21\">",
"     21",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3867557\">",
"    <span class=\"h2\">",
"     Late effects",
"    </span>",
"    &nbsp;&mdash;&nbsp;Long term survivors may have residual abnormalities related to the disease",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    treatment. In particular, patients diagnosed with LCH during childhood are at risk for developing long term complications of therapy. Specific long term follow-up guidelines following treatment of childhood cancer or in those who have received chemotherapy have been published by the Children's Oncology Group, and are available at",
"    <a class=\"external\" href=\"file://www.survivorshipguidelines.org/\">",
"     www.survivorshipguidelines.org",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?27/45/28378/abstract/52\">",
"     52",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The incidence of late effects is largely dependent upon the extent of disease at diagnosis and the treatment received. Children with low-risk disease most often complete treatment and have no long-term sequelae beyond mild obesity from treatment with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?37/43/38585?source=see_link\">",
"     prednisone",
"    </a>",
"    . In contrast, patients with multisystem involvement have a 71 percent incidence of long term problems versus 24 percent of those with single-system involvement [",
"    <a class=\"abstract\" href=\"UTD.htm?27/45/28378/abstract/28,53,54\">",
"     28,53,54",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Growth and development problems are more frequent (20 percent) because of the young age at presentation, as well as the more toxic effects of long-term",
"      <a class=\"drug drug_general\" href=\"UTD.htm?37/43/38585?source=see_link\">",
"       prednisone",
"      </a>",
"      therapy in the very young child. Significant cognitive defects may develop in some long term survivors [",
"      <a class=\"abstract\" href=\"UTD.htm?27/45/28378/abstract/55\">",
"       55",
"      </a>",
"      ]. Hearing loss was found in 13 percent [",
"      <a class=\"abstract\" href=\"UTD.htm?27/45/28378/abstract/54\">",
"       54",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Neurologic problems, either secondary to vertebral compression or CNS-LCH (11 percent), and orthopedic defects from lesions of the femur, tibia, or humerus (20 percent) may be seen.",
"     </li>",
"     <li>",
"      Diffuse pulmonary disease may leave a patient with poor lung function, putting him or her at higher risk for infections and decreased exercise tolerance.",
"     </li>",
"     <li>",
"      Liver disease may lead to ascending cholangitis, which is not amenable to any treatment other than liver transplant [",
"      <a class=\"abstract\" href=\"UTD.htm?27/45/28378/abstract/56\">",
"       56",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Dental problems from loss of teeth have been significant for some patients, usually related to overly aggressive dental surgery.",
"     </li>",
"     <li>",
"      Bone marrow damage from therapy is rare and is associated with a higher risk of malignancy. (See",
"      <a class=\"local\" href=\"#H3867564\">",
"       'Malignancy'",
"      </a>",
"      below.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3867891\">",
"    <span class=\"h3\">",
"     Endocrine abnormalities",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with diabetes insipidus (DI) are at risk for panhypopituitarism and should be monitored carefully for adequacy of growth and development. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/39/31348?source=see_link\">",
"     \"Clinical manifestations of hypopituitarism\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/28/41413?source=see_link\">",
"     \"Diagnosis of hypopituitarism\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      In a retrospective review of 141 patients with LCH and DI, 43 percent developed growth hormone (GH) deficiency [",
"      <a class=\"abstract\" href=\"UTD.htm?27/45/28378/abstract/57\">",
"       57",
"      </a>",
"      ]. The five- and 10-year risks of GH deficiency among children with LCH and DI were 35 and 54 percent, respectively. This study further showed that there was no increased reactivation of LCH in patients who received growth hormone compared with those who did not.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Another study of 144 patients with a history of multisystem LCH followed in a late effects clinic reported that 50 (35 percent) had an endocrinopathy, including 49 of 50 with DI [",
"      <a class=\"abstract\" href=\"UTD.htm?27/45/28378/abstract/58\">",
"       58",
"      </a>",
"      ]. Fifteen of these patients had received cranial irradiation for treatment of LCH causing DI. Growth hormone deficiency (GHd) was present in 21, seven of whom had other anterior pituitary deficiencies. The GHD occurred zero to 12 years (median 3.5 years) from the diagnosis of LCH. Growth hormone replacement was beneficial in some patients.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3867564\">",
"    <span class=\"h3\">",
"     Malignancy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with LCH have been reported to have malignancies before, coincident with, or after the diagnosis of LCH. Since no population-based study has been done, it is difficult to know if there is truly an increased rate secondary to therapy for LCH, or if this is coincidence [",
"    <a class=\"abstract\" href=\"UTD.htm?27/45/28378/abstract/59,60\">",
"     59,60",
"    </a>",
"    ]. Leukemia (usually acute myeloid leukemia) occurs after treatment, as does lymphoblastic lymphoma. Concurrent",
"    <span class=\"nowrap\">",
"     LCH/malignancy",
"    </span>",
"    has been reported in a few patients, and some patients have had their malignancy first, and developed LCH at a later date. Solid tumors reported to be associated with LCH include retinoblastoma, brain tumors, hepatocellular carcinoma, Askin tumor, and Ewing sarcoma.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3867571\">",
"    <span class=\"h2\">",
"     Long-term follow-up",
"    </span>",
"    &nbsp;&mdash;&nbsp;Specific long-term follow-up guidelines following treatment of childhood cancer or in those who have received chemotherapy have been published by the Children's Oncology Group, and are available at",
"    <a class=\"external\" href=\"file://www.survivorshipguidelines.org/\">",
"     www.survivorshipguidelines.org",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?27/45/28378/abstract/52\">",
"     52",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The need for long-term follow-up was shown in a retrospective study of 335 patients with multisystem LCH who had attained a documented first complete disease resolution following treatment according to standards developed by the Histiocyte Society [",
"    <a class=\"abstract\" href=\"UTD.htm?27/45/28378/abstract/61\">",
"     61",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The probability of disease reactivation within five years of achieving a first complete disease resolution was 46 percent, most of which occurred within the first two years. Reactivations confined to the skeleton were the most frequent clinical pattern, occurring in 35 percent, whereas risk organs were less commonly involved (10 percent of the reactivations).",
"     </li>",
"     <li>",
"      A second complete disease resolution was achieved in 85 percent of the cases; the probability of a second reactivation within five years of achieving this second resolution was 44 percent. Risk organs were involved in only 2 percent of the reactivations following a second complete disease resolution.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6873611\">",
"    <span class=\"h1\">",
"     RELAPSED OR REFRACTORY DISEASE",
"    </span>",
"    &nbsp;&mdash;&nbsp;There is a paucity of data regarding the treatment of relapsed or refractory LCH. Only case reports and small case series are available to guide the care of these patients. These patients should be considered for enrollment onto a clinical trial. Outside of a clinical trial, the treatment approach should be individualized based upon the patient&rsquo;s performance status, the timing of relapse, and the disease risk stratification. As examples:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Patients with low risk LCH who relapse more than 12 months from the end of the original",
"      <span class=\"nowrap\">",
"       <a class=\"drug drug_general\" href=\"UTD.htm?4/3/4152?source=see_link\">",
"        vinblastine",
"       </a>",
"       /",
"       <a class=\"drug drug_general\" href=\"UTD.htm?32/48/33536?source=see_link\">",
"        prednisolone",
"       </a>",
"      </span>",
"      treatment may be successfully re-treated with vinblastine plus prednisolone, usually administered in combination with oral",
"      <a class=\"drug drug_general\" href=\"UTD.htm?23/38/24170?source=see_link\">",
"       methotrexate",
"      </a>",
"      and",
"      <a class=\"drug drug_general\" href=\"UTD.htm?36/43/37559?source=see_link\">",
"       mercaptopurine",
"      </a>",
"      [",
"      <a class=\"abstract\" href=\"UTD.htm?27/45/28378/abstract/61\">",
"       61",
"      </a>",
"      ]. With this approach, approximately 85 percent of patients will achieve a second remission.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      For patients with low risk LCH who relapse less than 12 months from the end of the original",
"      <span class=\"nowrap\">",
"       <a class=\"drug drug_general\" href=\"UTD.htm?4/3/4152?source=see_link\">",
"        vinblastine",
"       </a>",
"       /",
"       <a class=\"drug drug_general\" href=\"UTD.htm?32/48/33536?source=see_link\">",
"        prednisolone",
"       </a>",
"      </span>",
"      treatment, single agent",
"      <a class=\"drug drug_general\" href=\"UTD.htm?19/22/19815?source=see_link\">",
"       cladribine",
"      </a>",
"      (2-CdA) (six months total duration of therapy) results in responses in approximately 60 percent [",
"      <a class=\"abstract\" href=\"UTD.htm?27/45/28378/abstract/62\">",
"       62",
"      </a>",
"      ]. This may also be administered as a continuous infusion via a portable pump [",
"      <a class=\"abstract\" href=\"UTD.htm?27/45/28378/abstract/63\">",
"       63",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Patients with relapsed or refractory high risk LCH are unlikely to respond to re-treatment with",
"      <a class=\"drug drug_general\" href=\"UTD.htm?4/3/4152?source=see_link\">",
"       vinblastine",
"      </a>",
"      plus",
"      <a class=\"drug drug_general\" href=\"UTD.htm?32/48/33536?source=see_link\">",
"       prednisolone",
"      </a>",
"      . Instead, the most effective treatment for this population appears to be a combination of higher dose",
"      <a class=\"drug drug_general\" href=\"UTD.htm?19/22/19815?source=see_link\">",
"       cladribine",
"      </a>",
"      plus high dose",
"      <a class=\"drug drug_general\" href=\"UTD.htm?19/53/20314?source=see_link\">",
"       cytarabine",
"      </a>",
"      [",
"      <a class=\"abstract\" href=\"UTD.htm?27/45/28378/abstract/64,65\">",
"       64,65",
"      </a>",
"      ]. While early results suggest high response rates, physicians must be prepared to support patients through long periods of pancytopenia after each course. In contrast, single agent cladribine is",
"      <strong>",
"       not",
"      </strong>",
"      sufficient for patients with",
"      <span class=\"nowrap\">",
"       relapsing/refractory",
"      </span>",
"      high risk LCH. A retrospective analysis of 17 children from Japan with refractory high risk, recurrent high risk or multisystem, and recurrent multifocal bone treated with cladribine for 2 to 12 months on JLSG trials reported responses in 4 of 10 patients with refractory high risk disease, 5 of 8 patients with multifocal bone involvement, and 6 of 7 patients with reactivation of multisystem disease (non-high risk group) [",
"      <a class=\"abstract\" href=\"UTD.htm?27/45/28378/abstract/66\">",
"       66",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Other approaches have included:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Two patients with multifocal LCH resistant to",
"      <a class=\"drug drug_general\" href=\"UTD.htm?19/22/19815?source=see_link\">",
"       cladribine",
"      </a>",
"      had dramatic responses to",
"      <a class=\"drug drug_general\" href=\"UTD.htm?33/5/33879?source=see_link\">",
"       clofarabine",
"      </a>",
"      [",
"      <a class=\"abstract\" href=\"UTD.htm?27/45/28378/abstract/67\">",
"       67",
"      </a>",
"      ]. Our clinical experience is that this is an especially effective therapy for patients with resistant LCH of bones, skin, and lymph nodes.",
"     </li>",
"     <li>",
"      An alternative treatment that has proven successful in several patients, confirmed by the author's experience, employs",
"      <a class=\"drug drug_general\" href=\"UTD.htm?1/29/1498?source=see_link\">",
"       vincristine",
"      </a>",
"      , cytosine arabinoside, and",
"      <a class=\"drug drug_general\" href=\"UTD.htm?32/48/33536?source=see_link\">",
"       prednisolone",
"      </a>",
"      [",
"      <a class=\"abstract\" href=\"UTD.htm?27/45/28378/abstract/68\">",
"       68",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?2/62/3048?source=see_link\">",
"       Pamidronate",
"      </a>",
"      (PAM) has been reported in a few small case series. In a report of 21 children (median age 9.4 years) with one or more bone lesions and no risk organ involvement treated with six courses of PAM at four-week intervals, responses were seen in 12 of 16 patients [",
"      <a class=\"abstract\" href=\"UTD.htm?27/45/28378/abstract/69\">",
"       69",
"      </a>",
"      ]. Of these, eight had no active disease for a median of 3.3 years. Responses were seen in skin and soft tissue, as well as bone lesions.",
"     </li>",
"     <li>",
"      In one report, two patients with BRAF V600E gene mutation positive LCH of the skin or lymph node and concomitant Erdheim-Chester disease demonstrated partial clinical responses following treatment with the BRAF inhibitor",
"      <a class=\"drug drug_general\" href=\"UTD.htm?16/48/17159?source=see_link\">",
"       vemurafenib",
"      </a>",
"      [",
"      <a class=\"abstract\" href=\"UTD.htm?27/45/28378/abstract/70\">",
"       70",
"      </a>",
"      ]. Clinically significant cutaneous side effects are common with vemurafenib and include squamous cell carcinomas and keratoacanthomas. At the time of publication, none of these patients had been followed for more than one year. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?19/30/19944?source=see_link&amp;anchor=H100472992#H100472992\">",
"       \"Molecularly targeted therapy for metastatic melanoma\", section on 'Vemurafenib'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?20/53/21338?source=see_link&amp;anchor=H452648797#H452648797\">",
"       \"Clinical manifestations, pathologic features, and diagnosis of Langerhans cell histiocytosis\", section on 'Pathogenesis'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6873633\">",
"    <span class=\"h2\">",
"     Hematopoietic cell transplantation",
"    </span>",
"    &nbsp;&mdash;&nbsp;The role of allogeneic hematopoietic cell transplantation (HCT) in LCH has not been directly studied. Case reports and small case series suggest that HCT may be effective in preventing relapse among patients in complete remission at the time of HCT [",
"    <a class=\"abstract\" href=\"UTD.htm?27/45/28378/abstract/71-75\">",
"     71-75",
"    </a>",
"    ]. In one series, allogeneic HCT resulted in the apparent cure of six out of 15 patients who received HCT after failing chemotherapy [",
"    <a class=\"abstract\" href=\"UTD.htm?27/45/28378/abstract/72\">",
"     72",
"    </a>",
"    ]. In another series, three of the five patients receiving an allogeneic HCT had initial complete remissions, although two died from toxicity of the procedure [",
"    <a class=\"abstract\" href=\"UTD.htm?27/45/28378/abstract/71\">",
"     71",
"    </a>",
"    ]. Reduced intensity conditioning resulted in seven of nine patients surviving HCT in a third series [",
"    <a class=\"abstract\" href=\"UTD.htm?27/45/28378/abstract/73\">",
"     73",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6873640\">",
"    <span class=\"h2\">",
"     Treatments not considered effective",
"    </span>",
"    &nbsp;&mdash;&nbsp;Other treatments, such as",
"    <a class=\"drug drug_general\" href=\"UTD.htm?31/39/32368?source=see_link\">",
"     cyclosporine",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?27/45/28378/abstract/76\">",
"     76",
"    </a>",
"    ] or alpha interferon [",
"    <a class=\"abstract\" href=\"UTD.htm?27/45/28378/abstract/77\">",
"     77",
"    </a>",
"    ], have been attempted in treating this disease. However, they are currently viewed as non-standard approaches. Extensive surgery is not indicated except for curettage of a circumscribed skull lesion. Importantly, extensive surgery involving the mandible may destroy any possibility of secondary tooth development.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H452650173\">",
"    <span class=\"h1\">",
"     CLINICAL TRIALS",
"    </span>",
"    &nbsp;&mdash;&nbsp;An International Directory of affiliated organizations dealing with the histiocytic disorders as well as the website for the Histiocytosis Association of America can be found at",
"    <a class=\"external\" href=\"file://www.histio.org/\">",
"     www.histio.org",
"    </a>",
"    . The optimal therapy for all patients with LCH is to be enrolled on clinical trials of the Histiocyte Society. Information can be found at",
"    <a class=\"external\" href=\"file://www.histiocytesociety.org/\">",
"     www.histiocytesociety.org",
"    </a>",
"    .",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H368766288\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Langerhans cell histiocytosis (LCH) is a rare histiocytic disorder most commonly characterized by single or multiple osteolytic bone lesions demonstrating infiltration with foamy histiocytes on biopsy with or without histiocytic infiltration of extraskeletal lesions (most notably the skin, lungs, and central nervous system). (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?20/53/21338?source=see_link\">",
"       \"Clinical manifestations, pathologic features, and diagnosis of Langerhans cell histiocytosis\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      At the time of diagnosis, patients are risk stratified based upon the extent of disease and whether or not &ldquo;risk organs&rdquo; are involved. Patients with single system LCH are those with unifocal or multifocal involvement of one",
"      <span class=\"nowrap\">",
"       organ/system",
"      </span>",
"      (eg, bone, skin, lymph node, soft tissue). Patients with multisystem LCH are those with two or more",
"      <span class=\"nowrap\">",
"       organs/systems",
"      </span>",
"      involved with or without involvement of &ldquo;risk organs&rdquo;. &ldquo;Risk organs&rdquo; include the hematopoietic system, liver,",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      spleen and denote a worse prognosis. In contrast, the term &ldquo;CNS-risk&rdquo; areas include the sphenoid, orbital, ethmoid, or temporal bones and denote an increased risk of involvement of the central nervous system. (See",
"      <a class=\"local\" href=\"#H42641525\">",
"       'Risk stratification'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For patients with single system LCH, the choice of therapy is generally made based upon the site of involvement and number of lesions with an aim to minimize toxicity. Treatment options include single agent",
"      <a class=\"drug drug_general\" href=\"UTD.htm?37/43/38585?source=see_link\">",
"       prednisone",
"      </a>",
"      , the combination of",
"      <a class=\"drug drug_general\" href=\"UTD.htm?4/3/4152?source=see_link\">",
"       vinblastine",
"      </a>",
"      and prednisone, curettage of bone lesions, and topical therapy for skin lesions. Alternatively, a subset of patients may select close observation with treatment upon progression. (See",
"      <a class=\"local\" href=\"#H6814315\">",
"       'Single system disease'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Patients with multisystem LCH should be encouraged to participate in a clinical trial. For patients who are not candidates for a clinical trial or for those who choose not to participate in a clinical trial, we suggest initial induction chemotherapy with",
"      <a class=\"drug drug_general\" href=\"UTD.htm?4/3/4152?source=see_link\">",
"       vinblastine",
"      </a>",
"      plus",
"      <a class=\"drug drug_general\" href=\"UTD.htm?32/48/33536?source=see_link\">",
"       prednisolone",
"      </a>",
"      (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). Subsequent therapy is dependent upon disease response at six weeks and whether &ldquo;risk organs&rdquo; (ie, hematopoietic system, liver,",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      spleen) were involved at the time of diagnosis (",
"      <a class=\"graphic graphic_algorithm graphicRef83046 \" href=\"UTD.htm?23/1/23568\">",
"       algorithm 1",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H932497\">",
"       'Induction chemotherapy'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H932504\">",
"       'Response evaluation and selection of subsequent management'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      For all patients who achieve no evidence of active disease after initial induction chemotherapy, we recommend the use of continuation chemotherapy, regardless of the &ldquo;risk organ&rdquo; status at the time of diagnosis (",
"      <a class=\"grade\" href=\"._grade_3?title=Grade 1C\">",
"       Grade 1C",
"      </a>",
"      ). Continuation therapy is an essential part of the management of these patients and decreases the risk of relapse. We administer",
"      <a class=\"drug drug_general\" href=\"UTD.htm?4/3/4152?source=see_link\">",
"       vinblastine",
"      </a>",
"      plus",
"      <a class=\"drug drug_general\" href=\"UTD.htm?32/48/33536?source=see_link\">",
"       prednisolone",
"      </a>",
"      for a total treatment duration of 12 months. Daily",
"      <a class=\"drug drug_general\" href=\"UTD.htm?36/43/37559?source=see_link\">",
"       mercaptopurine",
"      </a>",
"      is added to continuation for patients with &ldquo;risk organ&rdquo; involvement. (See",
"      <a class=\"local\" href=\"#H932511\">",
"       'Continuation therapy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For patients with evident but incomplete response after six weeks of induction chemotherapy who did not have &ldquo;risk organ&rdquo; involvement at diagnosis, we suggest proceeding to continuation therapy rather than a second induction course (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). For patients with &ldquo;risk organ&rdquo; involvement at diagnosis, we suggest another six-week induction with",
"      <a class=\"drug drug_general\" href=\"UTD.htm?37/43/38585?source=see_link\">",
"       prednisone",
"      </a>",
"      only given for three days each week rather than proceeding with continuation (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H932497\">",
"       'Induction chemotherapy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For patients with stable disease who did not have &ldquo;risk organ&rdquo; involvement at diagnosis, we suggest another six-week induction with",
"      <a class=\"drug drug_general\" href=\"UTD.htm?37/43/38585?source=see_link\">",
"       prednisone",
"      </a>",
"      only given for three days each week rather than second-line treatment (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). For patients with &ldquo;risk organ&rdquo; involvement who have unresponsive disease after six weeks of induction, we suggest the use of second-line treatment rather than another six-week induction (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H932497\">",
"       'Induction chemotherapy'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H6873611\">",
"       'Relapsed or refractory disease'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      All patients with progressive disease at six weeks should be changed to a second-line therapy, regardless of &ldquo;risk organ&rdquo; status at the time of diagnosis. (See",
"      <a class=\"local\" href=\"#H6873611\">",
"       'Relapsed or refractory disease'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The general treatment principles described above apply to most disease presentations of LCH in children. However, involvement of certain organs (eg, central nervous system, lungs, or bones at risk of collapse) has unique therapeutic implications. Importantly, adults with LCH require special consideration because toxicity rates are unacceptably high when these patients are treated with regimens usually offered to children.",
"     </li>",
"     <li>",
"      Following the completion of therapy, patients must be seen periodically to monitor for disease recurrence and late effects. (See",
"      <a class=\"local\" href=\"#H6872130\">",
"       'Post-treatment surveillance'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Patients with relapsed or refractory LCH should be encouraged to enroll onto a clinical trial. Outside of a clinical trial, the treatment approach should be individualized based upon the patient&rsquo;s performance status, the timing of relapse, and the disease risk stratification. (See",
"      <a class=\"local\" href=\"#H6873611\">",
"       'Relapsed or refractory disease'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/45/28378/abstract/1\">",
"      Phillips M, Allen C, Gerson P, McClain K. Comparison of FDG-PET scans to conventional radiography and bone scans in management of Langerhans cell histiocytosis. Pediatr Blood Cancer 2009; 52:97.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/45/28378/abstract/2\">",
"      Prayer D, Grois N, Prosch H, et al. MR imaging presentation of intracranial disease associated with Langerhans cell histiocytosis. AJNR Am J Neuroradiol 2004; 25:880.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/45/28378/abstract/3\">",
"      Minkov M. Multisystem Langerhans cell histiocytosis in children: current treatment and future directions. Paediatr Drugs 2011; 13:75.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/45/28378/abstract/4\">",
"      Braier J, Latella A, Balancini B, et al. Outcome in children with pulmonary Langerhans cell Histiocytosis. Pediatr Blood Cancer 2004; 43:765.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/45/28378/abstract/5\">",
"      Odame I, Li P, Lau L, et al. Pulmonary Langerhans cell histiocytosis: a variable disease in childhood. Pediatr Blood Cancer 2006; 47:889.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/45/28378/abstract/6\">",
"      Ronceray L, P&ouml;tschger U, Janka G, et al. Pulmonary involvement in pediatric-onset multisystem Langerhans cell histiocytosis: effect on course and outcome. J Pediatr 2012; 161:129.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/45/28378/abstract/7\">",
"      Grois N, P&ouml;tschger U, Prosch H, et al. Risk factors for diabetes insipidus in langerhans cell histiocytosis. Pediatr Blood Cancer 2006; 46:228.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/45/28378/abstract/8\">",
"      Gadner H, Grois N, Arico M, et al. A randomized trial of treatment for multisystem Langerhans' cell histiocytosis. J Pediatr 2001; 138:728.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/45/28378/abstract/9\">",
"      Gadner H, Grois N, P&ouml;tschger U, et al. Improved outcome in multisystem Langerhans cell histiocytosis is associated with therapy intensification. Blood 2008; 111:2556.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/45/28378/abstract/10\">",
"      Nauert C, Zornoza J, Ayala A, Harle TS. Eosinophilic granuloma of bone: diagnosis and management. Skeletal Radiol 1983; 10:227.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/45/28378/abstract/11\">",
"      Minkov M, Prosch H, Steiner M, et al. Langerhans cell histiocytosis in neonates. Pediatr Blood Cancer 2005; 45:802.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/45/28378/abstract/12\">",
"      Lau L, Krafchik B, Trebo MM, Weitzman S. Cutaneous Langerhans cell histiocytosis in children under one year. Pediatr Blood Cancer 2006; 46:66.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/45/28378/abstract/13\">",
"      Hoeger PH, Nanduri VR, Harper JI, et al. Long term follow up of topical mustine treatment for cutaneous langerhans cell histiocytosis. Arch Dis Child 2000; 82:483.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/45/28378/abstract/14\">",
"      Steen AE, Steen KH, Bauer R, Bieber T. Successful treatment of cutaneous Langerhans cell histiocytosis with low-dose methotrexate. Br J Dermatol 2001; 145:137.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/45/28378/abstract/15\">",
"      McClain KL, Kozinetz CA. A phase II trial using thalidomide for Langerhans cell histiocytosis. Pediatr Blood Cancer 2007; 48:44.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/45/28378/abstract/16\">",
"      Lindahl LM, Fenger-Gr&oslash;n M, Iversen L. Topical nitrogen mustard therapy in patients with Langerhans cell histiocytosis. Br J Dermatol 2012; 166:642.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/45/28378/abstract/17\">",
"      Gadner H, Heitger A, Grois N, et al. Treatment strategy for disseminated Langerhans cell histiocytosis. DAL HX-83 Study Group. Med Pediatr Oncol 1994; 23:72.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/45/28378/abstract/18\">",
"      Morimoto A, Ikushima S, Kinugawa N, et al. Improved outcome in the treatment of pediatric multifocal Langerhans cell histiocytosis: Results from the Japan Langerhans Cell Histiocytosis Study Group-96 protocol study. Cancer 2006; 107:613.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/45/28378/abstract/19\">",
"      Calming U, Bemstrand C, Mosskin M, et al. Brain 18-FDG PET scan in central nervous system langerhans cell histiocytosis. J Pediatr 2002; 141:435.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/45/28378/abstract/20\">",
"      Dhall G, Finlay JL, Dunkel IJ, et al. Analysis of outcome for patients with mass lesions of the central nervous system due to Langerhans cell histiocytosis treated with 2-chlorodeoxyadenosine. Pediatr Blood Cancer 2008; 50:72.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/45/28378/abstract/21\">",
"      Allen CE, Flores R, Rauch R, et al. Neurodegenerative central nervous system Langerhans cell histiocytosis and coincident hydrocephalus treated with vincristine/cytosine arabinoside. Pediatr Blood Cancer 2010; 54:416.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/45/28378/abstract/22\">",
"      Kasper EM, Aguirre-Padilla DH, Alter RY, Anderson M. Histiocytosis X: Characteristics, behavior, and treatments as illustrated in a case series. Surg Neurol Int 2011; 2:57.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/45/28378/abstract/23\">",
"      B&uuml;chler T, Cervinek L, Belohlavek O, et al. Langerhans cell histiocytosis with central nervous system involvement: follow-up by FDG-PET during treatment with cladribine. Pediatr Blood Cancer 2005; 44:286.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/45/28378/abstract/24\">",
"      Idbaih A, Donadieu J, Barthez MA, et al. Retinoic acid therapy in \"degenerative-like\" neuro-langerhans cell histiocytosis: a prospective pilot study. Pediatr Blood Cancer 2004; 43:55.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/45/28378/abstract/25\">",
"      Imashuku S, Okazaki N', Nakayama M, et al. Treatment of neurodegenerative CNS disease in Langerhans cell histiocytosis with a combination of intravenous immunoglobulin and chemotherapy. Pediatr Blood Cancer 2008; 50:308.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/45/28378/abstract/26\">",
"      Kaltsas GA, Powles TB, Evanson J, et al. Hypothalamo-pituitary abnormalities in adult patients with langerhans cell histiocytosis: clinical, endocrinological, and radiological features and response to treatment. J Clin Endocrinol Metab 2000; 85:1370.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/45/28378/abstract/27\">",
"      Yasko AW, Fanning CV, Ayala AG, et al. Percutaneous techniques for the diagnosis and treatment of localized Langerhans-cell histiocytosis (eosinophilic granuloma of bone). J Bone Joint Surg Am 1998; 80:219.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/45/28378/abstract/28\">",
"      Willis B, Ablin A, Weinberg V, et al. Disease course and late sequelae of Langerhans' cell histiocytosis: 25-year experience at the University of California, San Francisco. J Clin Oncol 1996; 14:2073.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/45/28378/abstract/29\">",
"      Selch MT, Parker RG. Radiation therapy in the management of Langerhans cell histiocytosis. Med Pediatr Oncol 1990; 18:97.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/45/28378/abstract/30\">",
"      el-Sayed S, Brewin TB. Histiocytosis X: does radiotherapy still have a role? Clin Oncol (R Coll Radiol) 1992; 4:27.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/45/28378/abstract/31\">",
"      Greenberger JS, Cassady JR, Jaffe N, et al. Radiation therapy in patients with histiocytosis: management of diabetes insipidus and bone lesions. Int J Radiat Oncol Biol Phys 1979; 5:1749.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/45/28378/abstract/32\">",
"      Baumgartner I, von Hochstetter A, Baumert B, et al. Langerhans'-cell histiocytosis in adults. Med Pediatr Oncol 1997; 28:9.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/45/28378/abstract/33\">",
"      Malpas JS, Norton AJ. Langerhans cell histiocytosis in the adult. Med Pediatr Oncol 1996; 27:540.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/45/28378/abstract/34\">",
"      Howarth DM, Gilchrist GS, Mullan BP, et al. Langerhans cell histiocytosis: diagnosis, natural history, management, and outcome. Cancer 1999; 85:2278.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/45/28378/abstract/35\">",
"      Islinger RB, Kuklo TR, Owens BD, et al. Langerhans' cell histiocytosis in patients older than 21 years. Clin Orthop Relat Res 2000; :231.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/45/28378/abstract/36\">",
"      G&ouml;tz G, Fichter J. Langerhans'-cell histiocytosis in 58 adults. Eur J Med Res 2004; 9:510.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/45/28378/abstract/37\">",
"      Aric&ograve; M, Girschikofsky M, G&eacute;n&eacute;reau T, et al. Langerhans cell histiocytosis in adults. Report from the International Registry of the Histiocyte Society. Eur J Cancer 2003; 39:2341.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/45/28378/abstract/38\">",
"      Saven A, Figueroa ML, Piro LD, Rosenblatt JD. 2-Chlorodeoxyadenosine to treat refractory histiocytosis X. N Engl J Med 1993; 329:734.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/45/28378/abstract/39\">",
"      Saven A, Foon KA, Piro LD. 2-Chlorodeoxyadenosine-induced complete remissions in Langerhans-cell histiocytosis. Ann Intern Med 1994; 121:430.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/45/28378/abstract/40\">",
"      Arzoo K, Sadeghi S, Pullarkat V. Pamidronate for bone pain from osteolytic lesions in Langerhans'-cell histiocytosis. N Engl J Med 2001; 345:225.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/45/28378/abstract/41\">",
"      Farran RP, Zaretski E, Egeler RM. Treatment of Langerhans cell histiocytosis with pamidronate. J Pediatr Hematol Oncol 2001; 23:54.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/45/28378/abstract/42\">",
"      Sivendran S, Harvey H, Lipton A, Drabick J. Treatment of Langerhans cell histiocytosis bone lesions with zoledronic acid: a case series. Int J Hematol 2011; 93:782.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/45/28378/abstract/43\">",
"      Derenzini E, Fina MP, Stefoni V, et al. MACOP-B regimen in the treatment of adult Langerhans cell histiocytosis: experience on seven patients. Ann Oncol 2010; 21:1173.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/45/28378/abstract/44\">",
"      Montella L, Insabato L, Palmieri G. Imatinib mesylate for cerebral Langerhans'-cell histiocytosis. N Engl J Med 2004; 351:1034.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/45/28378/abstract/45\">",
"      Janku F, Amin HM, Yang D, et al. Response of histiocytoses to imatinib mesylate: fire to ashes. J Clin Oncol 2010; 28:e633.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/45/28378/abstract/46\">",
"      Wagner C, Mohme H, Kr&ouml;mer-Olbrisch T, et al. Langerhans cell histiocytosis: treatment failure with imatinib. Arch Dermatol 2009; 145:949.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/45/28378/abstract/47\">",
"      Atalar B, Miller RC, Dincbas FO, et al. Adult langerhans cell histiocytosis of bones : a rare cancer network study. Acta Orthop Belg 2010; 76:663.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/45/28378/abstract/48\">",
"      Cantu MA, Lupo PJ, Bilgi M, et al. Optimal therapy for adults with Langerhans cell histiocytosis bone lesions. PLoS One 2012; 7:e43257.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/45/28378/abstract/49\">",
"      Vassallo R, Ryu JH, Colby TV, et al. Pulmonary Langerhans'-cell histiocytosis. N Engl J Med 2000; 342:1969.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/45/28378/abstract/50\">",
"      Dauriat G, Mal H, Thabut G, et al. Lung transplantation for pulmonary langerhans' cell histiocytosis: a multicenter analysis. Transplantation 2006; 81:746.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/45/28378/abstract/51\">",
"      Wnorowski M, Prosch H, Prayer D, et al. Pattern and course of neurodegeneration in Langerhans cell histiocytosis. J Pediatr 2008; 153:127.",
"     </a>",
"    </li>",
"    <li>",
"     www.survivorshipguidelines.org (Accessed on May 19, 2011).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/45/28378/abstract/53\">",
"      Komp DM. Long-term sequelae of histiocytosis X. Am J Pediatr Hematol Oncol 1981; 3:163.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/45/28378/abstract/54\">",
"      Haupt R, Nanduri V, Calevo MG, et al. Permanent consequences in Langerhans cell histiocytosis patients: a pilot study from the Histiocyte Society-Late Effects Study Group. Pediatr Blood Cancer 2004; 42:438.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/45/28378/abstract/55\">",
"      Nanduri VR, Lillywhite L, Chapman C, et al. Cognitive outcome of long-term survivors of multisystem langerhans cell histiocytosis: a single-institution, cross-sectional study. J Clin Oncol 2003; 21:2961.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/45/28378/abstract/56\">",
"      Braier J, Ciocca M, Latella A, et al. Cholestasis, sclerosing cholangitis, and liver transplantation in Langerhans cell Histiocytosis. Med Pediatr Oncol 2002; 38:178.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/45/28378/abstract/57\">",
"      Donadieu J, Rolon MA, Pion I, et al. Incidence of growth hormone deficiency in pediatric-onset Langerhans cell histiocytosis: efficacy and safety of growth hormone treatment. J Clin Endocrinol Metab 2004; 89:604.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/45/28378/abstract/58\">",
"      Nanduri VR, Bareille P, Pritchard J, Stanhope R. Growth and endocrine disorders in multisystem Langerhans' cell histiocytosis. Clin Endocrinol (Oxf) 2000; 53:509.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/45/28378/abstract/59\">",
"      Egeler RM, Neglia JP, Puccetti DM, et al. Association of Langerhans cell histiocytosis with malignant neoplasms. Cancer 1993; 71:865.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/45/28378/abstract/60\">",
"      Egeler RM, Neglia JP, Aric&ograve; M, et al. The relation of Langerhans cell histiocytosis to acute leukemia, lymphomas, and other solid tumors. The LCH-Malignancy Study Group of the Histiocyte Society. Hematol Oncol Clin North Am 1998; 12:369.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/45/28378/abstract/61\">",
"      Minkov M, Steiner M, P&ouml;tschger U, et al. Reactivations in multisystem Langerhans cell histiocytosis: data of the international LCH registry. J Pediatr 2008; 153:700.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/45/28378/abstract/62\">",
"      Weitzman S, Braier J, Donadieu J, et al. 2'-Chlorodeoxyadenosine (2-CdA) as salvage therapy for Langerhans cell histiocytosis (LCH). results of the LCH-S-98 protocol of the Histiocyte Society. Pediatr Blood Cancer 2009; 53:1271.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/45/28378/abstract/63\">",
"      Stine KC, Saylors RL, Saccente S, et al. Efficacy of continuous infusion 2-CDA (cladribine) in pediatric patients with Langerhans cell histiocytosis. Pediatr Blood Cancer 2004; 43:81.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/45/28378/abstract/64\">",
"      Bernard F, Thomas C, Bertrand Y, et al. Multi-centre pilot study of 2-chlorodeoxyadenosine and cytosine arabinoside combined chemotherapy in refractory Langerhans cell histiocytosis with haematological dysfunction. Eur J Cancer 2005; 41:2682.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/45/28378/abstract/65\">",
"      Apollonsky N, Lipton JM. Treatment of refractory Langerhans cell histiocytosis (LCH) with a combination of 2-chlorodeoxyadenosine and cytosine arabinoside. J Pediatr Hematol Oncol 2009; 31:53.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/45/28378/abstract/66\">",
"      Imamura T, Sato T, Shiota Y, et al. Outcome of pediatric patients with Langerhans cell histiocytosis treated with 2 chlorodeoxyadenosine: a nationwide survey in Japan. Int J Hematol 2010; 91:646.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/45/28378/abstract/67\">",
"      Rodriguez-Galindo C, Jeng M, Khuu P, et al. Clofarabine in refractory Langerhans cell histiocytosis. Pediatr Blood Cancer 2008; 51:703.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/45/28378/abstract/68\">",
"      Egeler RM, de Kraker J, Vo&ucirc;te PA. Cytosine-arabinoside, vincristine, and prednisolone in the treatment of children with disseminated Langerhans cell histiocytosis with organ dysfunction: experience at a single institution. Med Pediatr Oncol 1993; 21:265.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/45/28378/abstract/69\">",
"      Morimoto A, Shioda Y, Imamura T, et al. Nationwide survey of bisphosphonate therapy for children with reactivated Langerhans cell histiocytosis in Japan. Pediatr Blood Cancer 2011; 56:110.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/45/28378/abstract/70\">",
"      Haroche J, Cohen-Aubart F, Emile JF, et al. Dramatic efficacy of vemurafenib in both multisystemic and refractory Erdheim-Chester disease and Langerhans cell histiocytosis harboring the BRAF V600E mutation. Blood 2013; 121:1495.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/45/28378/abstract/71\">",
"      Akkari V, Donadieu J, Piguet C, et al. Hematopoietic stem cell transplantation in patients with severe Langerhans cell histiocytosis and hematological dysfunction: experience of the French Langerhans Cell Study Group. Bone Marrow Transplant 2003; 31:1097.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/45/28378/abstract/72\">",
"      Kudo K, Ohga S, Morimoto A, et al. Improved outcome of refractory Langerhans cell histiocytosis in children with hematopoietic stem cell transplantation in Japan. Bone Marrow Transplant 2010; 45:901.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/45/28378/abstract/73\">",
"      Steiner M, Matthes-Martin S, Attarbaschi A, et al. Improved outcome of treatment-resistant high-risk Langerhans cell histiocytosis after allogeneic stem cell transplantation with reduced-intensity conditioning. Bone Marrow Transplant 2005; 36:215.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/45/28378/abstract/74\">",
"      Nagarajan R, Neglia J, Ramsay N, Baker KS. Successful treatment of refractory Langerhans cell histiocytosis with unrelated cord blood transplantation. J Pediatr Hematol Oncol 2001; 23:629.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/45/28378/abstract/75\">",
"      Suminoe A, Matsuzaki A, Hattori H, et al. Unrelated cord blood transplantation for an infant with chemotherapy-resistant progressive Langerhans cell histiocytosis. J Pediatr Hematol Oncol 2001; 23:633.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/45/28378/abstract/76\">",
"      Minkov M, Grois N, Broadbent V, et al. Cyclosporine A therapy for multisystem langerhans cell histiocytosis. Med Pediatr Oncol 1999; 33:482.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/45/28378/abstract/77\">",
"      Lukina EA, Kuznetsov VP, Beliaev DL, et al. [The treatment of histiocytosis X (Langerhans-cell histiocytosis) with alpha-interferon preparations]. Ter Arkh 1993; 65:67.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 16627 Version 5.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0603-89.32.226.102-73EC6B31EE-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f27_45_28378=[""].join("\n");
var outline_f27_45_28378=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H368766288\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H42642367\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H452652744\">",
"      PRETREATMENT EVALUATION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H42641518\">",
"      INITIAL TREATMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H42641525\">",
"      Risk stratification",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6814315\">",
"      - Single system disease",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H42641532\">",
"      - Multisystem disease",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H932497\">",
"      Induction chemotherapy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H932504\">",
"      Response evaluation and selection of subsequent management",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H932511\">",
"      Continuation therapy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6872190\">",
"      Special populations",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H42641546\">",
"      - Central nervous system LCH",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6872801\">",
"      - Bone lesions at risk of collapse",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6872370\">",
"      - Adults",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H3864598\">",
"      - Lung involvement",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6872130\">",
"      POST-TREATMENT SURVEILLANCE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6872159\">",
"      Monitoring for recurrence",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3867557\">",
"      Late effects",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H3867891\">",
"      - Endocrine abnormalities",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H3867564\">",
"      - Malignancy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3867571\">",
"      Long-term follow-up",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6873611\">",
"      RELAPSED OR REFRACTORY DISEASE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6873633\">",
"      Hematopoietic cell transplantation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6873640\">",
"      Treatments not considered effective",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H452650173\">",
"      CLINICAL TRIALS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H368766288\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"HEME/16627\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"HEME/16627|ALG\">",
"      <a href=\"#\" title=\"ALGORITHMS\">",
"       ALGORITHMS",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_algorithm\" href=\"UTD.htm?23/1/23568\" title=\"algorithm 1\">",
"      Management LCH in children",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/39/31348?source=related_link\">",
"      Clinical manifestations of hypopituitarism",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/53/21338?source=related_link\">",
"      Clinical manifestations, pathologic features, and diagnosis of Langerhans cell histiocytosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/28/41413?source=related_link\">",
"      Diagnosis of hypopituitarism",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/47/24312?source=related_link\">",
"      Diagnosis of polyuria and diabetes insipidus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/31/34297?source=related_link\">",
"      Indications and contraindications for cardiac transplantation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/50/32551?source=related_link\">",
"      Langerhans cell histiocytosis (eosinophilic granuloma) of bone in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/20/26953?source=related_link\">",
"      Lung transplantation: General guidelines for recipient selection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/30/19944?source=related_link\">",
"      Molecularly targeted therapy for metastatic melanoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/32/43530?source=related_link\">",
"      Neurologic complications of non-platinum cancer chemotherapy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/48/35592?source=related_link\">",
"      Pulmonary Langerhans cell histiocytosis",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f27_45_28379="Hysterectomy outcome";
var content_f27_45_28379=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F55870&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=11\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F55870&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=11\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Frequency of common, severe symptoms before and after hysterectomy",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Symptom",
"       </td>",
"       <td class=\"subtitle1\">",
"        Frequency before, percent",
"       </td>",
"       <td class=\"subtitle1\">",
"        Frequency after, percent",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Vaginal bleeding",
"       </td>",
"       <td>",
"        59",
"       </td>",
"       <td>",
"        &lt;1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Pelvic pain",
"       </td>",
"       <td>",
"        63",
"       </td>",
"       <td>",
"        8",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Back pain",
"       </td>",
"       <td>",
"        43",
"       </td>",
"       <td>",
"        17",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Activity limitation",
"       </td>",
"       <td>",
"        58",
"       </td>",
"       <td>",
"        2",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Sleep disturbance",
"       </td>",
"       <td>",
"        41",
"       </td>",
"       <td>",
"        21",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Fatigue",
"       </td>",
"       <td>",
"        70",
"       </td>",
"       <td>",
"        25",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Abdominal bloating",
"       </td>",
"       <td>",
"        48",
"       </td>",
"       <td>",
"        12",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Urinary incontinence",
"       </td>",
"       <td>",
"        20",
"       </td>",
"       <td>",
"        8",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Adapted from data in Kjerulff, KH, Langenberg, PW, Rhodes, JS, et al. Obstet Gynecol 2000; 95:319.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f27_45_28379=[""].join("\n");
var outline_f27_45_28379=null;
var title_f27_45_28380="Likelihood ratios preop tests";
var content_f27_45_28380=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F75939&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F75939&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Value of preoperative tests in influencing preoperative management and predicting postoperative complications in adults",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tr>",
"      <td class=\"subtitle1\">",
"       Test",
"      </td>",
"      <td class=\"subtitle1\">",
"       Incidence of abnormalities that influence management, percent",
"      </td>",
"      <td class=\"subtitle1\">",
"       Positive likelihood ratio of postoperative complication, LR+",
"      </td>",
"      <td class=\"subtitle1\">",
"       Negative likelihood ratio of postoperative complication, LR-",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Hemoglobin",
"      </td>",
"      <td>",
"       0.1",
"      </td>",
"      <td>",
"       3.3",
"      </td>",
"      <td>",
"       0.90",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       White blood cell count",
"      </td>",
"      <td>",
"       0.0",
"      </td>",
"      <td>",
"       0.0",
"      </td>",
"      <td>",
"       1.00",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Platelet count",
"      </td>",
"      <td>",
"       0.0",
"      </td>",
"      <td>",
"       0.0",
"      </td>",
"      <td>",
"       1.00",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Prothrombin time (PT)",
"      </td>",
"      <td>",
"       0.0",
"      </td>",
"      <td>",
"       0.0",
"      </td>",
"      <td>",
"       1.01",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Partial thromboplastin time (PTT)",
"      </td>",
"      <td>",
"       0.1",
"      </td>",
"      <td>",
"       1.7",
"      </td>",
"      <td>",
"       0.86",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Electrolytes",
"      </td>",
"      <td>",
"       1.8",
"      </td>",
"      <td>",
"       4.3*",
"      </td>",
"      <td>",
"       0.80",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Renal function",
"      </td>",
"      <td>",
"       2.6",
"      </td>",
"      <td>",
"       3.3",
"      </td>",
"      <td>",
"       0.81",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Glucose",
"      </td>",
"      <td>",
"       0.5",
"      </td>",
"      <td>",
"       1.6",
"      </td>",
"      <td>",
"       0.85",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Liver function tests",
"      </td>",
"      <td>",
"       0.1",
"      </td>",
"      <td>",
"       NA**",
"      </td>",
"      <td>",
"       NA**",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Urinalysis",
"      </td>",
"      <td>",
"       1.4",
"      </td>",
"      <td>",
"       1.7",
"      </td>",
"      <td>",
"       0.97",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Electrocardiogram",
"      </td>",
"      <td>",
"       2.6",
"      </td>",
"      <td>",
"       1.6",
"      </td>",
"      <td>",
"       0.96",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Chest radiograph",
"      </td>",
"      <td>",
"       3.0",
"      </td>",
"      <td>",
"       2.5",
"      </td>",
"      <td>",
"       0.72",
"      </td>",
"     </tr>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    *Although the LR+ value is higher for electrolytes than for other preoperative tests, most of these patients could have been selectively identified as candidates for testing based on clinical criteria. The authors therefore do not recommend routine measurement of preoperative electrolytes.",
"    <br>",
"     **NA = Not available; no studies have reported the incidence of adverse events in a cohort of healthy patients with normal or abnormal liver function tests.",
"     <div class=\"footnotes\">",
"     </div>",
"     <div class=\"reference\">",
"      Reproduced with permission from Smetana, GW, Macpherson, DS. The case against routine preoperative laboratory testing. Med Clin North Am 2003; 87:7. Copyright &copy; 2003 Elsevier Science.",
"     </div>",
"    </br>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f27_45_28380=[""].join("\n");
var outline_f27_45_28380=null;
var title_f27_45_28381="Adherence to asthma meds";
var content_f27_45_28381=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F62344&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F62344&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Compliance with medication regimens in asthma",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 340px; height: 266px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Adherence to inhaled glucocorticoids, slow-release theophylline, and cromolyn among 14 adolescents in an HMO. Adherence was determined by dividing the amount of medication used (based on refill rates obtained from pharmacy reimbursement-claims data) by the expected amount (based on the prescribed doses recorded in the patients' charts). Adherence with the inhaled-drug regimens was particularly low among adolescents.",
"    <div class=\"footnotes\">",
"     HMO: health maintenance organization.",
"    </div>",
"    <div class=\"reference\">",
"     Data from: Kelloway JS, Wyatt RA, Adlis SA. Arch Intern Med 1994; 154:1349.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f27_45_28381=[""].join("\n");
var outline_f27_45_28381=null;
var title_f27_45_28382="Clinical manifestations RMSF";
var content_f27_45_28382=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F52138&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F52138&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 571px\">",
"   <div class=\"ttl\">",
"    Age-specific incidence of Rocky Mountain spotted fever (RMSF)* and case-fatality ratio, by age group - United States, 1990-1998&bull;",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 551px; height: 320px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     * Per million population.",
"     <br>",
"      &bull; Incidence rates were calculated using data from the National Electronic Telecommunications System for Surveillance and from 1990 - 1998 U.S. Bureau of the Census data. Case-fatality ratios were calculated from the laboratory-confirmed cases of RMSF reported to CDC through RMSF case report forms.",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"     Consequences of Delayed Diagnosis of Rocky Mountain Spotted Fever in Children - West Virginia, Michigan, Tennessee, and Oklahoma, May -July 2000. MMWR Morb Mortal Wkly Rep 2000; 49(39):885. file://www.cdc.gov/mmwr/preview/mmwrhtml/mm4839a2.htm.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f27_45_28382=[""].join("\n");
var outline_f27_45_28382=null;
var title_f27_45_28383="Postirradiation morphea";
var content_f27_45_28383=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F67509&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F67509&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Postirradiation morphea on the breast",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 324px; height: 300px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Morpheaform changes occurred after breast reconstruction and radiation therapy in this patient with a history of breast cancer.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f27_45_28383=[""].join("\n");
var outline_f27_45_28383=null;
